1	OOOOOOOOOOOO	NNP	O	OOOOOOOOOOOO	nn	2	SENT_1	[p1l926t81r1191b100],
2	CE	NNP	O	CE	_	0	SENT_1	[p1l1195t81r1233b100],

1	will	MD	O	will	aux	2	SENT_2	[p1l6t294r170b374],
2	have	VB	O	have	_	0	SENT_2	[p1l202t294r391b373],
3	only	RB	O	only	quantmod	4	SENT_2	[p1l425t294r609b395],
4	one	CD	NUMBER	one	num	6	SENT_2	[p1l637t320r788b373],
5	risk	NN	O	risk	nn	6	SENT_2	[p1l820t294r984b374],
6	factor	NN	O	factor	dobj	2	SENT_2	[p1l1012t294r1280b373],
7	.	.	O	.	_	0	SENT_2	[p1l1012t294r1280b373],

1	On	IN	O	on	_	0	SENT_3	[p1l1317t300r1444b373],
2	the	DT	O	the	det	3	SENT_3	[p1l1477t294r1609b373],
3	basis	NN	O	basis	prep_on	23	SENT_3	[p1l1643t294r1854b373],
4	of	IN	O	of	_	0	SENT_3	[p1l1888t294r1989b373],
5	the	DT	O	the	det	9	SENT_3	[p1l2003t294r2135b373],
6	hypothetical	JJ	O	hypothetical	amod	9	SENT_3	[p1l10t422r549b523],
7	mean	NN	O	mean	nn	9	SENT_3	[p1l589t448r826b501],
8	lifetime	NN	O	lifetime	nn	9	SENT_3	[p1l865t422r1201b501],
9	risk	NN	O	risk	prep_of	3	SENT_3	[p1l1241t422r1405b502],
10	of	IN	O	of	_	0	SENT_3	[p1l1442t422r1542b501],
11	prostate	NN	O	prostate	nn	12	SENT_3	[p1l1562t439r1912b523],
12	cancer	NN	O	cancer	prep_of	9	SENT_3	[p1l1954t448r2134b501, p1l11t576r138b629],
13	of	IN	O	of	_	0	SENT_3	[p1l171t550r271b629],
14	10	CD	PERCENT	10	num	15	SENT_3	[p1l292t555r497b646],
15	%	NN	PERCENT	%	prep_of	12	SENT_3	[p1l292t555r497b646],
16	,	,	O	,	_	0	SENT_3	[p1l292t555r497b646],
17	men	NNS	O	man	nsubj	23	SENT_3	[p1l539t576r725b629],
18	with	IN	O	with	_	0	SENT_3	[p1l756t550r952b630],
19	no	DT	O	no	det	21	SENT_3	[p1l988t576r1093b629],
20	risk	NN	O	risk	nn	21	SENT_3	[p1l1131t550r1294b630],
21	factors	NNS	O	factor	prep_with	17	SENT_3	[p1l1326t550r1616b629],
22	might	MD	O	might	aux	23	SENT_3	[p1l1654t550r1915b651],
23	have	VB	O	have	_	0	SENT_3	[p1l1946t550r2135b629],
24	less	JJR	O	less	dobj	23	SENT_3	[p1l9t678r165b757],
25	than	IN	O	than	_	0	SENT_3	[p1l208t678r405b757],
26	a	DT	O	a	det	30	SENT_3	[p1l445t705r489b757],
27	4	CD	PERCENT	4	number	28	SENT_3	[p1l527t684r661b757],
28	%	NN	PERCENT	%	amod	30	SENT_3	[p1l527t684r661b757],
29	lifelong	JJ	O	lifelong	amod	30	SENT_3	[p1l700t678r1032b779],
30	risk	NN	O	risk	prep_than	24	SENT_3	[p1l1069t678r1252b774],
31	,	,	O	,	_	0	SENT_3	[p1l1069t678r1252b774],
32	and	CC	O	and	_	0	SENT_3	[p1l1298t678r1456b757],
33	men	NNS	O	man	conj_and	30	SENT_3	[p1l1497t704r1683b757],
34	with	IN	O	with	_	0	SENT_3	[p1l1719t678r1914b758],
35	only	RB	O	only	quantmod	36	SENT_3	[p1l1956t678r2140b779],
36	one	CD	NUMBER	one	num	38	SENT_3	[p1l11t832r162b885],
37	risk	NN	O	risk	nn	38	SENT_3	[p1l205t806r369b886],
38	factor	NN	O	factor	npadvmod	39	SENT_3	[p1l407t806r658b885],
39	less	JJR	O	less	prep_with	33	SENT_3	[p1l697t806r852b885],
40	than	IN	O	than	_	0	SENT_3	[p1l897t806r1094b885],
41	a	DT	O	a	det	45	SENT_3	[p1l1136t833r1180b885],
42	6	CD	PERCENT	6	number	43	SENT_3	[p1l1222t811r1354b885],
43	%	NN	PERCENT	%	amod	45	SENT_3	[p1l1222t811r1354b885],
44	lifelong	JJ	O	lifelong	amod	45	SENT_3	[p1l1395t806r1727b907],
45	risk	NN	O	risk	prep_than	23	SENT_3	[p1l1767t806r1949b885],
46	.	.	O	.	_	0	SENT_3	[p1l1767t806r1949b885],

1	For	IN	O	for	_	0	SENT_4	[p1l1995t814r2139b885],
2	these	DT	O	these	det	3	SENT_4	[p1l11t934r234b1013],
3	subgroups	NNS	O	subgroup	prep_for	17	SENT_4	[p1l267t934r739b1035],
4	,	,	O	,	_	0	SENT_4	[p1l267t934r739b1035],
5	the	DT	O	the	det	6	SENT_4	[p1l776t934r909b1013],
6	benefit	NN	O	benefit	nsubj	17	SENT_4	[p1l941t934r1246b1013],
7	of	IN	O	of	_	0	SENT_4	[p1l1273t934r1373b1013],
8	screening	NN	O	screening	prep_of	6	SENT_4	[p1l1387t935r1804b1035],
9	in	IN	O	in	_	0	SENT_4	[p1l1832t935r1915b1012],
10	relation	NN	O	relation	prep_in	8	SENT_4	[p1l1946t934r2134b1013, p1l11t1063r180b1141],
11	to	TO	O	to	_	0	SENT_4	[p1l210t1079r292b1141],
12	the	DT	O	the	det	13	SENT_4	[p1l324t1062r457b1141],
13	risk	NN	O	risk	prep_to	10	SENT_4	[p1l486t1062r651b1142],
14	is	VBZ	O	be	cop	17	SENT_4	[p1l676t1063r741b1141],
15	even	RB	O	even	advmod	17	SENT_4	[p1l774t1088r963b1141],
16	more	RBR	O	more	advmod	17	SENT_4	[p1l993t1088r1213b1141],
17	doubtful	JJ	O	doubtful	_	0	SENT_4	[p1l1244t1062r1616b1141],
18	than	IN	O	than	mark	20	SENT_4	[p1l1645t1062r1843b1141],
19	it	PRP	O	it	nsubj	20	SENT_4	[p1l1871t1063r1931b1141],
20	is	VBZ	O	be	advcl	17	SENT_4	[p1l1955t1063r2021b1141],
21	in	IN	O	in	_	0	SENT_4	[p1l2052t1063r2136b1140],
22	the	DT	O	the	det	24	SENT_4	[p1l11t1190r143b1269],
23	general	JJ	O	general	amod	24	SENT_4	[p1l178t1190r495b1291],
24	population	NN	O	population	prep_in	20	SENT_4	[p1l528t1190r1023b1291],
25	.	.	O	.	_	0	SENT_4	[p1l528t1190r1023b1291],

1	Francois	NNP	PERSON	Francois	nn	2	SENT_5	[p1l19t1335r382b1432],
2	Eisinger	NNP	PERSON	Eisinger	_	0	SENT_5	[p1l426t1335r792b1433],
3	,	,	O	,	_	0	SENT_5	[p1l426t1335r792b1433],
4	M.D.	NNP	O	M.D.	nn	6	SENT_5	[p1l837t1335r1069b1422],
5	,	,	O	,	_	0	SENT_5	[p1l837t1335r1069b1422],
6	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_5	[p1l1114t1327r1343b1407],
7	.	.	O	.	_	0	SENT_5	[p1l1114t1327r1343b1407],

1	Institut	NNP	O	Institut	nn	4	SENT_6	[p1l15t1492r254b1548],
2	Paoli-Calmettes	NNP	O	Paoli-Calmettes	nn	4	SENT_6	[p1l282t1487r812b1548],
3	13009	CD	NUMBER	13009	num	4	SENT_6	[p1l15t1575r213b1632],
4	Marseille	NNP	LOCATION	Marseille	_	0	SENT_6	[p1l243t1571r564b1642],
5	,	,	O	,	_	0	SENT_6	[p1l243t1571r564b1642],
6	France	NNP	LOCATION	France	appos	4	SENT_6	[p1l596t1576r813b1631],
7	eisinger@marsei	FW	O	eisinger@marsei	nn	10	SENT_6	[p1l10t1656r997b1737],
8	|	FW	O	|	nn	10	SENT_6	[p1l10t1656r997b1737],
9	|	FW	O	|	nn	10	SENT_6	[p1l10t1656r997b1737],
10	e.	FW	O	e.	dep	6	SENT_6	[p1l10t1656r997b1737],
11	inserm	NN	O	inserm	dep	6	SENT_6	[p1l10t1656r997b1737],
12	.	.	O	.	_	0	SENT_6	[p1l10t1656r997b1737],

1	fr	NN	O	fr	_	0	SENT_7	[p1l10t1656r997b1737],

1	THE	DT	O	the	det	3	SENT_8	[p1l8t1921r172b1975],
2	AUTHORS	NNS	O	author	nn	3	SENT_8	[p1l215t1920r623b1975],
3	REPLY	NN	O	reply	nsubjpass	35	SENT_8	[p1l673t1921r938b1976],
4	:	:	O	:	_	0	SENT_8	[p1l673t1921r938b1976],
5	Our	PRP$	O	we	poss	6	SENT_8	[p1l988t1903r1155b1976],
6	finding	NN	O	finding	dep	3	SENT_8	[p1l1198t1897r1523b1998],
7	of	IN	O	of	_	0	SENT_8	[p1l1567t1897r1667b1976],
8	a	DT	O	a	det	10	SENT_8	[p1l1694t1924r1739b1976],
9	cumulative	JJ	O	cumulative	amod	10	SENT_8	[p1l1785t1897r2134b1976, p1l11t2026r157b2104],
10	effect	NN	O	effect	prep_of	6	SENT_8	[p1l192t2025r434b2104],
11	of	IN	O	of	_	0	SENT_8	[p1l463t2025r563b2104],
12	five	CD	NUMBER	five	num	14	SENT_8	[p1l578t2025r731b2104],
13	genetic	JJ	O	genetic	amod	14	SENT_8	[p1l764t2026r1073b2126],
14	variants	NNS	O	variant	prep_of	10	SENT_8	[p1l1101t2026r1445b2104],
15	and	CC	O	and	_	0	SENT_8	[p1l1480t2025r1638b2104],
16	family	NN	O	family	nn	17	SENT_8	[p1l1671t2025r1946b2126],
17	history	NN	O	history	nsubjpass	35	SENT_8	[p1l1975t2025r2134b2104, p1l11t2170r180b2254],
18	on	IN	O	on	_	0	SENT_8	[p1l205t2179r310b2232],
19	the	DT	O	the	det	20	SENT_8	[p1l338t2153r469b2232],
20	risk	NN	O	risk	prep_on	17	SENT_8	[p1l497t2153r658b2233],
21	of	IN	O	of	_	0	SENT_8	[p1l683t2153r782b2232],
22	prostate	NN	O	prostate	nn	23	SENT_8	[p1l790t2170r1133b2254],
23	cancer	NN	O	cancer	prep_of	20	SENT_8	[p1l1162t2179r1438b2232],
24	in	IN	O	in	_	0	SENT_8	[p1l1463t2154r1545b2231],
25	a	DT	O	a	det	30	SENT_8	[p1l1573t2180r1617b2232],
26	populationbased	JJ	O	populationbased	amod	30	SENT_8	[p1l1643t2153r2135b2254, p1l11t2281r255b2360],
27	case	NN	O	case	nn	30	SENT_8	[p1l289t2281r839b2360],
28	—	CD	NUMBER	—	num	30	SENT_8	[p1l289t2281r839b2360],
29	control	NN	O	control	nn	30	SENT_8	[p1l289t2281r839b2360],
30	study	NN	O	study	prep_in	23	SENT_8	[p1l873t2281r1103b2382],
31	in	IN	O	in	_	0	SENT_8	[p1l1131t2282r1214b2359],
32	Sweden	NNP	LOCATION	Sweden	prep_in	30	SENT_8	[p1l1250t2281r1573b2360],
33	was	VBD	O	be	auxpass	35	SENT_8	[p1l1602t2308r1765b2360],
34	recently	RB	DATE	recently	advmod	35	SENT_8	[p1l1800t2281r2140b2382],
35	confirmed	VBN	O	confirm	_	0	SENT_8	[p1l11t2409r465b2488],
36	in	IN	O	in	_	0	SENT_8	[p1l501t2410r584b2487],
37	two	CD	NUMBER	two	num	39	SENT_8	[p1l621t2426r779b2488],
38	U.S.	NNP	LOCATION	U.S.	nn	39	SENT_8	[p1l816t2415r984b2488],
39	populations	NNS	O	population	prep_in	35	SENT_8	[p1l1025t2409r1603b2510],
40	}	CD	NUMBER	}	tmod	35	SENT_8	[p1l1025t2409r1603b2510],
41	The	DT	O	the	det	43	SENT_8	[p1l1636t2409r1797b2488],
42	consistent	JJ	O	consistent	amod	43	SENT_8	[p1l1835t2410r2134b2488, p1l11t2554r174b2616],
43	fmding	NN	O	fmding	nsubj	66	SENT_8	[p1l200t2537r518b2638],
44	of	IN	O	of	_	0	SENT_8	[p1l546t2537r644b2616],
45	a	DT	O	a	det	48	SENT_8	[p1l656t2564r700b2616],
46	strong	JJ	O	strong	amod	48	SENT_8	[p1l730t2554r1002b2638],
47	cumulative	JJ	O	cumulative	amod	48	SENT_8	[p1l1030t2537r1490b2616],
48	effect	NN	O	effect	prep_of	43	SENT_8	[p1l1522t2537r1759b2616],
49	on	IN	O	on	_	0	SENT_8	[p1l1785t2563r1889b2616],
50	prostate	NN	O	prostate	nn	53	SENT_8	[p1l1918t2563r2134b2638, p1l11t2682r485b2744],
51	—	NN	O	—	nn	53	SENT_8	[p1l1918t2563r2134b2638, p1l11t2682r485b2744],
52	cancer	NN	O	cancer	nn	53	SENT_8	[p1l1918t2563r2134b2638, p1l11t2682r485b2744],
53	risk	NN	O	risk	prep_on	48	SENT_8	[p1l531t2665r714b2761],
54	,	,	O	,	_	0	SENT_8	[p1l531t2665r714b2761],
55	together	RB	O	together	rcmod	43	SENT_8	[p1l769t2665r1132b2766],
56	with	IN	O	with	dep	55	SENT_8	[p1l1174t2665r1369b2745],
57	a	DT	O	a	det	60	SENT_8	[p1l1418t2692r1462b2744],
58	relatively	RB	O	relatively	advmod	59	SENT_8	[p1l1510t2665r1896b2766],
59	high	JJ	O	high	amod	60	SENT_8	[p1l1941t2665r2135b2766],
60	frequency	NN	O	frequency	pobj	56	SENT_8	[p1l10t2793r434b2894],
61	in	IN	O	in	_	0	SENT_8	[p1l474t2794r558b2871],
62	the	DT	O	the	det	64	SENT_8	[p1l603t2793r736b2872],
63	general	JJ	O	general	amod	64	SENT_8	[p1l781t2793r1099b2894],
64	population	NN	O	population	prep_in	60	SENT_8	[p1l1142t2793r1636b2894],
65	,	,	O	,	_	0	SENT_8	[p1l1142t2793r1636b2894],
66	calls	VBZ	O	call	rcmod	40	SENT_8	[p1l1688t2793r1881b2872],
67	for	IN	O	for	_	0	SENT_8	[p1l1928t2793r2051b2872],
68	a	DT	O	a	det	70	SENT_8	[p1l2093t2820r2138b2872],
69	new	JJ	O	new	amod	70	SENT_8	[p1l10t2947r188b3001],
70	perspective	NN	O	perspective	prep_for	66	SENT_8	[p1l222t2922r705b3022],
71	in	IN	O	in	_	0	SENT_8	[p1l744t2922r828b2999],
72	the	DT	O	the	det	73	SENT_8	[p1l866t2921r1000b3000],
73	interpretation	NN	O	interpretation	prep_in	70	SENT_8	[p1l1038t2922r1638b3022],
74	and	CC	O	and	_	0	SENT_8	[p1l1676t2921r1834b3000],
75	use	NN	O	use	prep_in	70	SENT_8	[p1l1874t2948r2014b3000],
76	of	IN	O	of	_	0	SENT_8	[p1l2054t2921r2153b3000],
77	genetic	JJ	O	genetic	amod	78	SENT_8	[p1l10t3050r319b3150],
78	information	NN	O	information	prep_of	73	SENT_8	[p1l352t3049r899b3128],
79	.	.	O	.	_	0	SENT_8	[p1l352t3049r899b3128],

1	Until	IN	O	until	mark	12	SENT_9	[p1l139t3177r355b3256],
2	a	DT	O	a	det	4	SENT_9	[p1l390t3204r434b3256],
3	perfect	JJ	O	perfect	amod	4	SENT_9	[p1l467t3177r770b3278],
4	biomarker	NN	O	biomarker	nsubj	12	SENT_9	[p1l801t3177r1248b3257],
5	for	IN	O	for	_	0	SENT_9	[p1l1281t3177r1404b3256],
6	predicting	VBG	O	predict	prepc_for	4	SENT_9	[p1l1435t3177r1883b3278],
7	prostate	NN	O	prostate	nn	10	SENT_9	[p1l1914t3203r2134b3278, p1l11t3322r490b3384],
8	—	NN	O	—	nn	10	SENT_9	[p1l1914t3203r2134b3278, p1l11t3322r490b3384],
9	cancer	NN	O	cancer	nn	10	SENT_9	[p1l1914t3203r2134b3278, p1l11t3322r490b3384],
10	risk	NN	O	risk	dobj	6	SENT_9	[p1l538t3305r702b3385],
11	is	VBZ	O	be	cop	12	SENT_9	[p1l749t3306r815b3384],
12	available	JJ	O	available	advcl	15	SENT_9	[p1l867t3305r1262b3401],
13	,	,	O	,	_	0	SENT_9	[p1l867t3305r1262b3401],
14	there	EX	O	there	expl	15	SENT_9	[p1l1320t3305r1536b3384],
15	is	VBZ	O	be	_	0	SENT_9	[p1l1587t3306r1653b3384],
16	a	DT	O	a	det	17	SENT_9	[p1l1706t3332r1750b3384],
17	need	NN	O	need	nsubj	15	SENT_9	[p1l1799t3305r2001b3384],
18	to	TO	O	to	aux	19	SENT_9	[p1l2052t3322r2134b3384],
19	search	VB	O	search	infmod	17	SENT_9	[p1l12t3434r288b3513],
20	for	IN	O	for	_	0	SENT_9	[p1l342t3434r465b3513],
21	biomarkers	NNS	O	biomarker	prep_for	19	SENT_9	[p1l516t3434r1002b3513],
22	that	WDT	O	that	nsubj	26	SENT_9	[p1l1060t3434r1232b3513],
23	individually	RB	O	individually	advmod	26	SENT_9	[p1l1281t3434r1790b3535],
24	or	CC	O	or	_	0	SENT_9	[p1l1840t3460r1929b3513],
25	collectively	RB	O	collectively	conj_or	23	SENT_9	[p1l1981t3434r2134b3513, p1l9t3562r355b3663],
26	offer	VBP	O	offer	rcmod	21	SENT_9	[p1l383t3562r589b3641],
27	some	DT	O	some	det	28	SENT_9	[p1l620t3588r843b3641],
28	utility	NN	O	utility	dobj	26	SENT_9	[p1l875t3562r1134b3663],
29	for	IN	O	for	_	0	SENT_9	[p1l1161t3562r1284b3641],
30	risk	NN	O	risk	nn	31	SENT_9	[p1l1313t3562r1477b3642],
31	prediction	NN	O	prediction	prep_for	28	SENT_9	[p1l1503t3562r1968b3663],
32	.	.	O	.	_	0	SENT_9	[p1l1503t3562r1968b3663],

1	We	PRP	O	we	nsubj	2	SENT_10	[p1l2002t3570r2135b3641],
2	emphasize	VBP	O	emphasize	_	0	SENT_10	[p1l11t3690r469b3791],
3	that	IN	O	that	complm	6	SENT_10	[p1l514t3690r687b3769],
4	our	PRP$	O	we	poss	5	SENT_10	[p1l727t3716r873b3769],
5	approach	NN	O	approach	nsubj	6	SENT_10	[p1l914t3690r1309b3791],
6	represents	VBZ	O	represent	ccomp	2	SENT_10	[p1l1353t3707r1796b3791],
7	an	DT	O	a	det	8	SENT_10	[p1l1842t3716r1945b3769],
8	initial	JJ	O	initial	dobj	6	SENT_10	[p1l1989t3691r2134b3768, p2l11t20r143b99],

1	but	CC	O	but	dep	3	SENT_11	[p2l175t20r311b99],
2	important	JJ	O	important	amod	3	SENT_11	[p2l337t21r762b121],
3	step	NN	O	step	_	0	SENT_11	[p2l790t37r955b121],
4	toward	IN	O	toward	_	0	SENT_11	[p2l989t20r1278b99],
5	this	DT	O	this	det	6	SENT_11	[p2l1310t20r1463b99],
6	goal	NN	O	goal	prep_toward	3	SENT_11	[p2l1497t20r1695b121],
7	.	.	O	.	_	0	SENT_11	[p2l1497t20r1695b121],

1	We	PRP	O	we	nsubj	2	SENT_12	[p2l1729t28r1860b99],
2	found	VBD	O	find	_	0	SENT_12	[p2l1892t20r2136b99],
3	that	IN	O	that	complm	13	SENT_12	[p2l11t148r183b227],
4	a	DT	O	a	det	5	SENT_12	[p2l210t175r254b227],
5	cutoff	NN	O	cutoff	nsubj	13	SENT_12	[p2l286t148r559b227],
6	of	IN	O	of	_	0	SENT_12	[p2l573t148r674b227],
7	three	CD	NUMBER	three	prep_of	5	SENT_12	[p2l688t148r908b227],
8	of	IN	O	of	_	0	SENT_12	[p2l941t148r1042b227],
9	these	DT	O	these	det	12	SENT_12	[p2l1056t148r1280b227],
10	six	CD	NUMBER	six	num	12	SENT_12	[p2l1314t149r1432b227],
11	risk	NN	O	risk	nn	12	SENT_12	[p2l1462t148r1626b228],
12	factors	NNS	O	factor	prep_of	7	SENT_12	[p2l1654t148r1945b227],
13	had	VBD	O	have	ccomp	2	SENT_12	[p2l1980t148r2136b227],
14	a	DT	O	a	det	15	SENT_12	[p2l10t303r54b355],
15	speciﬁcity	NN	O	speciﬁcity	dobj	13	SENT_12	[p2l94t276r535b377],
16	of	IN	O	of	_	0	SENT_12	[p2l571t276r671b355],
17	80	CD	PERCENT	80	num	18	SENT_12	[p2l693t281r881b355],
18	%	NN	PERCENT	%	prep_of	15	SENT_12	[p2l693t281r881b355],
19	and	CC	O	and	_	0	SENT_12	[p2l919t276r1077b355],
20	a	DT	O	a	det	21	SENT_12	[p2l1117t303r1161b355],
21	sensitivity	NN	O	sensitivity	dobj	13	SENT_12	[p2l1201t277r1634b377],
22	of	IN	O	of	_	0	SENT_12	[p2l1670t276r1771b355],
23	32	CD	PERCENT	32	num	24	SENT_12	[p2l1792t282r1976b355],
24	%	NN	PERCENT	%	prep_of	21	SENT_12	[p2l1792t282r1976b355],
25	for	IN	O	for	_	0	SENT_12	[p2l2015t276r2139b355],
26	discriminating	VBG	O	discriminate	prepc_for	13	SENT_12	[p2l11t404r642b505],
27	between	IN	O	between	_	0	SENT_12	[p2l674t404r1026b484],
28	case	NN	O	case	nn	29	SENT_12	[p2l1062t431r1239b483],
29	subjects	NNS	O	subject	prep_between	26	SENT_12	[p2l1276t404r1608b505],
30	and	CC	O	and	_	0	SENT_12	[p2l1645t404r1800b483],
31	control	JJ	O	control	amod	32	SENT_12	[p2l1836t404r2136b483],
32	subjects	NNS	O	subject	prep_between	26	SENT_12	[p2l12t532r343b633],
33	in	IN	O	in	_	0	SENT_12	[p2l382t533r464b610],
34	this	DT	O	this	det	36	SENT_12	[p2l501t532r657b611],
35	Swedish	JJ	MISC	swedish	amod	36	SENT_12	[p2l698t532r1043b612],
36	population	NN	O	population	prep_in	26	SENT_12	[p2l1078t532r1562b633],
37	.	.	O	.	_	0	SENT_12	[p2l1078t532r1562b633],

1	Although	IN	O	although	mark	13	SENT_13	[p2l1601t532r2001b633],
2	its	PRP$	O	its	poss	3	SENT_13	[p2l2037t533r2133b611],
3	specificity	NN	O	specificity	nsubj	13	SENT_13	[p2l12t660r453b761],
4	is	VBZ	O	be	cop	13	SENT_13	[p2l490t661r556b739],
5	lower	JJR	O	lower	advmod	13	SENT_13	[p2l599t660r837b739],
6	than	IN	O	than	_	0	SENT_13	[p2l877t660r1073b739],
7	that	DT	O	that	prep_than	5	SENT_13	[p2l1116t660r1289b739],
8	of	IN	O	of	_	0	SENT_13	[p2l1326t660r1426b739],
9	PSA	NN	O	psa	prep_of	7	SENT_13	[p2l1449t666r1617b739],
10	(	CD	PERCENT	(	number	11	SENT_13	[p2l1661t666r1897b752],
11	94	CD	PERCENT	94	dep	12	SENT_13	[p2l1661t666r1897b752],
12	%	NN	PERCENT	%	dep	9	SENT_13	[p2l1661t666r1897b752],
13	)	CD	NUMBER	)	advcl	29	SENT_13	[p2l1661t666r1897b752],
14	with	IN	O	with	_	0	SENT_13	[p2l1940t660r2135b739],
15	the	DT	O	the	det	16	SENT_13	[p2l11t788r139b867],
16	use	NN	O	use	prep_with	13	SENT_13	[p2l176t815r312b867],
17	of	IN	O	of	_	0	SENT_13	[p2l351t788r448b867],
18	a	DT	O	a	det	19	SENT_13	[p2l467t815r511b867],
19	cutoff	NN	O	cutoff	prep_of	16	SENT_13	[p2l547t788r808b867],
20	of	IN	O	of	_	0	SENT_13	[p2l828t788r926b867],
21	4.1	CD	NUMBER	4.1	num	22	SENT_13	[p2l943t794r1064b867],
22	ng	NN	O	ng	prep_of	19	SENT_13	[p2l1102t814r1209b889],
23	per	IN	O	per	_	0	SENT_13	[p2l1241t814r1377b889],
24	milliliter	NN	O	milliliter	prep_per	22	SENT_13	[p2l1411t788r1791b884],
25	,	,	O	,	_	0	SENT_13	[p2l1411t788r1791b884],
26	its	PRP$	O	its	poss	27	SENT_13	[p2l1833t789r1927b867],
27	sensitivity	NN	O	sensitivity	nsubj	29	SENT_13	[p2l1968t814r2134b867, p2l12t917r281b1017],
28	is	VBZ	O	be	cop	29	SENT_13	[p2l307t917r373b995],
29	higher	JJR	O	higher	_	0	SENT_13	[p2l408t916r689b1017],
30	than	IN	O	than	_	0	SENT_13	[p2l719t916r916b995],
31	that	DT	O	that	prep_than	29	SENT_13	[p2l949t916r1122b995],
32	of	IN	O	of	_	0	SENT_13	[p2l1150t916r1250b995],
33	PSA	NN	O	psa	prep_of	31	SENT_13	[p2l1263t922r1431b995],
34	(	CD	PERCENT	(	num	36	SENT_13	[p2l1466t922r1763b1008],
35	21	CD	PERCENT	21	num	36	SENT_13	[p2l1466t922r1763b1008],
36	%	NN	PERCENT	%	tmod	29	SENT_13	[p2l1466t922r1763b1008],
37	)	CD	NUMBER	)	dep	36	SENT_13	[p2l1466t922r1763b1008],
38	?	.	O	?	_	0	SENT_13	[p2l1466t922r1763b1008],

1	With	IN	O	with	mark	6	SENT_14	[p2l1792t916r2006b995],
2	10	CD	NUMBER	10	num	5	SENT_14	[p2l2042t922r2135b995],
3	additional	JJ	O	additional	amod	5	SENT_14	[p2l10t1044r447b1123],
4	risk	NN	O	risk	nn	5	SENT_14	[p2l491t1044r656b1124],
5	variants	NNS	O	variant	nsubj	6	SENT_14	[p2l691t1045r1034b1123],
6	reported	VBD	O	report	advcl	13	SENT_14	[p2l1082t1044r1448b1145],
7	since	IN	O	since	_	0	SENT_14	[p2l1495t1045r1710b1123],
8	February	NNP	DATE	February	prep_since	6	SENT_14	[p2l1754t1044r2140b1145],
9	2008	CD	DATE	2008	num	8	SENT_14	[p2l10t1178r237b1268],
10	,	,	O	,	_	0	SENT_14	[p2l10t1178r237b1268],
11	it	PRP	O	it	nsubjpass	13	SENT_14	[p2l279t1173r337b1251],
12	is	VBZ	O	be	auxpass	13	SENT_14	[p2l368t1173r432b1251],
13	expected	VBN	O	expect	_	0	SENT_14	[p2l472t1172r841b1273],
14	that	IN	O	that	complm	22	SENT_14	[p2l877t1172r1046b1251],
15	the	DT	O	the	det	16	SENT_14	[p2l1078t1172r1209b1251],
16	sensitivity	NN	O	sensitivity	nsubjpass	22	SENT_14	[p2l1247t1173r1670b1273],
17	and	CC	O	and	_	0	SENT_14	[p2l1701t1172r1856b1251],
18	specificity	NN	O	specificity	nsubjpass	22	SENT_14	[p2l1894t1173r2134b1273, p2l10t1300r226b1401],
19	will	MD	O	will	aux	22	SENT_14	[p2l255t1300r420b1379],
20	be	VB	O	be	auxpass	22	SENT_14	[p2l459t1300r556b1379],
21	further	RB	O	further	advmod	22	SENT_14	[p2l596t1300r905b1379],
22	improved	VBN	O	improve	ccomp	13	SENT_14	[p2l940t1300r1369b1401],
23	.	.	O	.	_	0	SENT_14	[p2l940t1300r1369b1401],

1	We	PRP	O	we	nsubj	4	SENT_15	[p2l135t1436r267b1507],
2	do	VBP	O	do	aux	4	SENT_15	[p2l299t1428r401b1507],
3	not	RB	O	not	neg	4	SENT_15	[p2l434t1445r575b1507],
4	advocate	VB	O	advocate	_	0	SENT_15	[p2l600t1428r962b1507],
5	replacing	VBG	O	replace	xcomp	4	SENT_15	[p2l994t1428r1386b1529],
6	the	DT	O	the	det	8	SENT_15	[p2l1414t1428r1545b1507],
7	PSA	NN	O	psa	nn	8	SENT_15	[p2l1575t1434r1741b1507],
8	test	NN	O	test	dobj	5	SENT_15	[p2l1770t1445r1922b1507],
9	with	IN	O	with	_	0	SENT_15	[p2l1943t1428r2135b1508],
10	genetic	JJ	O	genetic	amod	11	SENT_15	[p2l10t1557r319b1657],
11	tests	NNS	O	test	prep_with	5	SENT_15	[p2l358t1573r577b1652],
12	;	:	O	;	_	0	SENT_15	[p2l358t1573r577b1652],
13	we	PRP	O	we	nsubj	14	SENT_15	[p2l616t1583r734b1635],
14	envision	VBP	O	envision	parataxis	4	SENT_15	[p2l774t1557r1129b1635],
15	combining	VBG	O	combine	xcomp	14	SENT_15	[p2l1170t1556r1639b1657],
16	these	DT	O	these	det	17	SENT_15	[p2l1675t1556r1899b1635],
17	tests	NNS	O	test	nsubj	19	SENT_15	[p2l1940t1573r2134b1635],
18	to	TO	O	to	aux	19	SENT_15	[p2l11t1701r92b1763],
19	improve	VB	O	improve	xcomp	15	SENT_15	[p2l137t1685r485b1785],
20	their	PRP$	O	they	poss	22	SENT_15	[p2l531t1684r735b1763],
21	predictive	JJ	O	predictive	amod	22	SENT_15	[p2l775t1684r1195b1785],
22	ability	NN	O	ability	dobj	19	SENT_15	[p2l1240t1684r1523b1785],
23	.	.	O	.	_	0	SENT_15	[p2l1240t1684r1523b1785],

1	Although	IN	O	although	mark	5	SENT_16	[p2l1569t1684r1977b1785],
2	we	PRP	O	we	nsubj	5	SENT_16	[p2l2017t1711r2135b1763],
3	could	MD	O	could	aux	5	SENT_16	[p2l11t1812r241b1891],
4	not	RB	O	not	neg	5	SENT_16	[p2l269t1829r410b1891],
5	assess	VB	O	assess	advcl	16	SENT_16	[p2l433t1839r692b1891],
6	joint	JJ	O	joint	amod	8	SENT_16	[p2l709t1813r915b1913],
7	discriminatory	JJ	O	discriminatory	amod	8	SENT_16	[p2l939t1812r1568b1913],
8	performance	NN	O	performance	dobj	5	SENT_16	[p2l1591t1812r2135b1913],
9	because	IN	O	because	_	0	SENT_16	[p2l11t1940r347b2019],
10	of	IN	O	of	prepc_because_of	5	SENT_16	[p2l393t1940r493b2019],
11	our	PRP$	O	we	poss	13	SENT_16	[p2l520t1966r666b2019],
12	study	NN	O	study	nn	13	SENT_16	[p2l709t1940r939b2041],
13	design	NN	O	design	pobj	5	SENT_16	[p2l980t1940r1284b2041],
14	,	,	O	,	_	0	SENT_16	[p2l980t1940r1284b2041],
15	we	PRP	O	we	nsubj	16	SENT_16	[p2l1330t1967r1448b2019],
16	found	VBD	O	find	_	0	SENT_16	[p2l1493t1940r1745b2019],
17	that	IN	O	that	complm	26	SENT_16	[p2l1790t1940r1963b2019],
18	the	DT	O	the	det	20	SENT_16	[p2l2003t1940r2136b2019],
19	cumulative	JJ	O	cumulative	amod	20	SENT_16	[p2l20t2068r491b2147],
20	effect	NN	O	effect	nsubj	26	SENT_16	[p2l533t2068r776b2147],
21	of	IN	O	of	_	0	SENT_16	[p2l812t2068r913b2147],
22	genetic	JJ	O	genetic	amod	24	SENT_16	[p2l935t2069r1244b2169],
23	risk	NN	O	risk	nn	24	SENT_16	[p2l1285t2068r1449b2148],
24	factors	NNS	O	factor	prep_of	20	SENT_16	[p2l1485t2068r1777b2147],
25	is	VBZ	O	be	cop	26	SENT_16	[p2l1819t2069r1885b2147],
26	independent	JJ	O	independent	ccomp	16	SENT_16	[p2l1928t2068r2145b2147, p2l18t2196r363b2297],
27	of	IN	O	of	dep	26	SENT_16	[p2l397t2196r496b2275],
28	PSA	NN	O	psa	nn	29	SENT_16	[p2l515t2202r681b2275],
29	levels	NNS	O	level	pobj	27	SENT_16	[p2l716t2196r942b2275],
30	and	CC	O	and	_	0	SENT_16	[p2l982t2196r1138b2275],
31	thus	RB	O	thus	dep	26	SENT_16	[p2l1177t2196r1358b2275],
32	can	MD	O	can	aux	33	SENT_16	[p2l1399t2222r1547b2275],
33	provide	VB	O	provide	dep	27	SENT_16	[p2l1584t2196r1896b2297],
34	complementary	JJ	O	complementary	amod	35	SENT_16	[p2l1936t2222r2145b2275, p2l18t2324r499b2425],
35	information	NN	O	information	dobj	33	SENT_16	[p2l532t2324r1080b2403],
36	.	.	O	.	_	0	SENT_16	[p2l532t2324r1080b2403],

1	Just	RB	O	just	advmod	12	SENT_17	[p2l138t2460r307b2544],
2	as	IN	O	as	dep	12	SENT_17	[p2l343t2479r429b2531],
3	men	NNS	O	man	nsubjpass	12	SENT_17	[p2l473t2478r659b2531],
4	with	IN	O	with	_	0	SENT_17	[p2l696t2452r892b2532],
5	a	DT	O	a	det	7	SENT_17	[p2l933t2479r978b2531],
6	family	NN	O	family	nn	7	SENT_17	[p2l1018t2452r1294b2553],
7	history	NN	O	history	prep_with	3	SENT_17	[p2l1331t2452r1636b2553],
8	of	IN	O	of	_	0	SENT_17	[p2l1674t2452r1774b2531],
9	prostate	NN	O	prostate	nn	10	SENT_17	[p2l1796t2469r2147b2553],
10	cancer	NN	O	cancer	prep_of	7	SENT_17	[p2l20t2606r296b2659],
11	are	VBP	O	be	auxpass	12	SENT_17	[p2l321t2606r449b2659],
12	encouraged	VBN	O	encourage	advcl	31	SENT_17	[p2l479t2580r967b2681],
13	to	TO	O	to	aux	14	SENT_17	[p2l997t2597r1077b2659],
14	start	VB	O	start	xcomp	12	SENT_17	[p2l1110t2597r1305b2659],
15	undergoing	VBG	O	undergo	xcomp	14	SENT_17	[p2l1329t2580r1821b2681],
16	screening	NN	O	screening	dobj	15	SENT_17	[p2l1849t2606r2145b2659, p2l19t2709r156b2809],
17	at	IN	O	at	_	0	SENT_17	[p2l192t2725r271b2787],
18	an	DT	O	a	det	20	SENT_17	[p2l307t2734r410b2787],
19	earlier	JJR	O	earlier	amod	20	SENT_17	[p2l452t2708r727b2787],
20	age	NN	O	age	prep_at	15	SENT_17	[p2l765t2735r932b2809],
21	,	,	O	,	_	0	SENT_17	[p2l765t2735r932b2809],
22	men	NNS	O	man	nsubjpass	31	SENT_17	[p2l980t2734r1165b2787],
23	with	IN	O	with	_	0	SENT_17	[p2l1203t2708r1398b2787],
24	multiple	JJ	O	multiple	amod	27	SENT_17	[p2l1440t2708r1797b2809],
25	genetic	JJ	O	genetic	amod	27	SENT_17	[p2l1839t2709r2148b2809],
26	risk	NN	O	risk	nn	27	SENT_17	[p2l19t2836r180b2916],
27	factors	NNS	O	factor	prep_with	22	SENT_17	[p2l214t2836r498b2915],
28	might	MD	O	might	aux	31	SENT_17	[p2l538t2836r794b2937],
29	similarly	RB	O	similarly	advmod	31	SENT_17	[p2l829t2836r1200b2937],
30	be	VB	O	be	auxpass	31	SENT_17	[p2l1234t2836r1329b2915],
31	encouraged	VBN	O	encourage	_	0	SENT_17	[p2l1369t2836r1857b2937],
32	to	TO	O	to	aux	33	SENT_17	[p2l1896t2853r1976b2915],
33	begin	VB	O	begin	xcomp	31	SENT_17	[p2l2017t2836r2145b2915, p2l19t2965r156b3065],
34	screening	VBG	O	screen	xcomp	33	SENT_17	[p2l187t2965r597b3065],
35	earlier	JJR	O	earlier	dobj	34	SENT_17	[p2l624t2964r909b3043],
36	.	.	O	.	_	0	SENT_17	[p2l624t2964r909b3043],

1	Unlike	IN	O	unlike	_	0	SENT_18	[p2l943t2964r1222b3044],
2	family	NN	O	family	nn	3	SENT_18	[p2l1251t2964r1522b3065],
3	history	NN	O	history	prep_unlike	33	SENT_18	[p2l1547t2964r1857b3065],
4	,	,	O	,	_	0	SENT_18	[p2l1547t2964r1857b3065],
5	which	WDT	O	which	nsubj	7	SENT_18	[p2l1888t2964r2147b3044],
6	is	VBZ	O	be	cop	7	SENT_18	[p2l19t3093r84b3171],
7	subject	JJ	O	subject	rcmod	3	SENT_18	[p2l123t3092r424b3193],
8	to	TO	O	to	_	0	SENT_18	[p2l453t3109r535b3171],
9	the	DT	O	the	det	10	SENT_18	[p2l571t3092r705b3171],
10	limitations	NNS	O	limitation	prep_to	7	SENT_18	[p2l738t3092r1212b3171],
11	of	IN	O	of	_	0	SENT_18	[p2l1249t3092r1349b3171],
12	family	NN	O	family	nn	13	SENT_18	[p2l1365t3092r1641b3193],
13	size	NN	O	size	prep_of	10	SENT_18	[p2l1673t3093r1858b3188],
14	,	,	O	,	_	0	SENT_18	[p2l1673t3093r1858b3188],
15	structure	NN	O	structure	prep_to	7	SENT_18	[p2l1901t3109r2145b3171, p2l20t3237r213b3316],
16	,	,	O	,	_	0	SENT_18	[p2l1901t3109r2145b3171, p2l20t3237r213b3316],
17	current	JJ	DATE	current	amod	18	SENT_18	[p2l253t3237r568b3299],
18	age	NN	O	age	appos	15	SENT_18	[p2l596t3247r739b3321],
19	of	IN	O	of	_	0	SENT_18	[p2l774t3220r874b3299],
20	male	JJ	O	male	amod	21	SENT_18	[p2l889t3220r1096b3299],
21	relatives	NNS	O	relative	prep_of	18	SENT_18	[p2l1130t3220r1507b3316],
22	,	,	O	,	_	0	SENT_18	[p2l1130t3220r1507b3316],
23	and	CC	O	and	_	0	SENT_18	[p2l1545t3220r1703b3299],
24	reliability	NN	O	reliability	conj_and	10	SENT_18	[p2l1736t3220r2151b3321],
25	of	IN	O	of	_	0	SENT_18	[p2l20t3348r120b3427],
26	reporting	NN	O	reporting	prep_of	24	SENT_18	[p2l147t3349r577b3449],
27	,	,	O	,	_	0	SENT_18	[p2l147t3349r577b3449],
28	genetic	JJ	O	genetic	amod	29	SENT_18	[p2l627t3349r936b3449],
29	markers	NNS	O	marker	nsubjpass	33	SENT_18	[p2l981t3348r1333b3428],
30	can	MD	O	can	aux	33	SENT_18	[p2l1381t3374r1530b3427],
31	be	VB	O	be	auxpass	33	SENT_18	[p2l1576t3348r1673b3427],
32	accurately	RB	O	accurately	advmod	33	SENT_18	[p2l1718t3348r2152b3449],
33	measured	VBN	O	measure	_	0	SENT_18	[p2l19t3476r438b3555],
34	anytime	RB	O	anytime	dobj	33	SENT_18	[p2l477t3477r849b3577],
35	.	.	O	.	_	0	SENT_18	[p2l477t3477r849b3577],

1	Although	IN	O	although	mark	4	SENT_19	[p2l144t3604r545b3705],
2	it	PRP	O	it	nsubj	4	SENT_19	[p2l575t3605r634b3683],
3	is	VBZ	O	be	cop	4	SENT_19	[p2l659t3605r724b3683],
4	difficult	JJ	O	difficult	_	0	SENT_19	[p2l757t3604r1104b3683],
5	to	TO	O	to	aux	6	SENT_19	[p2l1131t3621r1212b3683],
6	provide	VB	O	provide	xcomp	4	SENT_19	[p2l1242t3604r1554b3705],
7	risk	NN	O	risk	nn	8	SENT_19	[p2l1585t3604r1747b3684],
8	information	NN	O	information	dobj	6	SENT_19	[p2l1772t3604r2145b3683, p3l20t21r182b99],

1	with	IN	O	with	_	0	SENT_20	[p3l208t20r397b100],
2	confidence	NN	O	confidence	prep_with	6	SENT_20	[p3l426t20r880b99],
3	for	IN	O	for	_	0	SENT_20	[p3l909t20r1028b99],
4	most	JJS	O	most	amod	5	SENT_20	[p3l1055t37r1265b99],
5	men	NNS	O	man	prep_for	2	SENT_20	[p3l1289t46r1470b99],
6	(	VBP	O	(	_	0	SENT_20	[p3l1505t20r1703b112],
7	who	WP	O	who	nsubj	8	SENT_20	[p3l1505t20r1703b112],
8	carry	VBP	O	carry	ccomp	6	SENT_20	[p3l1735t46r1948b121],
9	one	CD	NUMBER	one	dobj	8	SENT_20	[p3l1973t46r2142b116],
10	,	,	O	,	_	0	SENT_20	[p3l1973t46r2142b116],
11	two	CD	NUMBER	two	num	9	SENT_20	[p3l20t165r200b244],
12	,	,	O	,	_	0	SENT_20	[p3l20t165r200b244],
13	or	CC	O	or	_	0	SENT_20	[p3l248t174r337b227],
14	three	CD	NUMBER	three	conj_or	9	SENT_20	[p3l377t148r597b227],
15	of	IN	O	of	_	0	SENT_20	[p3l641t148r741b227],
16	the	DT	O	the	det	20	SENT_20	[p3l765t148r898b227],
17	five	CD	NUMBER	five	num	20	SENT_20	[p3l941t148r1094b227],
18	genetic	JJ	O	genetic	amod	20	SENT_20	[p3l1136t149r1446b249],
19	risk	NN	O	risk	nn	20	SENT_20	[p3l1487t148r1651b228],
20	factors	NNS	O	factor	prep_of	9	SENT_20	[p3l1689t148r2006b239],
21	)	CD	NUMBER	)	nsubj	6	SENT_20	[p3l1689t148r2006b239],
22	by	IN	O	by	_	0	SENT_20	[p3l2054t148r2152b249],
23	means	NNS	O	means	_	0	SENT_20	[p3l19t302r299b355],
24	of	IN	O	of	_	0	SENT_20	[p3l336t276r436b355],
25	genetic	JJ	O	genetic	amod	26	SENT_20	[p3l452t277r761b377],
26	markers	NNS	O	marker	prep_by_means_of	21	SENT_20	[p3l795t276r1146b356],
27	alone	RB	O	alone	advmod	21	SENT_20	[p3l1182t276r1436b372],
28	,	,	O	,	_	0	SENT_20	[p3l1182t276r1436b372],
29	men	NNS	O	man	appos	21	SENT_20	[p3l1476t302r1662b355],
30	who	WP	O	who	nsubj	31	SENT_20	[p3l1692t276r1875b356],
31	are	VBP	O	be	rcmod	29	SENT_20	[p3l1910t302r2039b355],
32	at	IN	O	at	_	0	SENT_20	[p3l2074t293r2153b355],
33	the	DT	O	the	det	35	SENT_20	[p3l20t404r152b483],
34	two	CD	NUMBER	two	num	35	SENT_20	[p3l194t421r352b483],
35	extremes	NNS	O	extreme	prep_at	31	SENT_20	[p3l395t421r781b483],
36	in	IN	O	in	_	0	SENT_20	[p3l823t405r906b482],
37	terms	NNS	O	term	prep_in	35	SENT_20	[p3l947t421r1191b483],
38	of	IN	O	of	_	0	SENT_20	[p3l1235t404r1336b483],
39	the	DT	O	the	det	40	SENT_20	[p3l1359t404r1491b483],
40	number	NN	O	number	prep_of	37	SENT_20	[p3l1532t404r1871b483],
41	of	IN	O	of	_	0	SENT_20	[p3l1910t404r2010b483],
42	inherited	VBN	O	inherit	prep_of	40	SENT_20	[p3l2031t405r2145b482, p3l19t532r320b611],

1	factors	NNS	O	factor	nsubj	3	SENT_21	[p3l379t532r670b611],
2	may	MD	O	may	aux	3	SENT_21	[p3l731t558r910b633],
3	benefit	VB	O	benefit	_	0	SENT_21	[p3l966t532r1271b611],
4	substantially	RB	O	substantially	advmod	3	SENT_21	[p3l1327t532r1882b633],
5	from	IN	O	from	_	0	SENT_21	[p3l1936t532r2147b611],
6	categorization	NN	O	categorization	prep_from	3	SENT_21	[p3l20t661r639b761],
7	of	IN	O	of	_	0	SENT_21	[p3l680t660r780b739],
8	their	PRP$	O	they	poss	9	SENT_21	[p3l801t660r1005b739],
9	risk	NN	O	risk	prep_of	6	SENT_21	[p3l1042t660r1206b740],
10	for	IN	O	for	_	0	SENT_21	[p3l1241t660r1364b739],
11	prostate	NN	O	prostate	nn	12	SENT_21	[p3l1400t677r1750b761],
12	cancer	NN	O	cancer	prep_for	9	SENT_21	[p3l1791t686r2090b739],
13	.	.	O	.	_	0	SENT_21	[p3l1791t686r2090b739],

1	Additional	JJ	O	additional	amod	2	SENT_22	[p3l144t788r593b867],
2	studies	NNS	O	study	nsubjpass	9	SENT_22	[p3l625t788r943b884],
3	,	,	O	,	_	0	SENT_22	[p3l625t788r943b884],
4	especially	RB	O	especially	advmod	6	SENT_22	[p3l980t788r1390b889],
5	prospective	JJ	O	prospective	amod	6	SENT_22	[p3l1416t789r1895b889],
6	ones	NNS	O	one	appos	2	SENT_22	[p3l1927t814r2141b884],
7	,	,	O	,	_	0	SENT_22	[p3l1927t814r2141b884],
8	are	VBP	O	be	auxpass	9	SENT_22	[p3l19t942r146b995],
9	needed	VBN	O	need	_	0	SENT_22	[p3l182t916r480b995],
10	to	TO	O	to	aux	12	SENT_22	[p3l516t933r596b995],
11	further	JJ	O	further	advmod	12	SENT_22	[p3l633t916r936b995],
12	improve	VB	O	improve	xcomp	9	SENT_22	[p3l968t917r1310b1017],
13	prediction	NN	O	prediction	dobj	12	SENT_22	[p3l1345t916r1778b1017],
14	of	IN	O	of	_	0	SENT_22	[p3l1814t916r1914b995],
15	prostate	NN	O	prostate	nn	18	SENT_22	[p3l1929t942r2145b1017, p3l20t1061r495b1123],
16	—	NN	O	—	nn	18	SENT_22	[p3l1929t942r2145b1017, p3l20t1061r495b1123],
17	cancer	NN	O	cancer	nn	18	SENT_22	[p3l1929t942r2145b1017, p3l20t1061r495b1123],
18	risk	NN	O	risk	prep_of	13	SENT_22	[p3l527t1044r691b1124],
19	by	IN	O	by	_	0	SENT_22	[p3l722t1044r820b1145],
20	including	VBG	O	include	prepc_by	12	SENT_22	[p3l849t1044r1261b1145],
21	additional	JJ	O	additional	amod	23	SENT_22	[p3l1292t1044r1730b1123],
22	risk	NN	O	risk	nn	23	SENT_22	[p3l1765t1044r1929b1124],
23	variants	NNS	O	variant	dobj	20	SENT_22	[p3l1955t1045r2145b1123, p3l19t1189r221b1268],
24	,	,	O	,	_	0	SENT_22	[p3l1955t1045r2145b1123, p3l19t1189r221b1268],
25	combining	VBG	O	combine	conj_and	20	SENT_22	[p3l261t1172r732b1273],
26	them	PRP	O	they	dobj	25	SENT_22	[p3l762t1172r983b1251],
27	with	IN	O	with	_	0	SENT_22	[p3l1012t1172r1208b1251],
28	PSA	NN	O	psa	nn	32	SENT_22	[p3l1241t1178r1409b1251],
29	and	CC	O	and	_	0	SENT_22	[p3l1439t1172r1597b1251],
30	other	JJ	O	other	conj_and	28	SENT_22	[p3l1632t1172r1860b1251],
31	detection	NN	O	detection	nn	32	SENT_22	[p3l1892t1172r2145b1251, p3l20t1301r189b1379],
32	methods	NNS	O	method	prep_with	25	SENT_22	[p3l217t1300r616b1396],
33	,	,	O	,	_	0	SENT_22	[p3l217t1300r616b1396],
34	and	CC	O	and	_	0	SENT_22	[p3l649t1300r807b1379],
35	incorporating	VBG	O	incorporate	conj_and	20	SENT_22	[p3l833t1301r1434b1401],
36	genetic	JJ	O	genetic	amod	37	SENT_22	[p3l1457t1301r1767b1401],
37	markers	NNS	O	marker	dobj	35	SENT_22	[p3l1794t1300r2145b1380],
38	that	WDT	O	that	nsubj	39	SENT_22	[p3l20t1428r192b1507],
39	distinguish	VBP	O	distinguish	rcmod	37	SENT_22	[p3l237t1428r728b1529],
40	aggressive	JJ	O	aggressive	acomp	39	SENT_22	[p3l777t1429r1222b1529],
41	from	IN	O	from	_	0	SENT_22	[p3l1272t1428r1482b1507],
42	nonaggressive	JJ	O	nonaggressive	amod	44	SENT_22	[p3l1532t1429r2147b1529],
43	prostate	NN	O	prostate	nn	44	SENT_22	[p3l18t1573r368b1657],
44	cancer	NN	O	cancer	prep_from	40	SENT_22	[p3l415t1582r696b1635],
45	in	IN	O	in	mark	48	SENT_22	[p3l738t1557r821b1634],
46	order	NN	O	order	dep	48	SENT_22	[p3l868t1556r1096b1635],
47	to	TO	O	to	aux	48	SENT_22	[p3l1139t1573r1221b1635],
48	predict	VB	O	predict	purpcl	39	SENT_22	[p3l1266t1556r1570b1657],
49	disease	NN	O	disease	nn	50	SENT_22	[p3l1611t1556r1923b1635],
50	progression	NN	O	progression	dobj	48	SENT_22	[p3l1967t1582r2145b1657, p3l19t1686r406b1786],
51	.	.	O	.	_	0	SENT_22	[p3l1967t1582r2145b1657, p3l19t1686r406b1786],

1	Jianfeng	NNP	PERSON	Jianfeng	nn	8	SENT_23	[p3l6t1818r377b1925],
2	Xu	NNP	PERSON	Xu	nn	8	SENT_23	[p3l405t1827r543b1913],
3	,	,	O	,	_	0	SENT_23	[p3l405t1827r543b1913],
4	M.D.	NNP	O	M.D.	appos	8	SENT_23	[p3l588t1827r821b1913],
5	,	,	O	,	_	0	SENT_23	[p3l588t1827r821b1913],
6	Dr.	NNP	O	Dr.	appos	8	SENT_23	[p3l865t1827r1183b1899],
7	P.H.	NNP	ORGANIZATION	P.H.	nn	8	SENT_23	[p3l865t1827r1183b1899],
8	Wake	NNP	ORGANIZATION	Wake	_	0	SENT_23	[p3l16t1952r196b2013],
9	Forest	NNP	ORGANIZATION	Forest	nn	11	SENT_23	[p3l226t1957r432b2013],
10	University	NNP	ORGANIZATION	University	nn	11	SENT_23	[p3l458t1957r796b2031],
11	School	NNP	ORGANIZATION	School	dep	8	SENT_23	[p3l819t1952r1043b2013],
12	of	IN	ORGANIZATION	of	_	0	SENT_23	[p3l1071t1951r1144b2013],
13	Medicine	NNP	ORGANIZATION	Medicine	nn	14	SENT_23	[p3l1162t1952r1468b2013],
14	Winston-Salem	NNP	ORGANIZATION	Winston-Salem	prep_of	11	SENT_23	[p3l16t2049r554b2120],
15	,	,	O	,	_	0	SENT_23	[p3l16t2049r554b2120],
16	NC	NNP	O	NC	nn	18	SENT_23	[p3l587t2053r688b2109],
17	27157	CD	NUMBER	27157	num	18	SENT_23	[p3l712t2054r905b2109],
18	jxu@wfubmc.edu	NN	O	jxu@wfubmc.edu	appos	14	SENT_23	[p3l16t2134r615b2215],

1	William	NNP	PERSON	William	nn	3	SENT_24	[p3l17t2260r347b2340],
2	B.	NNP	PERSON	B.	nn	3	SENT_24	[p3l393t2268r464b2340],
3	Isaacs	NNP	PERSON	Isaacs	_	0	SENT_24	[p3l509t2268r795b2354],
4	,	,	O	,	_	0	SENT_24	[p3l509t2268r795b2354],
5	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_24	[p3l840t2260r1069b2340],
6	.	.	O	.	_	0	SENT_24	[p3l840t2260r1069b2340],

1	Johns	NNP	PERSON	Johns	nn	5	SENT_25	[p3l8t2393r205b2471],
2	Hopkins	NNP	PERSON	Hopkins	nn	5	SENT_25	[p3l236t2393r514b2472],
3	Medical	NNP	O	Medical	nn	5	SENT_25	[p3l546t2393r804b2454],
4	Institutions	NNP	O	Institutions	nn	5	SENT_25	[p3l837t2398r1219b2454],
5	Baltimore	NNP	O	Baltimore	_	0	SENT_25	[p3l24t2490r366b2561],
6	,	,	O	,	_	0	SENT_25	[p3l24t2490r366b2561],
7	MD	NNP	O	MD	appos	5	SENT_25	[p3l398t2495r514b2549],
8	21287	CD	NUMBER	21287	num	7	SENT_25	[p3l540t2494r736b2551],

1	Henrik	NNP	PERSON	Henrik	nn	2	SENT_26	[p3l28t2615r319b2695],
2	Gronberg	NNP	PERSON	Gronberg	_	0	SENT_26	[p3l350t2615r791b2721],
3	,	,	O	,	_	0	SENT_26	[p3l350t2615r791b2721],
4	M.D.	NNP	O	M.D.	nn	6	SENT_26	[p3l836t2623r1069b2709],
5	,	,	O	,	_	0	SENT_26	[p3l836t2623r1069b2709],
6	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_26	[p3l1113t2615r1343b2695],
7	.	.	O	.	_	0	SENT_26	[p3l1113t2615r1343b2695],

1	Karolinska	NNP	PERSON	Karolinska	nn	2	SENT_27	[p3l24t2748r367b2809],
2	Institutet	NNP	PERSON	Institutet	_	0	SENT_27	[p3l398t2753r702b2809],
3	SE-171	NN	O	se-171	nn	5	SENT_27	[p3l20t2849r235b2905],
4	77	CD	NUMBER	77	num	5	SENT_27	[p3l266t2850r337b2905],
5	Stockholm	NNP	ORGANIZATION	Stockholm	dep	2	SENT_27	[p3l363t2845r740b2916],
6	,	,	O	,	_	0	SENT_27	[p3l363t2845r740b2916],
7	Sweden	NNP	LOCATION	Sweden	appos	5	SENT_27	[p3l769t2845r1025b2906],

1	Since	IN	O	since	_	0	SENT_28	[p3l106t2927r277b2985],
2	publication	NN	O	publication	prep_since	9	SENT_28	[p3l303t2926r679b3001],
3	of	IN	O	of	_	0	SENT_28	[p3l706t2926r782b2985],
4	the	DT	O	the	det	5	SENT_28	[p3l796t2926r897b2985],
5	article	NN	O	article	prep_of	2	SENT_28	[p3l924t2926r1148b2998],
6	,	,	O	,	_	0	SENT_28	[p3l924t2926r1148b2998],
7	Dr.	NNP	O	Dr.	nn	8	SENT_28	[p3l1179t2931r1276b2985],
8	Xu	NNP	PERSON	Xu	nsubj	9	SENT_28	[p3l1304t2932r1391b2985],
9	reports	VBZ	O	report	_	0	SENT_28	[p3l1418t2939r1653b3001],
10	founding	NN	O	founding	nn	12	SENT_28	[p3l1682t2926r1987b3002],
11	Proactive	NNP	O	Proactive	nn	12	SENT_28	[p3l2011t2931r2147b2985, p3l18t3012r203b3071],
12	Genomics	NNP	O	Genomics	dobj	9	SENT_28	[p3l236t3012r587b3083],
13	,	,	O	,	_	0	SENT_28	[p3l236t3012r587b3083],
14	a	DT	O	a	det	15	SENT_28	[p3l624t3031r658b3070],
15	company	NN	O	company	appos	12	SENT_28	[p3l690t3030r989b3086],
16	that	WDT	O	that	nsubj	18	SENT_28	[p3l1020t3011r1152b3070],
17	will	MD	O	will	aux	18	SENT_28	[p3l1178t3011r1304b3070],
18	offer	VB	O	offer	rcmod	15	SENT_28	[p3l1337t3011r1496b3070],
19	genetic	JJ	O	genetic	amod	20	SENT_28	[p3l1527t3012r1764b3087],
20	testing	NN	O	testing	dobj	18	SENT_28	[p3l1797t3012r2025b3087],
21	for	IN	O	for	_	0	SENT_28	[p3l2056t3011r2151b3070],
22	predicting	VBG	O	predict	prepc_for	18	SENT_28	[p3l17t3096r361b3172],
23	individual	JJ	O	individual	amod	27	SENT_28	[p3l398t3096r729b3156],
24	prostate	NN	O	prostate	nn	27	SENT_28	[p3l768t3109r1284b3171],
25	—	NN	O	—	nn	27	SENT_28	[p3l768t3109r1284b3171],
26	cancer	NN	O	cancer	nn	27	SENT_28	[p3l768t3109r1284b3171],
27	risk	NN	O	risk	dobj	22	SENT_28	[p3l1321t3096r1463b3156],
28	.	.	O	.	_	0	SENT_28	[p3l1321t3096r1463b3156],

1	No	DT	O	no	det	4	SENT_29	[p3l1504t3102r1599b3156],
2	other	JJ	O	other	amod	4	SENT_29	[p3l1640t3096r1814b3155],
3	potential	JJ	O	potential	amod	4	SENT_29	[p3l1850t3096r2149b3171],
4	conflict	NN	O	conflict	nsubjpass	12	SENT_29	[p3l19t3182r278b3242],
5	of	IN	O	of	_	0	SENT_29	[p3l300t3182r376b3242],
6	interest	NN	O	interest	prep_of	4	SENT_29	[p3l387t3183r639b3241],
7	relevant	JJ	O	relevant	amod	6	SENT_29	[p3l660t3182r922b3242],
8	to	TO	O	to	_	0	SENT_29	[p3l944t3195r1006b3242],
9	this	DT	O	this	det	10	SENT_29	[p3l1033t3182r1156b3241],
10	letter	NN	O	letter	prep_to	7	SENT_29	[p3l1182t3182r1355b3241],
11	was	VBD	O	be	auxpass	12	SENT_29	[p3l1375t3202r1499b3242],
12	reported	VBN	O	report	_	0	SENT_29	[p3l1526t3182r1826b3257],
13	.	.	O	.	_	0	SENT_29	[p3l1526t3182r1826b3257],

1	1	LS	NUMBER	1	_	0	SENT_30	[p3l21t3293r70b3344],
2	.	.	O	.	_	0	SENT_30	[p3l21t3293r70b3344],

1	Sun	NNP	O	Sun	nn	2	SENT_31	[p3l149t3289r270b3344],
2	J	NNP	O	J	_	0	SENT_31	[p3l292t3290r335b3356],
3	,	,	O	,	_	0	SENT_31	[p3l292t3290r335b3356],
4	Chang	NNP	PERSON	Chang	nn	5	SENT_31	[p3l368t3285r582b3361],
5	B-L	NNP	O	B-L	appos	2	SENT_31	[p3l607t3290r736b3356],
6	,	,	O	,	_	0	SENT_31	[p3l607t3290r736b3356],
7	Isaacs	NNP	O	Isaacs	nn	8	SENT_31	[p3l768t3290r966b3343],
8	SD	NN	O	sd	appos	2	SENT_31	[p3l998t3289r1102b3356],
9	,	,	O	,	_	0	SENT_31	[p3l998t3289r1102b3356],
10	et	FW	O	et	nn	11	SENT_31	[p3l1135t3298r1194b3343],
11	al.	FW	O	al.	appos	2	SENT_31	[p3l1218t3285r1292b3344],
12	.	.	O	.	_	0	SENT_31	[p3l1218t3285r1292b3344],

1	Cumulative	JJ	O	cumulative	amod	2	SENT_32	[p3l1325t3285r1699b3344],
2	effect	NN	O	effect	nsubj	10	SENT_32	[p3l1729t3285r1915b3343],
3	of	IN	O	of	_	0	SENT_32	[p3l1940t3285r2016b3344],
4	five	CD	NUMBER	five	num	6	SENT_32	[p3l2030t3285r2148b3344],
5	genetic	JJ	O	genetic	amod	6	SENT_32	[p3l18t3371r255b3446],
6	variants	NNS	O	variant	prep_of	2	SENT_32	[p3l279t3371r543b3429],
7	on	IN	O	on	_	0	SENT_32	[p3l572t3389r653b3429],
8	prostate	NN	O	prostate	nn	9	SENT_32	[p3l678t3383r947b3445],
9	cancer	NN	O	cancer	prep_on	6	SENT_32	[p3l975t3389r1191b3428],
10	risk	NN	O	risk	_	0	SENT_32	[p3l1215t3370r1341b3429],
11	in	IN	O	in	_	0	SENT_32	[p3l1365t3371r1428b3428],
12	multiple	JJ	O	multiple	amod	14	SENT_32	[p3l1455t3370r1729b3445],
13	study	NN	O	study	nn	14	SENT_32	[p3l1757t3370r1933b3445],
14	populations	NNS	O	population	prep_in	10	SENT_32	[p3l1956t3389r2147b3445, p3l17t3454r260b3513],
15	.	.	O	.	_	0	SENT_32	[p3l1956t3389r2147b3445, p3l17t3454r260b3513],

1	Prostate	NN	O	prostate	nn	2	SENT_33	[p3l289t3459r557b3513],
2	(	NN	O	(	_	0	SENT_33	[p3l587t3455r672b3523],
3	in	IN	O	in	_	0	SENT_33	[p3l587t3455r672b3523],
4	press	NN	O	press	nn	5	SENT_33	[p3l697t3459r908b3529],
5	)	NN	O	)	prep_in	2	SENT_33	[p3l697t3459r908b3529],
6	.	.	O	.	_	0	SENT_33	[p3l697t3459r908b3529],

1	2	LS	NUMBER	2	_	0	SENT_34	[p3l17t3546r71b3597],
2	.	.	O	.	_	0	SENT_34	[p3l17t3546r71b3597],

1	Thompson	NNP	PERSON	Thompson	nn	2	SENT_35	[p3l145t3539r502b3614],
2	IM	NNP	O	IM	_	0	SENT_35	[p3l532t3544r641b3611],
3	,	,	O	,	_	0	SENT_35	[p3l532t3544r641b3611],
4	Ankerst	NNP	O	Ankerst	nn	5	SENT_35	[p3l674t3539r937b3598],
5	DP	NN	O	dp	appos	2	SENT_35	[p3l964t3544r1068b3611],
6	,	,	O	,	_	0	SENT_35	[p3l964t3544r1068b3611],
7	Chi	NNP	O	Chi	nn	8	SENT_35	[p3l1104t3539r1216b3598],
8	C	NNP	O	C	appos	2	SENT_35	[p3l1246t3543r1310b3611],
9	,	,	O	,	_	0	SENT_35	[p3l1246t3543r1310b3611],
10	et	FW	O	et	nn	11	SENT_35	[p3l1346t3552r1406b3597],
11	al.	FW	O	al.	appos	2	SENT_35	[p3l1432t3539r1508b3598],
12	.	.	O	.	_	0	SENT_35	[p3l1432t3539r1508b3598],

1	Operating	VBG	O	operate	amod	2	SENT_36	[p3l1543t3540r1879b3615],
2	characteristics	NNS	O	characteristic	_	0	SENT_36	[p3l1908t3539r2147b3597, p3l19t3625r278b3683],
3	of	IN	O	of	_	0	SENT_36	[p3l308t3624r385b3684],
4	prostate-specific	JJ	O	prostate-specific	amod	5	SENT_36	[p3l398t3624r953b3700],
5	antigen	NN	O	antigen	prep_of	2	SENT_36	[p3l980t3625r1228b3701],
6	in	IN	O	in	_	0	SENT_36	[p3l1255t3625r1319b3683],
7	men	NNS	O	man	prep_in	5	SENT_36	[p3l1347t3644r1489b3683],
8	with	IN	O	with	_	0	SENT_36	[p3l1514t3624r1663b3684],
9	an	DT	O	a	det	12	SENT_36	[p3l1691t3644r1769b3683],
10	initial	JJ	O	initial	amod	12	SENT_36	[p3l1797t3624r1995b3683],
11	PSA	NN	O	psa	nn	12	SENT_36	[p3l2022t3629r2150b3684],
12	level	NN	O	level	prep_with	7	SENT_36	[p3l17t3710r163b3769],
13	of	IN	O	of	_	0	SENT_36	[p3l189t3710r265b3769],
14	3.0	CD	NUMBER	3.0	num	15	SENT_36	[p3l278t3715r374b3769],
15	ng/ml	NN	O	ng/ml	prep_of	12	SENT_36	[p3l400t3710r593b3786],
16	or	CC	O	or	_	0	SENT_36	[p3l619t3729r687b3769],
17	lower	JJR	O	lower	prep_of	12	SENT_36	[p3l710t3710r907b3769],
18	.	.	O	.	_	0	SENT_36	[p3l710t3710r907b3769],

1	JAMA	NNP	O	JAMA	_	0	SENT_37	[p3l929t3715r1126b3778],
2	2005	CD	DATE	2005	num	1	SENT_37	[p3l1150t3714r1671b3781],
3	;	:	O	;	_	0	SENT_37	[p3l1150t3714r1671b3781],
4	294:66	CD	NUMBER	294:66	number	5	SENT_37	[p3l1150t3714r1671b3781],
5	-70	CD	NUMBER	-70	dep	1	SENT_37	[p3l1150t3714r1671b3781],
6	.	.	O	.	_	0	SENT_37	[p3l1150t3714r1671b3781],

1	Genetics	NNP	O	Genetics	nn	2	SENT_38	[p4l528t60r757b107],
2	ofwarfarin	NNP	O	ofwarfarin	_	0	SENT_38	[p4l778t58r1069b107],
3	Response	NN	O	response	dep	2	SENT_38	[p4l1096t63r1345b121],

1	To	TO	O	to	dep	12	SENT_39	[p4l93t157r136b178],
2	THE	DT	O	the	det	3	SENT_39	[p4l147t157r210b178],
3	EDITOR	NN	O	editor	pobj	1	SENT_39	[p4l224t157r355b178],
4	:	:	O	:	_	0	SENT_39	[p4l224t157r355b178],
5	In	IN	O	in	_	0	SENT_39	[p4l367t151r401b178],
6	the	DT	O	the	det	7	SENT_39	[p4l413t148r465b178],
7	study	NN	O	study	prep_in	12	SENT_39	[p4l477t148r566b187],
8	reported	VBN	O	report	partmod	7	SENT_39	[p4l576t148r718b187],
9	by	IN	O	by	_	0	SENT_39	[p4l729t148r767b187],
10	Schwarz	NNP	PERSON	Schwarz	agent	8	SENT_39	[p4l778t148r916b179],
11	ternational	JJ	O	ternational	nsubj	12	SENT_39	[p4l956t148r1140b179],
12	normalized	VBD	O	normalize	_	0	SENT_39	[p4l1152t148r1345b179],
13	ratio	NN	O	ratio	dobj	12	SENT_39	[p4l1357t148r1434b179],
14	(	CD	NUMBER	(	num	17	SENT_39	[p4l1448t151r1541b183],
15	INR	NN	O	inr	nn	17	SENT_39	[p4l1448t151r1541b183],
16	)	NN	O	)	nn	17	SENT_39	[p4l1448t151r1541b183],
17	tests	NNS	O	test	dep	13	SENT_39	[p4l1555t154r1640b179],
18	.	.	O	.	_	0	SENT_39	[p4l1555t154r1640b179],

1	A	DT	O	a	det	2	SENT_40	[p4l1653t151r1679b178],
2	pharet	NN	O	pharet	dep	12	SENT_40	[p4l1689t148r1778b187, p4l94t203r124b227],
3	al.	FW	O	al.	nn	4	SENT_40	[p4l139t197r177b228],
4	(	FW	O	(	dep	2	SENT_40	[p4l198t197r315b232],
5	March	NNP	DATE	March	tmod	4	SENT_40	[p4l198t197r315b232],
6	6	CD	DATE	6	num	5	SENT_40	[p4l332t199r351b228],
7	issue	NN	O	issue	dep	12	SENT_40	[p4l368t198r485b234],
8	)	CD	NUMBER	)	num	7	SENT_40	[p4l368t198r485b234],
9	,1	CD	NUMBER	,1	num	12	SENT_40	[p4l368t198r485b234],
10	specific	JJ	O	specific	amod	12	SENT_40	[p4l503t197r631b236],
11	genetic	JJ	O	genetic	amod	12	SENT_40	[p4l647t197r767b236],
12	variants	NNS	O	variant	dep	15	SENT_40	[p4l782t197r915b228],
13	macogenetic	JJ	O	macogenetic	amod	14	SENT_40	[p4l956t197r1296b236],
14	—	NN	O	—	dep	12	SENT_40	[p4l956t197r1296b236],
15	guided	VBD	O	guide	_	0	SENT_40	[p4l956t197r1296b236],
16	dosing	NN	O	dosing	nn	17	SENT_40	[p4l1309t197r1422b236],
17	algorithm	NN	O	algorithm	nsubj	32	SENT_40	[p4l1433t197r1600b236],
18	for	IN	O	for	mark	23	SENT_40	[p4l1613t197r1661b228],
19	warfarelated	VBN	O	warfarelate	csubj	23	SENT_40	[p4l1671t197r1778b228, p4l93t246r207b277],
20	to	TO	O	to	_	0	SENT_40	[p4l220t252r252b277],
21	warfarin	NN	O	warfarin	nn	22	SENT_40	[p4l263t246r409b277],
22	metabolism	NN	O	metabolism	prep_to	19	SENT_40	[p4l422t246r620b277],
23	reduced	VBD	O	reduce	dep	17	SENT_40	[p4l633t246r763b277],
24	the	DT	O	the	det	26	SENT_40	[p4l776t246r828b276],
25	time	NN	O	time	nn	26	SENT_40	[p4l841t246r916b276],
26	rin	NN	O	rin	iobj	23	SENT_40	[p4l956t246r1028b283],
27	,2	CD	NUMBER	,2	dobj	23	SENT_40	[p4l956t246r1028b283],
28	however	RB	O	however	advmod	23	SENT_40	[p4l1047t246r1193b283],
29	,	,	O	,	_	0	SENT_40	[p4l1047t246r1193b283],
30	did	VBD	O	do	aux	32	SENT_40	[p4l1214t246r1266b277],
31	not	RB	O	not	neg	32	SENT_40	[p4l1285t252r1340b277],
32	increase	VB	O	increase	ccomp	15	SENT_40	[p4l1357t246r1493b276],
33	the	DT	O	the	det	34	SENT_40	[p4l1512t246r1564b276],
34	time	NN	O	time	dobj	32	SENT_40	[p4l1583t246r1657b276],
35	in	IN	O	in	_	0	SENT_40	[p4l1676t246r1708b276],
36	the	DT	O	the	prep_in	34	SENT_40	[p4l1727t246r1779b276],
37	to	TO	O	to	_	0	SENT_40	[p4l94t301r125b326],
38	the	DT	O	the	det	46	SENT_40	[p4l142t295r193b325],
39	first	JJ	ORDINAL	first	amod	46	SENT_40	[p4l209t295r281b325],
40	therapeutic	JJ	O	therapeutic	amod	46	SENT_40	[p4l295t295r483b334],
41	and	CC	O	and	_	0	SENT_40	[p4l498t295r560b326],
42	supratherapeutic	JJ	O	supratherapeutic	amod	46	SENT_40	[p4l576t295r856b334],
43	in	IN	O	in	prep	42	SENT_40	[p4l871t295r916b325],
44	-	:	O	-	_	0	SENT_40	[p4l871t295r916b325],
45	therapeutic	JJ	O	therapeutic	amod	46	SENT_40	[p4l956t295r1144b334],
46	range	NN	O	range	prep_to	32	SENT_40	[p4l1156t305r1249b334],
47	or	CC	O	or	_	0	SENT_40	[p4l1262t305r1297b326],
48	reduce	VB	O	reduce	ccomp	15	SENT_40	[p4l1307t295r1416b326],
49	the	DT	O	the	det	50	SENT_40	[p4l1429t295r1480b325],
50	proportion	NN	O	proportion	dobj	48	SENT_40	[p4l1492t295r1674b334],
51	of	IN	O	of	_	0	SENT_40	[p4l1686t295r1725b326],
52	suN	NN	O	sun	prep_of	50	SENT_40	[p4l1731t305r1778b326, p4l584t419r598b434],

1	ENGLJ	NNP	MISC	ENGLJ	nn	2	SENT_41	[p4l613t419r690b441],
2	MED	NNP	MISC	MED	_	0	SENT_41	[p4l705t419r757b434],
3	358	CD	NUMBER	358	num	5	SENT_41	[p4l767t413r842b441],
4	;	:	O	;	_	0	SENT_41	[p4l767t413r842b441],
5	25	CD	NUMBER	25	dep	2	SENT_41	[p4l767t413r842b441],
6	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	7	SENT_41	[p4l875t419r1077b441],
7	JUNE	NNP	DATE	JUNE	dep	5	SENT_41	[p4l1108t419r1171b441],
8	19	CD	DATE	19	num	7	SENT_41	[p4l1183t419r1215b440],
9	,	,	DATE	,	_	0	SENT_41	[p4l1183t419r1215b440],
10	2008	CD	DATE	2008	num	7	SENT_41	[p4l1227t413r1290b435],
11	2741	CD	DATE	2741	dep	2	SENT_41	[p4l1989t409r2066b431],

1	The	DT	O	the	det	5	SENT_42	[p4l752t476r803b500],
2	New	NNP	O	New	nn	5	SENT_42	[p4l812t477r874b500],
3	England	NNP	O	England	nn	5	SENT_42	[p4l883t476r994b507],
4	J	NNP	O	J	nn	5	SENT_42	[p4l1002t477r1015b500],
5	oumal	NN	O	oumal	_	0	SENT_42	[p4l1016t476r1100b500],
6	of	IN	O	of	_	0	SENT_42	[p4l1109t476r1138b500],
7	Medicine	NN	O	medicine	prep_of	5	SENT_42	[p4l1145t476r1270b500],

1	Downloaded	VBN	O	download	_	0	SENT_43	[p4l194t517r364b540],
2	from	IN	O	from	_	0	SENT_43	[p4l373t517r437b540],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_43	[p4l446t517r564b547],
4	at	IN	O	at	_	0	SENT_43	[p4l574t521r597b540],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_43	[p4l606t517r788b540],
6	on	IN	O	on	_	0	SENT_43	[p4l798t524r830b540],
7	January	NNP	DATE	January	prep_on	1	SENT_43	[p4l839t517r942b547],
8	5	CD	DATE	5	num	7	SENT_43	[p4l952t517r974b545],
9	,	,	DATE	,	_	0	SENT_43	[p4l952t517r974b545],
10	2014	CD	DATE	2014	num	7	SENT_43	[p4l985t517r1057b540],
11	.	.	O	.	_	0	SENT_43	[p4l985t517r1057b540],

1	For	IN	O	for	_	0	SENT_44	[p4l1068t517r1114b540],
2	personal	JJ	O	personal	amod	3	SENT_44	[p4l1122t517r1235b547],
3	use	NN	O	use	pobj	1	SENT_44	[p4l1244t524r1287b540],
4	only	RB	O	only	advmod	3	SENT_44	[p4l1297t517r1362b547],
5	.	.	O	.	_	0	SENT_44	[p4l1297t517r1362b547],

1	No	DT	O	no	det	3	SENT_45	[p4l1372t517r1412b540],
2	other	JJ	O	other	amod	3	SENT_45	[p4l1422t517r1490b540],
3	uses	NNS	O	use	_	0	SENT_45	[p4l1498t524r1554b540],
4	without	IN	O	without	_	0	SENT_45	[p4l1564t517r1666b540],
5	permission	NN	O	permission	prep_without	3	SENT_45	[p4l1674t517r1826b547],
6	.	.	O	.	_	0	SENT_45	[p4l1674t517r1826b547],

1	Copyright	NN	O	copyright	_	0	SENT_46	[p4l544t558r679b589],
2	©	CD	NUMBER	©	num	6	SENT_46	[p4l688t558r711b582],
3	2008	CD	DATE	2008	num	6	SENT_46	[p4l721t558r786b582],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_46	[p4l796t558r987b582],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_46	[p4l997t558r1105b582],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_46	[p4l1115t558r1220b589],
7	.	.	O	.	_	0	SENT_46	[p4l1115t558r1220b589],

1	All	DT	O	all	det	2	SENT_47	[p4l1231t558r1273b582],
2	rights	NNS	O	rights	nsubj	3	SENT_47	[p4l1282t558r1356b589],
3	reserved	VBN	O	reserve	_	0	SENT_47	[p4l1366t558r1485b582],
4	.	.	O	.	_	0	SENT_47	[p4l1366t558r1485b582],

1	The	DT	O	the	det	4	SENT_48	[p4l673t664r718b685],
2	NEW	NNP	O	NEW	nn	4	SENT_48	[p4l737t666r822b685],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_48	[p4l841t666r1029b685],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_48	[p4l1048t666r1227b692],
5	of	IN	O	of	_	0	SENT_48	[p4l1247t664r1275b691],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_48	[p4l1287t666r1486b685],

1	pratherapeutic	JJ	O	pratherapeutic	_	0	SENT_49	[p4l10t886r640b987],
2	IN	IN	O	in	_	0	SENT_49	[p4l671t894r781b965],
3	R	NN	O	r	nn	4	SENT_49	[p4l785t893r857b970],
4	values	NNS	O	value	prep_in	1	SENT_49	[p4l876t886r1164b966],
5	.	.	O	.	_	0	SENT_49	[p4l876t886r1164b966],

1	An	DT	O	a	det	3	SENT_50	[p4l1200t894r1324b964],
2	exploratory	JJ	O	exploratory	amod	3	SENT_50	[p4l1359t886r1851b987],
3	analysis	NN	O	analysis	nsubj	4	SENT_50	[p4l1879t886r2138b987, p4l12t1013r116b1091],
4	suggested	VBD	O	suggest	_	0	SENT_50	[p4l150t1012r569b1113],
5	that	IN	O	that	complm	10	SENT_50	[p4l599t1012r768b1091],
6	the	DT	O	the	det	7	SENT_50	[p4l793t1012r923b1091],
7	algorithm	NN	O	algorithm	nsubj	10	SENT_50	[p4l953t1012r1375b1113],
8	may	MD	O	may	aux	10	SENT_50	[p4l1404t1038r1581b1113],
9	be	VB	O	be	cop	10	SENT_50	[p4l1607t1012r1702b1091],
10	useful	JJ	O	useful	ccomp	4	SENT_50	[p4l1731t1012r1991b1091],
11	for	IN	O	for	_	0	SENT_50	[p4l2020t1012r2142b1091],
12	genetic	JJ	O	genetic	amod	13	SENT_50	[p4l11t1139r320b1239],
13	subtypes	NNS	O	subtype	prep_for	10	SENT_50	[p4l371t1138r772b1239],
14	.	.	O	.	_	0	SENT_50	[p4l371t1138r772b1239],

1	Although	IN	O	although	mark	8	SENT_51	[p4l825t1138r1232b1239],
2	scientific	JJ	O	scientific	amod	3	SENT_51	[p4l1285t1138r1678b1217],
3	discourse	NN	O	discourse	nsubj	8	SENT_51	[p4l1729t1138r2139b1217],
4	about	IN	O	about	_	0	SENT_51	[p4l10t1264r251b1343],
5	personalized	JJ	O	personalized	amod	6	SENT_51	[p4l271t1264r818b1365],
6	medicine	NN	O	medicine	prep_about	3	SENT_51	[p4l844t1264r1230b1343],
7	has	VBZ	O	have	aux	8	SENT_51	[p4l1257t1264r1399b1343],
8	focused	VBN	O	focus	advcl	14	SENT_51	[p4l1428t1264r1755b1343],
9	on	IN	O	on	_	0	SENT_51	[p4l1782t1290r1887b1343],
10	pharmacogenomics	NNS	O	pharmacogenomic	prep_on	8	SENT_51	[p4l1912t1264r2138b1365, p4l11t1391r671b1491],
11	,	,	O	,	_	0	SENT_51	[p4l1912t1264r2138b1365, p4l11t1391r671b1491],
12	this	DT	O	this	det	13	SENT_51	[p4l739t1390r899b1469],
13	View	NNP	O	View	nsubj	14	SENT_51	[p4l960t1391r1159b1469],
14	limits	VBZ	O	limit	_	0	SENT_51	[p4l1218t1390r1468b1469],
15	the	DT	O	the	det	16	SENT_51	[p4l1535t1390r1667b1469],
16	extent	NN	O	extent	dobj	14	SENT_51	[p4l1733t1407r1997b1469],
17	to	TO	O	to	_	0	SENT_51	[p4l2056t1407r2138b1469],
18	which	WDT	O	which	rel	21	SENT_51	[p4l6t1516r270b1595],
19	discovery	NN	O	discovery	nsubj	21	SENT_51	[p4l305t1516r710b1617],
20	can	MD	O	can	aux	21	SENT_51	[p4l740t1542r890b1595],
21	improve	VB	O	improve	rcmod	16	SENT_51	[p4l923t1517r1272b1617],
22	the	DT	O	the	det	23	SENT_51	[p4l1307t1516r1440b1595],
23	public	JJ	O	public	poss	25	SENT_51	[p4l1474t1516r1803b1617],
24	’s	POS	O	’s	_	0	SENT_51	[p4l1474t1516r1803b1617],
25	health	NN	O	health	dobj	21	SENT_51	[p4l1839t1516r2133b1595],
26	.	.	O	.	_	0	SENT_51	[p4l1839t1516r2133b1595],

1	My	PRP$	O	my	poss	3	SENT_52	[p4l8t1650r139b1743],
2	research	NN	O	research	nn	3	SENT_52	[p4l180t1642r543b1721],
3	group	NN	O	group	nsubj	5	SENT_52	[p4l587t1668r840b1743],
4	has	VBZ	O	have	aux	5	SENT_52	[p4l886t1642r1031b1721],
5	shown	VBN	O	show	_	0	SENT_52	[p4l1079t1642r1362b1721],
6	that	IN	O	that	complm	26	SENT_52	[p4l1407t1642r1580b1721],
7	discordance	NN	O	discordance	nsubjpass	26	SENT_52	[p4l1620t1642r2139b1721],
8	with	IN	O	with	_	0	SENT_52	[p4l6t1768r203b1847],
9	regard	NN	O	regard	_	0	SENT_52	[p4l231t1768r509b1869],
10	to	TO	O	to	_	0	SENT_52	[p4l539t1785r620b1847],
11	the	DT	O	the	det	12	SENT_52	[p4l651t1768r784b1847],
12	dose	NN	O	dose	prep_with_regard_to	7	SENT_52	[p4l814t1768r1008b1847],
13	of	IN	O	of	_	0	SENT_52	[p4l1038t1768r1138b1847],
14	warfarin	NN	O	warfarin	prep_of	12	SENT_52	[p4l1144t1768r1519b1847],
15	(	CD	NUMBER	(	num	14	SENT_52	[p4l1553t1769r1726b1864],
16	i.e.	FW	O	i.e.	dep	14	SENT_52	[p4l1553t1769r1726b1864],
17	,	,	O	,	_	0	SENT_52	[p4l1553t1769r1726b1864],
18	miscom	FW	O	miscom	nn	20	SENT_52	[p4l1761t1769r2138b1847],
19	—	FW	O	—	nn	20	SENT_52	[p4l1761t1769r2138b1847],
20	munication	NN	O	munication	appos	14	SENT_52	[p4l11t1895r507b1973],
21	regarding	VBG	O	regard	_	0	SENT_52	[p4l541t1894r966b1995],
22	the	DT	O	the	det	24	SENT_52	[p4l998t1894r1131b1973],
23	regimen	NN	O	regimen	nn	24	SENT_52	[p4l1167t1895r1549b1995],
24	)	NN	O	)	prep_regarding	20	SENT_52	[p4l1167t1895r1549b1995],
25	is	VBZ	O	be	auxpass	26	SENT_52	[p4l1590t1895r1656b1973],
26	associated	VBN	O	associate	ccomp	5	SENT_52	[p4l1693t1894r2139b1973],
27	with	IN	O	with	_	0	SENT_52	[p4l6t2020r203b2099],
28	variation	NN	O	variation	prep_with	26	SENT_52	[p4l245t2021r629b2100],
29	in	IN	O	in	_	0	SENT_52	[p4l676t2021r760b2098],
30	the	DT	O	the	det	31	SENT_52	[p4l808t2020r941b2099],
31	INR3	NN	O	inr3	prep_in	28	SENT_52	[p4l988t2026r1201b2104],
32	and	CC	O	and	_	0	SENT_52	[p4l1250t2020r1408b2099],
33	that	IN	O	that	complm	36	SENT_52	[p4l1456t2020r1629b2099],
34	Visual	JJ	MISC	visual	amod	35	SENT_52	[p4l1667t2020r1919b2099],
35	aids	NNS	O	aid	nsubj	36	SENT_52	[p4l1967t2020r2137b2099],
36	improve	VBP	O	improve	ccomp	5	SENT_52	[p4l10t2147r358b2247],
37	concordancef	NN	O	concordancef	nn	38	SENT_52	[p4l407t2146r1019b2225],
38	‘	NN	O	‘	dobj	36	SENT_52	[p4l407t2146r1019b2225],
39	A	DT	O	a	det	41	SENT_52	[p4l1062t2154r1128b2224],
40	communication	NN	O	communication	nn	41	SENT_52	[p4l1173t2146r2139b2225],
41	—	NN	O	—	nsubj	54	SENT_52	[p4l1173t2146r2139b2225],
42	based	VBN	O	base	partmod	41	SENT_52	[p4l1173t2146r2139b2225],
43	algorithm	NN	O	algorithm	dobj	42	SENT_52	[p4l10t2272r441b2373],
44	reduced	VBD	O	reduce	rcmod	38	SENT_52	[p4l473t2272r811b2351],
45	the	DT	O	the	det	46	SENT_52	[p4l843t2272r976b2351],
46	time	NN	O	time	dobj	44	SENT_52	[p4l1009t2273r1202b2351],
47	to	TO	O	to	_	0	SENT_52	[p4l1235t2289r1316b2351],
48	the	DT	O	the	det	50	SENT_52	[p4l1351t2272r1483b2351],
49	first	JJ	ORDINAL	first	amod	50	SENT_52	[p4l1516t2272r1700b2351],
50	therapeutic	JJ	O	therapeutic	prep_to	44	SENT_52	[p4l1728t2272r2137b2373, p4l11t2399r115b2477],
51	IN	IN	O	in	_	0	SENT_52	[p4l149t2406r259b2477],
52	R5	NN	O	r5	prep_in	50	SENT_52	[p4l263t2404r361b2482],
53	and	CC	O	and	_	0	SENT_52	[p4l399t2398r557b2477],
54	increased	VBD	O	increase	rcmod	38	SENT_52	[p4l593t2398r1002b2477],
55	the	DT	O	the	det	56	SENT_52	[p4l1039t2398r1172b2477],
56	time	NN	O	time	dobj	54	SENT_52	[p4l1209t2399r1402b2477],
57	in	IN	O	in	_	0	SENT_52	[p4l1438t2399r1522b2476],
58	the	DT	O	the	det	60	SENT_52	[p4l1558t2398r1691b2477],
59	therapeutic	JJ	O	therapeutic	amod	60	SENT_52	[p4l1728t2398r2138b2499, p4l11t2525r115b2603],
60	range	NN	O	range	prep_in	56	SENT_52	[p4l143t2550r384b2625],
61	for	IN	O	for	_	0	SENT_52	[p4l413t2524r537b2603],
62	the	DT	O	the	det	63	SENT_52	[p4l563t2524r696b2603],
63	subgroup	NN	O	subgroup	prep_for	60	SENT_52	[p4l727t2524r1131b2625],
64	with	IN	O	with	_	0	SENT_52	[p4l1157t2524r1353b2603],
65	discordance	NN	O	discordance	prep_with	54	SENT_52	[p4l1382t2524r1924b2620],
66	,	,	O	,	_	0	SENT_52	[p4l1382t2524r1924b2620],
67	suggesting	VBG	O	suggest	dep	54	SENT_52	[p4l1960t2551r2138b2625, p4l11t2651r331b2751],
68	that	IN	O	that	complm	76	SENT_52	[p4l351t2650r524b2729],
69	decision	NN	O	decision	nn	70	SENT_52	[p4l543t2650r896b2729],
70	making	NN	O	making	nsubjpass	76	SENT_52	[p4l919t2650r1254b2751],
71	and	CC	O	and	_	0	SENT_52	[p4l1273t2650r1432b2729],
72	communication	NN	O	communication	nn	73	SENT_52	[p4l1456t2651r2139b2729],
73	intensity	NN	O	intensity	conj_and	70	SENT_52	[p4l10t2777r385b2877],
74	should	MD	O	should	aux	76	SENT_52	[p4l420t2776r708b2855],
75	be	VB	O	be	auxpass	76	SENT_52	[p4l747t2776r843b2855],
76	tailored	VBN	O	tailor	ccomp	67	SENT_52	[p4l882t2776r1214b2855],
77	according	VBG	O	accord	_	0	SENT_52	[p4l1252t2776r1680b2877],
78	to	TO	O	to	prepc_according_to	76	SENT_52	[p4l1714t2793r1796b2855],
79	the	DT	O	the	det	80	SENT_52	[p4l1836t2776r1969b2855],
80	degree	NN	O	degree	pobj	76	SENT_52	[p4l2008t2776r2138b2855, p4l11t2928r194b3003],
81	of	IN	O	of	_	0	SENT_52	[p4l226t2902r327b2981],
82	discordance	NN	O	discordance	prep_of	80	SENT_52	[p4l340t2902r882b2981],
83	.	.	O	.	_	0	SENT_52	[p4l340t2902r882b2981],

1	These	DT	O	these	det	5	SENT_53	[p4l915t2902r1167b2981],
2	disparate	JJ	O	disparate	amod	5	SENT_53	[p4l1200t2902r1595b3003],
3	but	CC	O	but	_	0	SENT_53	[p4l1628t2902r1768b2981],
4	complementary	JJ	O	complementary	conj_but	2	SENT_53	[p4l1795t2902r2138b3003, p4l11t3045r372b3129],
5	approaches	NNS	O	approach	nsubj	23	SENT_53	[p4l405t3028r889b3129],
6	to	TO	O	to	_	0	SENT_53	[p4l930t3045r1011b3107],
7	a	DT	O	a	det	10	SENT_53	[p4l1051t3055r1095b3107],
8	common	JJ	O	common	amod	10	SENT_53	[p4l1132t3054r1515b3107],
9	clinical	JJ	O	clinical	amod	10	SENT_53	[p4l1554t3028r1868b3107],
10	problem	NN	O	problem	prep_to	5	SENT_53	[p4l1905t3028r2138b3129, p4l10t3154r167b3233],
11	highlight	VBP	O	highlight	_	0	SENT_53	[p4l209t3154r613b3255],
12	the	DT	O	the	det	13	SENT_53	[p4l650t3154r782b3233],
13	need	NN	O	need	dobj	11	SENT_53	[p4l825t3154r1027b3233],
14	to	TO	O	to	aux	15	SENT_53	[p4l1069t3171r1151b3233],
15	expand	VB	O	expand	xcomp	11	SENT_53	[p4l1195t3154r1505b3255],
16	the	DT	O	the	det	17	SENT_53	[p4l1547t3154r1680b3233],
17	paradigm	NN	O	paradigm	dobj	15	SENT_53	[p4l1721t3154r2139b3255],
18	of	IN	O	of	_	0	SENT_53	[p4l11t3280r112b3359],
19	personalized	JJ	O	personalized	amod	21	SENT_53	[p4l138t3280r697b3381],
20	medicine	NN	O	medicine	nn	21	SENT_53	[p4l742t3280r1134b3359],
21	(	NN	O	(	prep_of	17	SENT_53	[p4l1185t3280r1368b3372],
22	and	CC	O	and	_	0	SENT_53	[p4l1185t3280r1368b3372],
23	associated	VBN	O	associate	conj_and	11	SENT_53	[p4l1413t3280r1858b3359],
24	funding	NN	O	funding	nn	25	SENT_53	[p4l1904t3280r2138b3359, p4l10t3407r150b3507],
25	streams	NNS	O	stream	dobj	23	SENT_53	[p4l194t3413r557b3498],
26	)	CD	NUMBER	)	tmod	23	SENT_53	[p4l194t3413r557b3498],
27	to	TO	O	to	aux	28	SENT_53	[p4l610t3423r691b3485],
28	include	VB	O	include	xcomp	23	SENT_53	[p4l738t3406r1049b3485],
29	disciplines	NNS	O	discipline	dobj	28	SENT_53	[p4l1095t3406r1553b3507],
30	at	IN	O	at	_	0	SENT_53	[p4l1601t3423r1680b3485],
31	the	DT	O	the	det	33	SENT_53	[p4l1721t3406r1854b3485],
32	distal	JJ	O	distal	amod	33	SENT_53	[p4l1901t3406r2139b3485],
33	end	NN	O	end	prep_at	28	SENT_53	[p4l11t3532r165b3611],
34	of	IN	O	of	_	0	SENT_53	[p4l200t3532r301b3611],
35	the	DT	O	the	det	38	SENT_53	[p4l317t3532r450b3611],
36	translational	JJ	O	translational	amod	38	SENT_53	[p4l486t3532r1038b3611],
37	research	NN	O	research	nn	38	SENT_53	[p4l1072t3532r1435b3611],
38	process	NN	O	process	prep_of	33	SENT_53	[p4l1468t3558r1817b3633],
39	.	.	O	.	_	0	SENT_53	[p4l1468t3558r1817b3633],

1	Dean	NNP	PERSON	Dean	nn	2	SENT_54	[p4l19t3665r236b3737],
2	Schillinger	NNP	PERSON	Schillinger	_	0	SENT_54	[p4l275t3658r757b3763],
3	,	,	O	,	_	0	SENT_54	[p4l275t3658r757b3763],
4	M.D.	NNP	O	M.D.	appos	2	SENT_54	[p4l802t3665r1008b3737],

1	University	NNP	O	University	nn	2	SENT_55	[p5l15t32r352b106],
2	ofCa	NNP	O	ofCa	_	0	SENT_55	[p5l375t26r782b87],
3	|	NN	O	|	nn	4	SENT_55	[p5l375t26r782b87],
4	ifornia	NN	O	ifornium	dep	2	SENT_55	[p5l375t26r782b87],
5	at	IN	O	at	_	0	SENT_55	[p5l809t38r868b87],
6	San	NNP	LOCATION	San	nn	13	SENT_55	[p5l892t31r1008b87],
7	Francisco	NNP	LOCATION	Francisco	nn	13	SENT_55	[p5l1042t32r1356b87],
8	San	NNP	LOCATION	San	nn	13	SENT_55	[p5l11t127r128b183],
9	Francisco	NNP	LOCATION	Francisco	nn	13	SENT_55	[p5l161t128r494b193],
10	,	,	O	,	_	0	SENT_55	[p5l161t128r494b193],
11	CA	NNP	O	CA	appos	13	SENT_55	[p5l522t127r618b183],
12	94143	CD	NUMBER	94143	num	13	SENT_55	[p5l641t127r828b183],
13	dschi	NNS	O	dschus	prep_at	4	SENT_55	[p5l11t201r1089b281],
14	|	CD	NUMBER	|	number	15	SENT_55	[p5l11t201r1089b281],
15	|	CD	NUMBER	|	dep	2	SENT_55	[p5l11t201r1089b281],
16	inger@medsfglmucsfedu	NN	O	inger@medsfglmucsfedu	dep	15	SENT_55	[p5l11t201r1089b281],
17	1	CD	NUMBER	1	num	16	SENT_55	[p5l12t311r62b362],
18	.	.	O	.	_	0	SENT_55	[p5l12t311r62b362],

1	Schwarz	NNP	PERSON	Schwarz	nn	2	SENT_56	[p5l141t304r415b363],
2	U1	NN	O	u1	_	0	SENT_56	[p5l441t309r537b375],
3	,	,	O	,	_	0	SENT_56	[p5l441t309r537b375],
4	Ritchie	NNP	PERSON	Ritchie	nn	5	SENT_56	[p5l567t304r800b366],
5	MD	NNP	O	MD	appos	2	SENT_56	[p5l825t309r961b375],
6	,	,	O	,	_	0	SENT_56	[p5l825t309r961b375],
7	Bradford	NNP	ORGANIZATION	Bradford	nn	8	SENT_56	[p5l991t303r1282b362],
8	Y	NN	ORGANIZATION	y	appos	2	SENT_56	[p5l1306t309r1361b375],
9	,	,	O	,	_	0	SENT_56	[p5l1306t309r1361b375],
10	et	FW	O	et	nn	11	SENT_56	[p5l1392t316r1451b362],
11	al.	FW	O	al.	appos	2	SENT_56	[p5l1474t304r1548b362],
12	.	.	O	.	_	0	SENT_56	[p5l1474t304r1548b362],

1	Genetic	JJ	O	genetic	amod	2	SENT_57	[p5l1579t304r1832b362],
2	determinants	NNS	O	determinant	_	0	SENT_57	[p5l1859t304r2139b362, p5l10t395r191b441],
3	of	IN	O	of	_	0	SENT_57	[p5l234t382r310b441],
4	response	NN	O	response	prep_of	2	SENT_57	[p5l336t402r628b458],
5	to	TO	O	to	_	0	SENT_57	[p5l670t395r732b441],
6	Warfarin	NNP	MISC	Warfarin	prep_to	2	SENT_57	[p5l770t382r1058b442],
7	during	IN	O	during	_	0	SENT_57	[p5l1099t383r1320b458],
8	initial	JJ	O	initial	amod	9	SENT_57	[p5l1357t383r1556b441],
9	anticoagulation	NN	O	anticoagulation	prep_during	2	SENT_57	[p5l1595t383r2135b458],
10	.	.	O	.	_	0	SENT_57	[p5l1595t383r2135b458],

1	N	NN	O	n	nn	2	SENT_58	[p5l8t484r64b537],
2	EnglJ	NN	O	englj	nsubj	3	SENT_58	[p5l89t479r283b554],
3	Med	VBD	O	med	_	0	SENT_58	[p5l305t479r447b537],
4	2008	CD	DATE	2008	dobj	3	SENT_58	[p5l473t483r1114b550],
5	;	:	O	;	_	0	SENT_58	[p5l473t483r1114b550],
6	358:999	CD	NUMBER	358:999	number	7	SENT_58	[p5l473t483r1114b550],
7	—	CD	NUMBER	—	dep	4	SENT_58	[p5l473t483r1114b550],
8	1008	CD	DATE	1008	dep	7	SENT_58	[p5l473t483r1114b550],
9	.	.	O	.	_	0	SENT_58	[p5l473t483r1114b550],

1	2	LS	NUMBER	2	_	0	SENT_59	[p5l9t562r63b613],
2	.	.	O	.	_	0	SENT_59	[p5l9t562r63b613],

1	Anderson	NNP	PERSON	Anderson	nn	2	SENT_60	[p5l136t555r457b613],
2	IL	NN	O	il	_	0	SENT_60	[p5l473t560r562b626],
3	,	,	O	,	_	0	SENT_60	[p5l473t560r562b626],
4	Home	NNP	O	Home	nn	5	SENT_60	[p5l589t560r795b613],
5	BD	NNP	O	BD	appos	2	SENT_60	[p5l818t560r931b626],
6	,	,	O	,	_	0	SENT_60	[p5l818t560r931b626],
7	Stevens	NNP	PERSON	Stevens	nn	8	SENT_60	[p5l961t559r1202b614],
8	SM	NNP	O	SM	appos	2	SENT_60	[p5l1229t559r1347b626],
9	,	,	O	,	_	0	SENT_60	[p5l1229t559r1347b626],
10	et	FW	O	et	nn	11	SENT_60	[p5l1376t567r1434b613],
11	al.	FW	O	al.	appos	2	SENT_60	[p5l1454t555r1529b613],
12	.	.	O	.	_	0	SENT_60	[p5l1454t555r1529b613],

1	Randomized	VBN	O	randomize	_	0	SENT_61	[p5l1555t555r1979b617],
2	trial	NN	O	trial	dobj	1	SENT_61	[p5l2003t555r2140b613],
3	of	IN	O	of	_	0	SENT_61	[p5l11t633r86b692],
4	genotype	NN	O	genotype	nn	5	SENT_61	[p5l99t634r658b709],
5	—	NN	O	—	prep_of	2	SENT_61	[p5l99t634r658b709],
6	guided	VBD	O	guide	dep	1	SENT_61	[p5l99t634r658b709],
7	versus	CC	O	versus	prep	6	SENT_61	[p5l680t653r885b693],
8	standard	JJ	O	standard	amod	9	SENT_61	[p5l914t634r1205b692],
9	Warfarin	NNP	O	Warfarin	dep	7	SENT_61	[p5l1227t633r1514b693],
10	dosing	NN	O	dosing	nsubj	1	SENT_61	[p5l1541t634r1764b709],
11	in	IN	O	in	_	0	SENT_61	[p5l1787t634r1851b691],
12	patients	NNS	O	patient	prep_in	10	SENT_61	[p5l1876t634r2139b709],
13	initiating	VBG	O	initiate	partmod	12	SENT_61	[p5l10t711r321b786],
14	oral	JJ	O	oral	amod	15	SENT_61	[p5l345t711r472b769],
15	anticoagulation	NN	O	anticoagulation	dobj	13	SENT_61	[p5l497t711r1038b786],
16	.	.	O	.	_	0	SENT_61	[p5l497t711r1038b786],

1	Circulation	NN	O	circulation	_	0	SENT_62	[p5l1068t711r1438b770],
2	2007	CD	DATE	2007	num	1	SENT_62	[p5l1465t715r2053b782],
3	;	:	O	;	_	0	SENT_62	[p5l1465t715r2053b782],
4	116:2563	CD	NUMBER	116:2563	number	5	SENT_62	[p5l1465t715r2053b782],
5	—	CD	NUMBER	—	dep	1	SENT_62	[p5l1465t715r2053b782],
6	70	CD	NUMBER	70	dep	5	SENT_62	[p5l1465t715r2053b782],
7	.	.	O	.	_	0	SENT_62	[p5l1465t715r2053b782],

1	3	LS	NUMBER	3	_	0	SENT_63	[p5l10t794r60b846],
2	.	.	O	.	_	0	SENT_63	[p5l10t794r60b846],

1	Schillinger	NN	PERSON	schillinger	nn	2	SENT_64	[p5l141t788r501b863],
2	D	NN	PERSON	d	_	0	SENT_64	[p5l527t793r596b859],
3	,	,	O	,	_	0	SENT_64	[p5l527t793r596b859],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_64	[p5l627t793r818b863],
5	F	NN	PERSON	f	appos	2	SENT_64	[p5l844t793r896b859],
6	,	,	O	,	_	0	SENT_64	[p5l844t793r896b859],
7	Rodriguez	NNP	PERSON	Rodriguez	nn	8	SENT_64	[p5l928t788r1272b863],
8	M	NNP	O	M	appos	2	SENT_64	[p5l1299t793r1382b859],
9	,	,	O	,	_	0	SENT_64	[p5l1299t793r1382b859],
10	et	FW	O	et	nn	11	SENT_64	[p5l1416t800r1475b846],
11	al.	FW	O	al.	appos	2	SENT_64	[p5l1501t788r1575b846],
12	.	.	O	.	_	0	SENT_64	[p5l1501t788r1575b846],

1	The	DT	O	the	det	2	SENT_65	[p5l1607t788r1729b846],
2	importance	NN	O	importance	_	0	SENT_65	[p5l1758t788r2139b863],
3	of	IN	O	of	_	0	SENT_65	[p5l11t866r86b925],
4	establishing	VBG	O	establish	prepc_of	2	SENT_65	[p5l104t867r510b942],
5	regimen	NN	O	regimen	nn	6	SENT_65	[p5l539t867r812b942],
6	concordance	NN	O	concordance	dobj	4	SENT_65	[p5l843t867r1261b925],
7	in	IN	O	in	_	0	SENT_65	[p5l1291t867r1355b924],
8	preventing	VBG	O	prevent	prepc_in	4	SENT_65	[p5l1385t867r1741b942],
9	medication	NN	O	medication	nn	10	SENT_65	[p5l1769t867r2140b925],
10	errors	NNS	O	error	dobj	8	SENT_65	[p5l11t961r204b1000],
11	in	IN	O	in	_	0	SENT_65	[p5l231t942r295b999],
12	anticoagulant	JJ	O	anticoagulant	amod	13	SENT_65	[p5l320t942r782b1017],
13	care	NN	O	care	prep_in	8	SENT_65	[p5l805t961r957b1000],
14	.	.	O	.	_	0	SENT_65	[p5l805t961r957b1000],

1	J	NNP	O	J	nn	3	SENT_66	[p5l980t947r1008b1010],
2	Health	NNP	O	Health	nn	3	SENT_66	[p5l1032t942r1254b1000],
3	Commun	NNP	O	Commun	_	0	SENT_66	[p5l1280t946r1588b1001],
4	2006	CD	DATE	2006	num	3	SENT_66	[p5l1614t946r2129b1013],
5	;	:	O	;	_	0	SENT_66	[p5l1614t946r2129b1013],
6	11:555	CD	NUMBER	11:555	number	7	SENT_66	[p5l1614t946r2129b1013],
7	—	CD	NUMBER	—	dep	3	SENT_66	[p5l1614t946r2129b1013],
8	67	CD	NUMBER	67	dep	7	SENT_66	[p5l1614t946r2129b1013],
9	.	.	O	.	_	0	SENT_66	[p5l1614t946r2129b1013],

1	4	LS	NUMBER	4	_	0	SENT_67	[p5l8t1026r62b1077],
2	.	.	O	.	_	0	SENT_67	[p5l8t1026r62b1077],

1	Schillinger	NN	PERSON	schillinger	nn	2	SENT_68	[p5l141t1019r501b1094],
2	D	NN	PERSON	d	_	0	SENT_68	[p5l522t1024r591b1090],
3	,	,	O	,	_	0	SENT_68	[p5l522t1024r591b1090],
4	Machtinger	NNP	ORGANIZATION	Machtinger	nn	5	SENT_68	[p5l617t1019r999b1094],
5	EL	NNP	ORGANIZATION	EL	conj_and	2	SENT_68	[p5l1020t1024r1121b1090],
6	,	,	O	,	_	0	SENT_68	[p5l1020t1024r1121b1090],
7	Wang	NNP	PERSON	Wang	nn	8	SENT_68	[p5l1147t1024r1339b1094],
8	F	NN	PERSON	f	conj_and	2	SENT_68	[p5l1360t1024r1411b1090],
9	,	,	O	,	_	0	SENT_68	[p5l1360t1024r1411b1090],
10	Palacios	NNP	PERSON	Palacios	nn	11	SENT_68	[p5l1439t1019r1706b1077],
11	J	NNP	PERSON	J	conj_and	2	SENT_68	[p5l1725t1024r1768b1090],
12	,	,	O	,	_	0	SENT_68	[p5l1725t1024r1768b1090],
13	Rodriguez	NNP	PERSON	Rodriguez	nn	14	SENT_68	[p5l1796t1019r2140b1094],
14	M	NNP	O	M	conj_and	2	SENT_68	[p5l7t1101r90b1167],
15	,	,	O	,	_	0	SENT_68	[p5l7t1101r90b1167],
16	Bindman	NNP	PERSON	Bindman	nn	18	SENT_68	[p5l121t1096r424b1154],
17	A.	NNP	PERSON	A.	nn	18	SENT_68	[p5l449t1101r516b1154],
18	Language	NNP	PERSON	Language	conj_and	2	SENT_68	[p5l547t1101r887b1171],
19	,	,	O	,	_	0	SENT_68	[p5l547t1101r887b1171],
20	literacy	NN	O	literacy	conj_and	2	SENT_68	[p5l918t1096r1170b1171],
21	,	,	O	,	_	0	SENT_68	[p5l918t1096r1170b1171],
22	and	CC	O	and	_	0	SENT_68	[p5l1202t1096r1322b1154],
23	communication	NN	O	communication	conj_and	2	SENT_68	[p5l1350t1096r1874b1155],
24	regarding	VBG	O	regard	_	0	SENT_68	[p5l1901t1096r2139b1171, p5l10t1172r116b1247],
25	medication	NN	O	medication	prep_regarding	2	SENT_68	[p5l152t1172r522b1230],
26	in	IN	O	in	_	0	SENT_68	[p5l560t1172r624b1229],
27	an	DT	O	a	det	29	SENT_68	[p5l661t1191r740b1230],
28	anticoagulation	NN	O	anticoagulation	nn	29	SENT_68	[p5l777t1172r1300b1247],
29	clinic	NN	O	clinic	prep_in	25	SENT_68	[p5l1338t1172r1536b1230],
30	:	:	O	:	_	0	SENT_68	[p5l1338t1172r1536b1230],
31	a	DT	O	a	det	32	SENT_68	[p5l1577t1191r1610b1230],
32	comparison	NN	O	comparison	dep	2	SENT_68	[p5l1647t1172r2039b1247],
33	of	IN	O	of	_	0	SENT_68	[p5l2078t1171r2153b1230],
34	verbal	JJ	O	verbal	amod	37	SENT_68	[p5l6t1250r206b1309],
35	VS.	NNP	O	VS.	nn	37	SENT_68	[p5l229t1269r313b1309],
36	visual	JJ	O	visual	amod	37	SENT_68	[p5l341t1250r534b1309],
37	assessment	NN	O	assessment	prep_of	32	SENT_68	[p5l560t1262r953b1308],
38	.	.	O	.	_	0	SENT_68	[p5l560t1262r953b1308],

1	J	NNP	O	J	nn	3	SENT_69	[p5l977t1255r1005b1317],
2	Health	NNP	O	Health	nn	3	SENT_69	[p5l1030t1250r1252b1308],
3	Commun	NNP	O	Commun	_	0	SENT_69	[p5l1279t1254r1587b1309],
4	2006	CD	DATE	2006	num	3	SENT_69	[p5l1613t1254r2135b1321],
5	;	:	O	;	_	0	SENT_69	[p5l1613t1254r2135b1321],
6	11:651	CD	NUMBER	11:651	number	7	SENT_69	[p5l1613t1254r2135b1321],
7	—	CD	NUMBER	—	dep	3	SENT_69	[p5l1613t1254r2135b1321],
8	64	CD	NUMBER	64	dep	7	SENT_69	[p5l1613t1254r2135b1321],
9	.	.	O	.	_	0	SENT_69	[p5l1613t1254r2135b1321],

1	[	NN	O	[	_	0	SENT_70	[p5l16t1330r331b1396],
2	Erratum	NN	O	erratum	dep	1	SENT_70	[p5l16t1330r331b1396],
3	,	,	O	,	_	0	SENT_70	[p5l16t1330r331b1396],
4	J	NNP	O	J	nn	6	SENT_70	[p5l354t1330r382b1392],
5	Health	NNP	O	Health	nn	6	SENT_70	[p5l406t1325r628b1383],
6	Commun	NNP	O	Commun	appos	2	SENT_70	[p5l654t1329r962b1384],
7	2006	CD	DATE	2006	rcmod	6	SENT_70	[p5l988t1329r1426b1396],
8	;	:	O	;	_	0	SENT_70	[p5l988t1329r1426b1396],
9	11:811	CD	NUMBER	11:811	dep	7	SENT_70	[p5l988t1329r1426b1396],
10	.	.	O	.	_	0	SENT_70	[p5l988t1329r1426b1396],
11	]	SYM	O	]	dep	7	SENT_70	[p5l988t1329r1426b1396],

1	5	CD	NUMBER	5	_	0	SENT_71	[p5l11t1409r61b1460],
2	.	.	O	.	_	0	SENT_71	[p5l11t1409r61b1460],

1	Machtinger	NNP	ORGANIZATION	Machtinger	nn	2	SENT_72	[p5l137t1402r519b1477],
2	EL	NNP	ORGANIZATION	EL	_	0	SENT_72	[p5l539t1407r640b1473],
3	,	,	O	,	_	0	SENT_72	[p5l539t1407r640b1473],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_72	[p5l664t1407r856b1477],
5	F	NN	PERSON	f	appos	2	SENT_72	[p5l875t1407r926b1473],
6	,	,	O	,	_	0	SENT_72	[p5l875t1407r926b1473],
7	Chen	NNP	O	Chen	nn	8	SENT_72	[p5l953t1402r1121b1460],
8	LL	NNP	O	LL	appos	2	SENT_72	[p5l1143t1407r1242b1473],
9	,	,	O	,	_	0	SENT_72	[p5l1143t1407r1242b1473],
10	Rodriguez	NNP	PERSON	Rodriguez	nn	11	SENT_72	[p5l1268t1402r1612b1477],
11	M	NNP	O	M	appos	2	SENT_72	[p5l1633t1407r1715b1473],
12	,	,	O	,	_	0	SENT_72	[p5l1633t1407r1715b1473],
13	Wu	NNP	LOCATION	Wu	nn	14	SENT_72	[p5l1739t1407r1850b1461],
14	S	NNP	LOCATION	S	appos	2	SENT_72	[p5l1875t1406r1926b1473],
15	,	,	O	,	_	0	SENT_72	[p5l1875t1406r1926b1473],
16	Schillinger	NNP	PERSON	Schillinger	nn	21	SENT_72	[p5l1955t1402r2139b1460, p5l9t1481r204b1556],
17	D.	NNP	O	D.	nn	21	SENT_72	[p5l230t1486r298b1539],
18	A	NNP	O	A	nn	21	SENT_72	[p5l328t1486r379b1538],
19	visual	JJ	O	visual	amod	21	SENT_72	[p5l402t1481r595b1540],
20	medication	NN	O	medication	nn	21	SENT_72	[p5l624t1481r994b1539],
21	schedule	NN	O	schedule	appos	2	SENT_72	[p5l1025t1481r1310b1540],
22	to	TO	O	to	aux	23	SENT_72	[p5l1339t1493r1402b1539],
23	improve	VB	O	improve	infmod	21	SENT_72	[p5l1431t1481r1698b1556],
24	anticoagulation	NN	O	anticoagulation	nn	25	SENT_72	[p5l1726t1481r2139b1556, p5l10t1558r140b1616],
25	control	NN	O	control	dobj	23	SENT_72	[p5l180t1558r434b1616],
26	:	:	O	:	_	0	SENT_72	[p5l180t1558r434b1616],
27	a	DT	O	a	dep	21	SENT_72	[p5l475t1577r509b1616],
28	randomized	VBN	O	randomize	partmod	27	SENT_72	[p5l547t1558r965b1629],
29	,	,	O	,	_	0	SENT_72	[p5l547t1558r965b1629],
30	controlled	VBN	O	control	partmod	21	SENT_72	[p5l1009t1558r1345b1616],
31	trial	NN	O	trial	dobj	30	SENT_72	[p5l1385t1558r1540b1616],
32	.	.	O	.	_	0	SENT_72	[p5l1385t1558r1540b1616],

1	Jt	NNP	O	Jt	nn	6	SENT_73	[p5l1575t1563r1629b1625],
2	Comm	NNP	O	Comm	nn	6	SENT_73	[p5l1665t1562r1886b1616],
3	J	NNP	O	J	nn	6	SENT_73	[p5l1917t1563r1946b1625],
4	Qual	NNP	O	Qual	nn	6	SENT_73	[p5l1983t1558r2140b1630],
5	Patient	NNP	O	Patient	nn	6	SENT_73	[p5l9t1652r240b1710],
6	Saf	NNP	O	Saf	_	0	SENT_73	[p5l263t1651r376b1710],
7	2007	CD	DATE	2007	num	6	SENT_73	[p5l387t1656r900b1723],
8	;	:	O	;	_	0	SENT_73	[p5l387t1656r900b1723],
9	33:625	CD	NUMBER	33:625	number	10	SENT_73	[p5l387t1656r900b1723],
10	-35	CD	NUMBER	-35	dep	6	SENT_73	[p5l387t1656r900b1723],
11	.	.	O	.	_	0	SENT_73	[p5l387t1656r900b1723],

1	TO	TO	O	to	aux	3	SENT_74	[p5l9t1940r121b1995],
2	THE	DT	O	the	det	3	SENT_74	[p5l167t1941r332b1995],
3	EDITOR	NN	O	editor	_	0	SENT_74	[p5l386t1940r723b1996],
4	:	:	O	:	_	0	SENT_74	[p5l386t1940r723b1996],
5	Schwarz	NNP	PERSON	Schwarz	dep	3	SENT_74	[p5l781t1917r1139b1997],
6	et	FW	O	et	nn	8	SENT_74	[p5l1192t1934r1269b1996],
7	al.	FW	O	al.	nn	8	SENT_74	[p5l1316t1917r1412b1996],
8	report	NN	O	report	dep	5	SENT_74	[p5l1470t1934r1738b2018],
9	that	IN	O	that	complm	22	SENT_74	[p5l1785t1917r1958b1996],
10	the	DT	O	the	det	14	SENT_74	[p5l2005t1917r2139b1996],
11	Vitamin	NN	O	vitamin	nn	14	SENT_74	[p5l6t2046r341b2124],
12	K	NN	O	k	nn	14	SENT_74	[p5l376t2053r443b2126],
13	epoxide	NN	O	epoxide	nn	14	SENT_74	[p5l475t2045r806b2146],
14	reductase	NN	O	reductase	nsubjpass	22	SENT_74	[p5l841t2045r1250b2124],
15	(	CD	NUMBER	(	num	16	SENT_74	[p5l1290t2052r1673b2137],
16	VKORC1	NN	O	vkorc1	dep	14	SENT_74	[p5l1290t2052r1673b2137],
17	)	CD	NUMBER	)	num	18	SENT_74	[p5l1290t2052r1673b2137],
18	haplotype	NN	O	haplotype	dep	14	SENT_74	[p5l1713t2045r2139b2146],
19	was	VBD	O	be	auxpass	22	SENT_74	[p5l7t2200r169b2252],
20	more	RBR	O	more	advmod	21	SENT_74	[p5l215t2199r436b2252],
21	strongly	RB	O	strongly	advmod	22	SENT_74	[p5l482t2173r834b2274],
22	associated	VBN	O	associate	ccomp	3	SENT_74	[p5l873t2173r1319b2252],
23	with	IN	O	with	_	0	SENT_74	[p5l1359t2173r1554b2253],
24	genetic	JJ	O	genetic	amod	25	SENT_74	[p5l1598t2174r1907b2274],
25	Variability	NN	O	variability	prep_with	22	SENT_74	[p5l1946t2174r2138b2252, p5l11t2301r281b2402],
26	than	IN	O	than	_	0	SENT_74	[p5l325t2301r522b2380],
27	the	DT	O	the	det	29	SENT_74	[p5l571t2301r703b2380],
28	cytochrome	NN	O	cytochrome	nn	29	SENT_74	[p5l753t2301r1261b2402],
29	P	NN	O	p	prep_than	25	SENT_74	[p5l1307t2307r1546b2380],
30	—	CD	NUMBER	—	number	31	SENT_74	[p5l1307t2307r1546b2380],
31	450	CD	NUMBER	450	num	35	SENT_74	[p5l1307t2307r1546b2380],
32	2C9	NN	O	2c9	nn	35	SENT_74	[p5l1595t2307r1757b2380],
33	enzyme	NN	O	enzyme	nn	35	SENT_74	[p5l1808t2327r2139b2402],
34	(	CD	NUMBER	(	num	35	SENT_74	[p5l16t2436r366b2520],
35	CYPZC9	NN	O	cypzc9	dep	29	SENT_74	[p5l16t2436r366b2520],
36	)	CD	NUMBER	)	num	37	SENT_74	[p5l16t2436r366b2520],
37	genotype	NN	O	genotype	dep	35	SENT_74	[p5l401t2446r796b2530],
38	in	IN	O	in	_	0	SENT_74	[p5l838t2430r922b2507],
39	determining	VBG	O	determine	prepc_in	22	SENT_74	[p5l965t2429r1505b2530],
40	the	DT	O	the	det	43	SENT_74	[p5l1544t2429r1677b2508],
41	early	JJ	O	early	amod	43	SENT_74	[p5l1721t2429r1927b2530],
42	INR	NN	O	inr	nn	43	SENT_74	[p5l1963t2436r2150b2513],
43	response	NN	O	response	dobj	39	SENT_74	[p5l11t2583r393b2658],
44	to	TO	O	to	_	0	SENT_74	[p5l436t2574r518b2636],
45	warfarin	NN	O	warfarin	nn	46	SENT_74	[p5l558t2557r933b2636],
46	therapy	NN	O	therapy	prep_to	39	SENT_74	[p5l977t2557r1299b2658],
47	in	IN	O	in	_	0	SENT_74	[p5l1337t2558r1420b2635],
48	adults	NNS	O	adult	prep_in	46	SENT_74	[p5l1463t2557r1745b2636],
49	.	.	O	.	_	0	SENT_74	[p5l1463t2557r1745b2636],

1	This	DT	O	this	det	2	SENT_75	[p5l1790t2557r1978b2636],
2	information	NN	O	information	nsubj	7	SENT_75	[p5l2022t2558r2138b2635, p5l11t2685r446b2764],
3	and	CC	O	and	_	0	SENT_75	[p5l478t2685r636b2764],
4	available	JJ	O	available	amod	6	SENT_75	[p5l668t2685r1040b2764],
5	computer	NN	O	computer	nn	6	SENT_75	[p5l1073t2685r1787b2786],
6	—	NN	O	—	nsubj	7	SENT_75	[p5l1073t2685r1787b2786],
7	based	VBN	O	base	partmod	15	SENT_75	[p5l1073t2685r1787b2786],
8	,	,	O	,	_	0	SENT_75	[p5l1073t2685r1787b2786],
9	clinical	JJ	O	clinical	amod	11	SENT_75	[p5l1826t2685r2140b2764],
10	pharmacogenetic	JJ	O	pharmacogenetic	amod	11	SENT_75	[p5l10t2813r761b2914],
11	programs	NNS	O	program	nsubj	15	SENT_75	[p5l804t2839r1223b2914],
12	for	IN	O	for	_	0	SENT_75	[p5l1269t2813r1393b2892],
13	warfarin	NN	O	warfarin	nn	14	SENT_75	[p5l1430t2813r1805b2892],
14	dosing	NN	O	dosing	prep_for	11	SENT_75	[p5l1850t2813r2143b2914],
15	ignore	VBP	O	ignore	_	0	SENT_75	[p5l11t2942r285b3042],
16	the	DT	O	the	det	17	SENT_75	[p5l315t2941r447b3020],
17	implications	NNS	O	implication	dobj	15	SENT_75	[p5l476t2941r1013b3042],
18	for	IN	O	for	_	0	SENT_75	[p5l1044t2941r1168b3020],
19	pediatric	JJ	O	pediatric	amod	20	SENT_75	[p5l1192t2941r1575b3042],
20	patients	NNS	O	patient	prep_for	17	SENT_75	[p5l1602t2942r1969b3042],
21	.	.	O	.	_	0	SENT_75	[p5l1602t2942r1969b3042],

1	Because	IN	O	because	_	0	SENT_76	[p5l2003t2948r2138b3020, p5l12t3096r241b3148],
2	of	IN	O	of	prepc_because_of	26	SENT_76	[p5l270t3069r369b3148],
3	the	DT	O	the	det	6	SENT_76	[p5l378t3069r509b3148],
4	intrinsic	JJ	O	intrinsic	amod	6	SENT_76	[p5l537t3070r890b3148],
5	developmental	JJ	O	developmental	amod	6	SENT_76	[p5l918t3069r1534b3170],
6	differences	NNS	O	difference	pobj	26	SENT_76	[p5l1562t3069r2027b3148],
7	in	IN	O	in	_	0	SENT_76	[p5l2056t3070r2139b3147],
8	the	DT	O	the	det	10	SENT_76	[p5l12t3197r146b3276],
9	coagulation	NN	O	coagulation	nn	10	SENT_76	[p5l175t3197r687b3298],
10	systems	NNS	O	system	prep_in	6	SENT_76	[p5l717t3214r1053b3298],
11	of	IN	O	of	_	0	SENT_76	[p5l1084t3197r1185b3276],
12	adults	NNS	O	adult	prep_of	10	SENT_76	[p5l1193t3197r1452b3276],
13	and	CC	O	and	_	0	SENT_76	[p5l1482t3197r1640b3276],
14	children	NNS	O	child	prep_of	10	SENT_76	[p5l1669t3197r2148b3293],
15	,	,	O	,	_	0	SENT_76	[p5l1669t3197r2148b3293],
16	”	NN	O	”	nn	17	SENT_76	[p5l1669t3197r2148b3293],
17	guidelines	NNS	O	guideline	nsubjpass	26	SENT_76	[p5l12t3325r459b3426],
18	for	IN	O	for	_	0	SENT_76	[p5l510t3325r634b3404],
19	antithrombotic	JJ	O	antithrombotic	amod	20	SENT_76	[p5l679t3325r1340b3404],
20	therapy	NN	O	therapy	prep_for	17	SENT_76	[p5l1388t3325r1712b3426],
21	in	IN	O	in	_	0	SENT_76	[p5l1756t3326r1839b3403],
22	adults	NNS	O	adult	prep_in	20	SENT_76	[p5l1888t3325r2145b3404],
23	can	MD	O	can	aux	26	SENT_76	[p5l12t3470r313b3532],
24	not	RB	O	not	neg	26	SENT_76	[p5l12t3470r313b3532],
25	be	VB	O	be	auxpass	26	SENT_76	[p5l337t3453r434b3532],
26	extrapolated	VBN	O	extrapolate	_	0	SENT_76	[p5l464t3453r1002b3554],
27	to	TO	O	to	_	0	SENT_76	[p5l1030t3470r1112b3532],
28	therapy	NN	O	therapy	prep_to	26	SENT_76	[p5l1143t3453r1466b3554],
29	in	IN	O	in	_	0	SENT_76	[p5l1490t3454r1574b3531],
30	children	NNS	O	child	prep_in	28	SENT_76	[p5l1604t3453r1961b3532],
31	and	CC	O	and	_	0	SENT_76	[p5l1989t3453r2148b3532],
32	adolescents	NNS	O	adolescent	prep_in	28	SENT_76	[p5l11t3582r533b3661],
33	.	.	O	.	_	0	SENT_76	[p5l11t3582r533b3661],

1	Although	IN	O	although	mark	8	SENT_77	[p5l138t3710r541b3811],
2	several	JJ	O	several	amod	3	SENT_77	[p5l573t3710r860b3789],
3	studies	NNS	O	study	nsubjpass	8	SENT_77	[p5l892t3710r1187b3789],
4	of	IN	O	of	_	0	SENT_77	[p5l1221t3710r1321b3789],
5	Warfarin	NNP	MISC	Warfarin	prep_of	3	SENT_77	[p5l1329t3710r1698b3789],
6	have	VBP	O	have	aux	8	SENT_77	[p5l1729t3710r1917b3789],
7	been	VBN	O	be	auxpass	8	SENT_77	[p5l1949t3710r2148b3789],
8	performed	VBN	O	perform	advcl	13	SENT_77	[p6l11t22r470b123],
9	in	IN	O	in	_	0	SENT_77	[p6l508t23r591b100],
10	children	NNS	O	child	prep_in	8	SENT_77	[p6l630t22r1011b118],
11	,	,	O	,	_	0	SENT_77	[p6l630t22r1011b118],
12	there	EX	O	there	expl	13	SENT_77	[p6l1056t22r1274b101],
13	is	VBZ	O	be	_	0	SENT_77	[p6l1312t23r1378b101],
14	a	DT	O	a	det	15	SENT_77	[p6l1418t49r1462b101],
15	paucity	NN	O	paucity	nsubj	13	SENT_77	[p6l1498t23r1810b123],
16	of	IN	O	of	_	0	SENT_77	[p6l1845t22r1945b101],
17	data	NNS	O	datum	prep_of	15	SENT_77	[p6l1966t22r2150b101],
18	about	IN	O	about	_	0	SENT_77	[p6l11t150r257b229],
19	how	WRB	O	how	advmod	22	SENT_77	[p6l292t150r477b230],
20	developmental	JJ	O	developmental	amod	21	SENT_77	[p6l514t150r1145b251],
21	expression	NN	O	expression	nsubj	22	SENT_77	[p6l1186t151r1645b251],
22	affects	VBZ	O	affect	prepc_about	17	SENT_77	[p6l1684t150r1971b229],
23	the	DT	O	the	det	24	SENT_77	[p6l2014t150r2148b229],
24	pharmacokinetics	NNS	O	pharmacokinetic	dobj	22	SENT_77	[p6l11t278r759b379],
25	and	CC	O	and	_	0	SENT_77	[p6l796t278r951b357],
26	pharmacodynamics	NNS	O	pharmacodynamic	dobj	22	SENT_77	[p6l985t278r1811b379],
27	of	IN	O	of	_	0	SENT_77	[p6l1849t278r1948b357],
28	warfarin	NN	O	warfarin	prep_of	24	SENT_77	[p6l1961t304r2147b358, p6l12t406r232b485],
29	.	.	O	.	_	0	SENT_77	[p6l1961t304r2147b358, p6l12t406r232b485],

1	This	DT	O	this	nsubj	4	SENT_78	[p6l262t406r444b485],
2	is	VBZ	O	be	cop	4	SENT_78	[p6l474t407r538b485],
3	especially	RB	O	especially	advmod	4	SENT_78	[p6l568t406r971b507],
4	true	JJ	O	true	_	0	SENT_78	[p6l995t423r1160b485],
5	with	IN	O	with	_	0	SENT_78	[p6l1183t406r1373b485],
6	regard	NN	O	regard	prep_with	4	SENT_78	[p6l1401t406r1670b507],
7	to	TO	O	to	_	0	SENT_78	[p6l1697t423r1778b485],
8	VKORC1	NN	O	vkorc1	prep_to	4	SENT_78	[p6l1806t413r2143b502],
9	,	,	O	,	_	0	SENT_78	[p6l1806t413r2143b502],
10	for	IN	O	for	_	0	SENT_78	[p6l12t534r136b613],
11	which	WDT	O	which	rel	19	SENT_78	[p6l168t534r433b613],
12	the	DT	O	the	det	13	SENT_78	[p6l473t534r607b613],
13	patterns	NNS	O	pattern	nsubjpass	19	SENT_78	[p6l646t551r1002b635],
14	of	IN	O	of	_	0	SENT_78	[p6l1044t534r1145b613],
15	developmental	JJ	O	developmental	amod	16	SENT_78	[p6l1167t534r1798b635],
16	expression	NN	O	expression	prep_of	13	SENT_78	[p6l1839t560r2147b635, p6l14t663r190b741],
17	are	VBP	O	be	auxpass	19	SENT_78	[p6l225t688r355b741],
18	not	RB	O	not	neg	19	SENT_78	[p6l391t679r534b741],
19	known	VBN	O	know	rcmod	8	SENT_78	[p6l565t662r887b742],
20	.	.	O	.	_	0	SENT_78	[p6l565t662r887b742],

1	In	IN	O	in	mark	4	SENT_79	[p6l927t670r1017b740],
2	order	NN	O	order	dep	4	SENT_79	[p6l1053t662r1282b741],
3	to	TO	O	to	aux	4	SENT_79	[p6l1315t679r1398b741],
4	provide	VB	O	provide	dep	27	SENT_79	[p6l1434t662r1753b763],
5	children	NNS	O	child	dobj	4	SENT_79	[p6l1790t662r2148b741],
6	and	CC	O	and	_	0	SENT_79	[p6l12t790r170b869],
7	adolescents	NNS	O	adolescent	dobj	4	SENT_79	[p6l205t790r701b869],
8	who	WP	O	who	nsubj	9	SENT_79	[p6l735t790r919b869],
9	need	VBP	O	need	rcmod	5	SENT_79	[p6l956t790r1158b869],
10	warfarin	NN	O	warfarin	nn	11	SENT_79	[p6l1189t790r1565b870],
11	therapy	NN	O	therapy	dobj	9	SENT_79	[p6l1601t790r1925b891],
12	with	IN	O	with	_	0	SENT_79	[p6l1952t790r2148b869],
13	the	DT	O	the	det	16	SENT_79	[p6l12t918r142b997],
14	same	JJ	O	same	amod	16	SENT_79	[p6l180t944r395b997],
15	pharmacogenomic	JJ	O	pharmacogenomic	amod	16	SENT_79	[p6l430t918r1216b1019],
16	advances	NNS	O	advance	prep_with	11	SENT_79	[p6l1252t918r1621b997],
17	that	WDT	O	that	nsubjpass	20	SENT_79	[p6l1660t918r1827b997],
18	are	VBP	O	be	aux	20	SENT_79	[p6l1857t944r1983b997],
19	being	VBG	O	be	auxpass	20	SENT_79	[p6l2020t918r2147b997, p6l12t1047r147b1147],
20	integrated	VBN	O	integrate	rcmod	11	SENT_79	[p6l196t1046r639b1147],
21	into	IN	O	into	_	0	SENT_79	[p6l696t1047r866b1125],
22	adult	JJ	O	adult	amod	23	SENT_79	[p6l923t1046r1143b1125],
23	care	NN	O	care	prep_into	20	SENT_79	[p6l1195t1072r1395b1142],
24	,	,	O	,	_	0	SENT_79	[p6l1195t1072r1395b1142],
25	it	PRP	O	it	nsubj	27	SENT_79	[p6l1457t1047r1516b1125],
26	is	VBZ	O	be	cop	27	SENT_79	[p6l1567t1047r1634b1125],
27	imperative	JJ	O	imperative	_	0	SENT_79	[p6l1692t1047r2148b1147],
28	that	IN	O	that	complm	32	SENT_79	[p6l12t1174r180b1253],
29	pediatric	JJ	O	pediatric	amod	30	SENT_79	[p6l207t1174r574b1275],
30	studies	NNS	O	study	nsubjpass	32	SENT_79	[p6l610t1174r898b1253],
31	be	VB	O	be	auxpass	32	SENT_79	[p6l935t1174r1030b1253],
32	completed	VBN	O	complete	ccomp	27	SENT_79	[p6l1066t1174r1496b1275],
33	to	TO	O	to	aux	34	SENT_79	[p6l1531t1191r1610b1253],
34	develop	VB	O	develop	xcomp	32	SENT_79	[p6l1647t1174r1958b1275],
35	and	CC	O	and	_	0	SENT_79	[p6l1993t1174r2148b1253],
36	validate	VB	O	validate	conj_and	34	SENT_79	[p6l8t1302r342b1381],
37	a	DT	O	a	det	39	SENT_79	[p6l389t1329r433b1381],
38	dosing	NN	O	dosing	nn	39	SENT_79	[p6l479t1302r772b1403],
39	nomogram	NN	O	nomogram	dobj	34	SENT_79	[p6l814t1328r1298b1403],
40	that	WDT	O	that	nsubj	41	SENT_79	[p6l1344t1302r1518b1381],
41	considers	VBZ	O	consider	rcmod	39	SENT_79	[p6l1560t1302r1966b1381],
42	the	DT	O	the	det	43	SENT_79	[p6l2014t1302r2148b1381],
43	effect	NN	O	effect	dobj	41	SENT_79	[p6l13t1430r245b1509],
44	of	IN	O	of	_	0	SENT_79	[p6l277t1430r376b1509],
45	both	DT	O	both	det	46	SENT_79	[p6l394t1430r586b1509],
46	development	NN	O	development	prep_of	43	SENT_79	[p6l622t1430r1153b1531],
47	and	CC	O	and	_	0	SENT_79	[p6l1183t1430r1338b1509],
48	concomitant	JJ	O	concomitant	amod	49	SENT_79	[p6l1375t1431r1903b1509],
49	treatment	NN	O	treatment	conj_and	46	SENT_79	[p6l1933t1447r2147b1509, p6l12t1575r231b1637],
50	on	IN	O	on	_	0	SENT_79	[p6l260t1584r366b1637],
51	the	DT	O	the	det	55	SENT_79	[p6l400t1558r531b1637],
52	disposition	NN	O	disposition	nn	55	SENT_79	[p6l566t1558r1038b1659],
53	and	CC	O	and	_	0	SENT_79	[p6l1070t1558r1227b1637],
54	action	NN	O	action	conj_and	52	SENT_79	[p6l1260t1559r1519b1637],
55	ofwarfarin	NN	O	ofwarfarin	prep_on	41	SENT_79	[p6l1553t1558r2032b1638],
56	in	IN	O	in	_	0	SENT_79	[p6l2066t1559r2148b1636],
57	children	NNS	O	child	prep_in	55	SENT_79	[p6l13t1687r371b1766],
58	and	CC	O	and	_	0	SENT_79	[p6l409t1687r568b1766],
59	adolescents	NNS	O	adolescent	conj_and	57	SENT_79	[p6l608t1687r1129b1766],
60	.	.	O	.	_	0	SENT_79	[p6l608t1687r1129b1766],

1	Kathleen	NNP	PERSON	Kathleen	nn	3	SENT_80	[p6l20t1826r391b1906],
2	A.	NNP	PERSON	A.	nn	3	SENT_80	[p6l426t1831r509b1906],
3	Neville	NNP	PERSON	Neville	_	0	SENT_80	[p6l553t1826r871b1921],
4	,	,	O	,	_	0	SENT_80	[p6l553t1826r871b1921],
5	M.D.	NNP	PERSON	M.D.	nn	8	SENT_80	[p6l916t1833r1123b1906],
6	Brian	NNP	PERSON	Brian	nn	8	SENT_80	[p6l20t1962r238b2035],
7	M.	NNP	PERSON	M.	nn	8	SENT_80	[p6l283t1962r386b2035],
8	Wicklund	NNP	PERSON	Wicklund	appos	3	SENT_80	[p6l420t1955r856b2050],
9	,	,	O	,	_	0	SENT_80	[p6l420t1955r856b2050],
10	M.D.C.M.	NNP	O	M.D.C.M.	appos	3	SENT_80	[p6l902t1960r1350b2050],
11	,	,	O	,	_	0	SENT_80	[p6l902t1960r1350b2050],
12	M.P.H.	NNP	O	M.P.H.	nn	15	SENT_80	[p6l1395t1962r1696b2035],
13	Gregory	NNP	PERSON	Gregory	nn	15	SENT_80	[p6l15t2091r364b2190],
14	L.	NNP	PERSON	L.	nn	15	SENT_80	[p6l402t2092r464b2164],
15	Kearns	NNP	PERSON	Kearns	appos	3	SENT_80	[p6l508t2092r823b2179],
16	,	,	O	,	_	0	SENT_80	[p6l508t2092r823b2179],
17	Pharm	NNP	O	Pharm	appos	3	SENT_80	[p6l868t2085r1304b2179],
18	.	.	O	.	_	0	SENT_80	[p6l868t2085r1304b2179],

1	D.	NNP	O	D.	_	0	SENT_81	[p6l868t2085r1304b2179],
2	,	,	O	,	_	0	SENT_81	[p6l868t2085r1304b2179],
3	Ph.D.	NNP	O	Ph.D.	appos	1	SENT_81	[p6l1349t2085r1579b2164],
4	.	.	O	.	_	0	SENT_81	[p6l1349t2085r1579b2164],

1	Children	NNS	O	child	poss	5	SENT_82	[p6l12t2228r350b2289],
2	’s	POS	O	’s	_	0	SENT_82	[p6l12t2228r350b2289],
3	Mercy	NNP	O	Mercy	nn	5	SENT_82	[p6l382t2234r585b2308],
4	Hospital	NNP	O	Hospital	nn	5	SENT_82	[p6l613t2228r893b2307],
5	Kansas	NNP	LOCATION	Kansas	_	0	SENT_82	[p6l17t2329r247b2385],
6	City	NNP	LOCATION	City	nn	8	SENT_82	[p6l274t2328r416b2404],
7	,	,	O	,	_	0	SENT_82	[p6l274t2328r416b2404],
8	MO	NNP	DURATION	MO	dep	5	SENT_82	[p6l450t2328r572b2385],
9	64079	CD	NUMBER	64079	number	10	SENT_82	[p6l599t2327r798b2385],
10	1	CD	NUMBER	1	dep	8	SENT_82	[p6l13t2436r63b2488],
11	.	.	O	.	_	0	SENT_82	[p6l13t2436r63b2488],

1	Andrew	NNP	PERSON	Andrew	nn	2	SENT_83	[p6l138t2429r402b2489],
2	M	NNP	PERSON	M	_	0	SENT_83	[p6l422t2434r505b2501],
3	,	,	O	,	_	0	SENT_83	[p6l422t2434r505b2501],
4	Vegh	NNP	PERSON	Vegh	nn	5	SENT_83	[p6l533t2429r696b2505],
5	P	NN	PERSON	p	appos	2	SENT_83	[p6l721t2434r772b2501],
6	,	,	O	,	_	0	SENT_83	[p6l721t2434r772b2501],
7	Johnston	NNP	PERSON	Johnston	nn	8	SENT_83	[p6l795t2429r1098b2498],
8	M	NNP	O	M	appos	2	SENT_83	[p6l1121t2434r1204b2501],
9	,	,	O	,	_	0	SENT_83	[p6l1121t2434r1204b2501],
10	Bowker	NNP	PERSON	Bowker	nn	11	SENT_83	[p6l1233t2429r1484b2489],
11	J	NNP	PERSON	J	appos	2	SENT_83	[p6l1500t2434r1544b2501],
12	,	,	O	,	_	0	SENT_83	[p6l1500t2434r1544b2501],
13	Ofosu	NNP	PERSON	Ofosu	nn	14	SENT_83	[p6l1574t2428r1771b2489],
14	F	NN	O	f	appos	2	SENT_83	[p6l1796t2434r1847b2501],
15	,	,	O	,	_	0	SENT_83	[p6l1796t2434r1847b2501],
16	Mitchell	NNP	PERSON	Mitchell	nn	18	SENT_83	[p6l1875t2429r2149b2488],
17	L.	NNP	O	L.	nn	18	SENT_83	[p6l10t2520r68b2574],
18	Maturation	NNP	O	Maturation	appos	2	SENT_83	[p6l92t2515r465b2575],
19	of	IN	O	of	_	0	SENT_83	[p6l488t2514r564b2574],
20	the	DT	O	the	det	22	SENT_83	[p6l573t2515r675b2574],
21	hemostatic	JJ	O	hemostatic	amod	22	SENT_83	[p6l698t2515r1064b2574],
22	system	NN	O	system	prep_of	18	SENT_83	[p6l1087t2527r1311b2591],
23	during	IN	O	during	_	0	SENT_83	[p6l1334t2515r1556b2591],
24	childhood	NN	O	childhood	prep_during	22	SENT_83	[p6l1576t2515r1931b2574],
25	.	.	O	.	_	0	SENT_83	[p6l1576t2515r1931b2574],

1	Blood	NN	O	blood	_	0	SENT_84	[p6l1957t2515r2149b2574],
2	1992	CD	DATE	1992	num	1	SENT_84	[p6l13t2613r652b2681],
3	;	:	O	;	_	0	SENT_84	[p6l13t2613r652b2681],
4	80:1998	CD	DURATION	80:1998	number	5	SENT_84	[p6l13t2613r652b2681],
5	-2005	CD	DURATION	-2005	dep	1	SENT_84	[p6l13t2613r652b2681],
6	.	.	O	.	_	0	SENT_84	[p6l13t2613r652b2681],

1	2	LS	NUMBER	2	_	0	SENT_85	[p6l9t2702r64b2754],
2	.	.	O	.	_	0	SENT_85	[p6l9t2702r64b2754],

1	Sosothikul	NN	O	sosothikul	nn	2	SENT_86	[p6l142t2695r502b2755],
2	D	NN	O	d	_	0	SENT_86	[p6l529t2700r597b2767],
3	,	,	O	,	_	0	SENT_86	[p6l529t2700r597b2767],
4	Seksarn	NNP	PERSON	Seksarn	nn	5	SENT_86	[p6l630t2695r890b2755],
5	P	NN	PERSON	p	appos	2	SENT_86	[p6l917t2700r968b2767],
6	,	,	O	,	_	0	SENT_86	[p6l917t2700r968b2767],
7	Lusher	NNP	PERSON	Lusher	nn	8	SENT_86	[p6l998t2695r1222b2755],
8	JM	NN	O	jm	appos	5	SENT_86	[p6l1240t2700r1352b2763],
9	.	.	O	.	_	0	SENT_86	[p6l1240t2700r1352b2763],

1	Pediatric	NNP	O	Pediatric	nn	3	SENT_87	[p6l1383t2695r1676b2754],
2	reference	NN	O	reference	nn	3	SENT_87	[p6l1703t2694r2006b2754],
3	values	NNS	O	value	_	0	SENT_87	[p6l2031t2695r2148b2755, p6l11t2801r117b2841],
4	for	IN	O	for	_	0	SENT_87	[p6l143t2780r238b2840],
5	molecular	JJ	O	molecular	amod	6	SENT_87	[p6l260t2781r594b2841],
6	markers	NNS	O	marker	prep_for	3	SENT_87	[p6l616t2781r886b2841],
7	in	IN	O	in	_	0	SENT_87	[p6l912t2781r975b2839],
8	hemostasis	NN	O	hemostasis	prep_in	3	SENT_87	[p6l1000t2781r1389b2840],
9	.	.	O	.	_	0	SENT_87	[p6l1000t2781r1389b2840],

1	J	NNP	O	J	nn	4	SENT_88	[p6l1410t2786r1439b2849],
2	Pediatr	NNP	O	Pediatr	nn	4	SENT_88	[p6l1461t2781r1697b2840],
3	Hematol	NNP	O	Hematol	nn	4	SENT_88	[p6l1719t2781r2003b2840],
4	Oncol	NNP	O	Oncol	_	0	SENT_88	[p6l2027t2785r2148b2840, p6l12t2874r106b2932],
5	2007	CD	DATE	2007	num	4	SENT_88	[p6l131t2878r608b2945],
6	;	:	O	;	_	0	SENT_88	[p6l131t2878r608b2945],
7	29:19	CD	NUMBER	29:19	number	8	SENT_88	[p6l131t2878r608b2945],
8	—	CD	NUMBER	—	dep	4	SENT_88	[p6l131t2878r608b2945],
9	22	CD	NUMBER	22	dep	8	SENT_88	[p6l131t2878r608b2945],
10	.	.	O	.	_	0	SENT_88	[p6l131t2878r608b2945],

1	To	TO	O	to	dep	7	SENT_89	[p6l10t3147r123b3202],
2	TH	NN	O	th	nn	4	SENT_89	[p6l150t3148r258b3202],
3	E	NN	O	e	nn	4	SENT_89	[p6l277t3148r314b3202],
4	EDITOR	NN	O	editor	pobj	1	SENT_89	[p6l350t3147r687b3203],
5	:	:	O	:	_	0	SENT_89	[p6l350t3147r687b3203],
6	The	DT	O	the	det	7	SENT_89	[p6l716t3124r878b3203],
7	study	NN	O	study	_	0	SENT_89	[p6l908t3124r1139b3225],
8	reported	VBN	O	report	partmod	7	SENT_89	[p6l1164t3124r1533b3225],
9	by	IN	O	by	_	0	SENT_89	[p6l1562t3124r1660b3225],
10	Schwarz	NNP	PERSON	Schwarz	agent	8	SENT_89	[p6l1686t3124r2045b3203],
11	et	FW	O	et	nn	12	SENT_89	[p6l2075t3141r2153b3203],
12	al.	FW	O	al.	tmod	8	SENT_89	[p6l11t3252r108b3331],
13	shows	VBZ	O	show	rcmod	12	SENT_89	[p6l155t3252r420b3332],
14	that	IN	O	that	complm	17	SENT_89	[p6l463t3252r636b3331],
15	genetic	JJ	O	genetic	amod	16	SENT_89	[p6l670t3253r981b3353],
16	polymorphisms	NNS	O	polymorphism	nsubj	17	SENT_89	[p6l1018t3252r1700b3353],
17	influence	VBP	O	influence	ccomp	13	SENT_89	[p6l1741t3252r2148b3331],
18	the	DT	O	the	det	20	SENT_89	[p6l12t3380r146b3459],
19	initial	JJ	O	initial	amod	20	SENT_89	[p6l180t3380r438b3459],
20	response	NN	O	response	dobj	17	SENT_89	[p6l472t3406r855b3481],
21	to	TO	O	to	_	0	SENT_89	[p6l890t3397r972b3459],
22	warfarin	NN	O	warfarin	nn	23	SENT_89	[p6l1003t3380r1379b3459],
23	therapy	NN	O	therapy	prep_to	17	SENT_89	[p6l1414t3380r1751b3481],
24	,	,	O	,	_	0	SENT_89	[p6l1414t3380r1751b3481],
25	suggesting	VBG	O	suggest	partmod	17	SENT_89	[p6l1793t3397r2147b3481, p6l11t3509r151b3609],
26	that	IN	O	that	complm	30	SENT_89	[p6l198t3508r371b3587],
27	pharmacogenomic	JJ	O	pharmacogenomic	amod	28	SENT_89	[p6l413t3508r1229b3609],
28	testing	NN	O	testing	nsubj	30	SENT_89	[p6l1278t3509r1577b3609],
29	could	MD	O	could	aux	30	SENT_89	[p6l1623t3508r1860b3587],
30	guide	VB	O	guide	ccomp	25	SENT_89	[p6l1908t3508r2148b3609],
31	warfarin	NN	O	warfarin	nn	32	SENT_89	[p6l7t3636r384b3715],
32	dosing	NN	O	dosing	dobj	30	SENT_89	[p6l422t3636r734b3737],
33	.	.	O	.	_	0	SENT_89	[p6l422t3636r734b3737],

1	However	RB	O	however	advmod	4	SENT_90	[p6l776t3644r1173b3732],
2	,	,	O	,	_	0	SENT_90	[p6l776t3644r1173b3732],
3	a	DT	O	a	nsubj	4	SENT_90	[p6l1216t3663r1260b3715],
4	recent	JJ	O	recent	_	0	SENT_90	[p6l1296t3653r1562b3715],
5	randomized	VBN	O	randomize	partmod	4	SENT_90	[p6l1595t3636r2142b3732],
6	,	,	O	,	_	0	SENT_90	[p6l1595t3636r2142b3732],

1	controlled	JJ	O	controlled	amod	2	SENT_91	[p7l12t20r453b99],
2	trial1	NN	O	trial1	nsubj	3	SENT_91	[p7l503t20r719b99],
3	concluded	VBD	O	conclude	_	0	SENT_91	[p7l769t20r1208b99],
4	that	IN	O	that	complm	32	SENT_91	[p7l1257t20r1431b99],
5	although	IN	O	although	mark	10	SENT_91	[p7l1475t20r1864b121],
6	fewer	JJR	O	fewer	amod	8	SENT_91	[p7l1913t20r2152b99],
7	dose	NN	O	dose	nn	8	SENT_91	[p7l12t148r208b227],
8	changes	NNS	O	change	nsubjpass	10	SENT_91	[p7l243t148r593b249],
9	were	VBD	O	be	auxpass	10	SENT_91	[p7l625t174r828b227],
10	required	VBN	O	require	advcl	32	SENT_91	[p7l862t148r1226b249],
11	to	TO	O	to	aux	12	SENT_91	[p7l1261t165r1343b227],
12	achieve	VB	O	achieve	xcomp	10	SENT_91	[p7l1379t148r1692b227],
13	the	DT	O	the	det	14	SENT_91	[p7l1727t148r1860b227],
14	target	NN	O	target	dobj	12	SENT_91	[p7l1896t165r2153b249],
15	IN	IN	O	in	_	0	SENT_91	[p7l11t284r120b355],
16	R	NN	O	r	prep_in	14	SENT_91	[p7l122t283r195b360],
17	with	IN	O	with	mark	20	SENT_91	[p7l210t276r403b355],
18	genotype	NN	O	genotype	nn	19	SENT_91	[p7l433t276r1150b377],
19	—	NN	O	—	nsubj	20	SENT_91	[p7l433t276r1150b377],
20	guided	VBD	O	guide	advcl	12	SENT_91	[p7l433t276r1150b377],
21	dosing	NN	O	dosing	dobj	20	SENT_91	[p7l1180t276r1468b377],
22	than	IN	O	than	prep	20	SENT_91	[p7l1495t276r1689b355],
23	with	IN	O	with	pcomp	22	SENT_91	[p7l1714t276r1908b356],
24	standard	JJ	O	standard	amod	26	SENT_91	[p7l1939t293r2147b355, p7l12t404r205b483],
25	warfarin	NN	O	warfarin	nn	26	SENT_91	[p7l231t404r607b484],
26	dosing	NN	O	dosing	pobj	23	SENT_91	[p7l642t404r953b505],
27	,	,	O	,	_	0	SENT_91	[p7l642t404r953b505],
28	the	DT	O	the	det	31	SENT_91	[p7l992t404r1126b483],
29	primary	JJ	O	primary	amod	31	SENT_91	[p7l1157t405r1510b505],
30	end	NN	O	end	nn	31	SENT_91	[p7l1539t404r1694b483],
31	point	NN	O	point	nsubj	32	SENT_91	[p7l1725t405r1956b505],
32	(	VBD	O	(	ccomp	3	SENT_91	[p7l1989t404r2148b496],
33	the	DT	O	the	det	34	SENT_91	[p7l1989t404r2148b496],
34	percent	NN	O	percent	nsubj	44	SENT_91	[p7l11t549r335b633],
35	out	IN	O	out	_	0	SENT_91	[p7l372t532r900b633],
36	—	NN	O	—	prep_out	34	SENT_91	[p7l372t532r900b633],
37	of	IN	O	of	_	0	SENT_91	[p7l372t532r900b633],
38	—	NN	O	—	nn	41	SENT_91	[p7l372t532r900b633],
39	range	NN	O	range	nn	41	SENT_91	[p7l372t532r900b633],
40	INR	NN	O	inr	nn	41	SENT_91	[p7l940t539r1150b623],
41	)	NN	O	)	prep_of	36	SENT_91	[p7l940t539r1150b623],
42	did	VBD	O	do	aux	44	SENT_91	[p7l1198t532r1333b611],
43	not	RB	O	not	neg	44	SENT_91	[p7l1374t549r1518b611],
44	differ	VB	O	differ	ccomp	32	SENT_91	[p7l1555t532r1814b611],
45	.	.	O	.	_	0	SENT_91	[p7l1555t532r1814b611],

1	A	DT	O	a	det	3	SENT_92	[p7l1858t540r1925b610],
2	possible	JJ	O	possible	amod	3	SENT_92	[p7l1962t558r2147b633, p7l13t660r206b739],
3	explanation	NN	O	explanation	nsubj	7	SENT_92	[p7l251t660r760b761],
4	for	IN	O	for	_	0	SENT_92	[p7l803t660r927b739],
5	this	DT	O	this	det	6	SENT_92	[p7l969t660r1129b739],
6	finding	NN	O	finding	prep_for	3	SENT_92	[p7l1174t660r1501b761],
7	is	VBZ	O	be	_	0	SENT_92	[p7l1540t661r1607b739],
8	that	IN	O	that	complm	15	SENT_92	[p7l1653t660r1826b739],
9	the	DT	O	the	det	10	SENT_92	[p7l1865t660r1999b739],
10	effect	NN	O	effect	nsubjpass	15	SENT_92	[p7l2043t660r2147b739, p7l12t788r171b867],
11	of	IN	O	of	_	0	SENT_92	[p7l195t788r296b867],
12	Warfarin	NNP	MISC	Warfarin	prep_of	10	SENT_92	[p7l302t788r678b868],
13	is	VBZ	O	be	auxpass	15	SENT_92	[p7l706t789r772b867],
14	also	RB	O	also	advmod	15	SENT_92	[p7l803t788r975b867],
15	influenced	VBN	O	influence	ccomp	7	SENT_92	[p7l1004t788r1468b867],
16	by	IN	O	by	_	0	SENT_92	[p7l1497t788r1595b889],
17	the	DT	O	the	det	18	SENT_92	[p7l1619t788r1753b867],
18	patient	NN	O	patient	poss	20	SENT_92	[p7l1780t789r2145b889],
19	’s	POS	O	’s	_	0	SENT_92	[p7l1780t789r2145b889],
20	age	NN	O	age	agent	15	SENT_92	[p7l11t943r179b1017],
21	,	,	O	,	_	0	SENT_92	[p7l11t943r179b1017],
22	body	NN	O	body	nn	23	SENT_92	[p7l219t916r429b1017],
23	Weight	NNP	O	Weight	appos	20	SENT_92	[p7l455t916r771b1017],
24	,	,	O	,	_	0	SENT_92	[p7l455t916r771b1017],
25	smoking	NN	O	smoking	nn	26	SENT_92	[p7l812t916r1191b1017],
26	status	NN	O	status	appos	23	SENT_92	[p7l1224t933r1502b1012],
27	,	,	O	,	_	0	SENT_92	[p7l1224t933r1502b1012],
28	use	NN	O	use	appos	23	SENT_92	[p7l1541t943r1683b995],
29	or	CC	O	or	_	0	SENT_92	[p7l1718t942r1807b995],
30	nonuse	NN	O	nonuse	conj_or	28	SENT_92	[p7l1838t942r2148b995],
31	of	IN	O	of	_	0	SENT_92	[p7l12t1044r113b1123],
32	concomitant	JJ	O	concomitant	amod	33	SENT_92	[p7l147t1045r697b1123],
33	drugs	NNS	O	drug	prep_of	28	SENT_92	[p7l744t1044r989b1145],
34	that	WDT	O	that	nsubj	35	SENT_92	[p7l1043t1044r1217b1123],
35	modify	VBP	O	modify	rcmod	28	SENT_92	[p7l1263t1044r1577b1145],
36	CYPZC9	NN	O	cypzc9	nn	38	SENT_92	[p7l1623t1050r1962b1123],
37	enzyme	NN	O	enzyme	nn	38	SENT_92	[p7l2016t1070r2147b1123, p7l12t1198r234b1273],
38	activity	NN	O	activity	dobj	35	SENT_92	[p7l261t1173r577b1273],
39	,	,	O	,	_	0	SENT_92	[p7l261t1173r577b1273],
40	and	CC	O	and	_	0	SENT_92	[p7l610t1172r767b1251],
41	dietary	JJ	O	dietary	amod	44	SENT_92	[p7l795t1172r1091b1273],
42	vitamin	NN	O	vitamin	nn	44	SENT_92	[p7l1110t1173r1439b1251],
43	K	NN	O	k	nn	44	SENT_92	[p7l1466t1180r1534b1253],
44	intake	NN	O	intake	dobj	35	SENT_92	[p7l1557t1172r1842b1252],
45	.	.	O	.	_	0	SENT_92	[p7l1557t1172r1842b1252],

1	Therefore	RB	O	therefore	advmod	19	SENT_93	[p7l1871t1172r2147b1251, p7l12t1300r203b1396],
2	,	,	O	,	_	0	SENT_93	[p7l1871t1172r2147b1251, p7l12t1300r203b1396],
3	although	IN	O	although	mark	6	SENT_93	[p7l261t1300r650b1401],
4	genetic	JJ	O	genetic	amod	5	SENT_93	[p7l704t1301r1014b1401],
5	variations	NNS	O	variation	nsubj	6	SENT_93	[p7l1062t1301r1490b1380],
6	explain	VBP	O	explain	advcl	19	SENT_93	[p7l1547t1300r1861b1401],
7	inter	NN	O	inter	dobj	6	SENT_93	[p7l1914t1301r2147b1379],
8	—	CD	NUMBER	—	num	10	SENT_93	[p7l1914t1301r2147b1379],
9	individual	JJ	O	individual	amod	10	SENT_93	[p7l11t1428r436b1507],
10	variations	NNS	O	variation	dep	7	SENT_93	[p7l467t1429r908b1524],
11	,	,	O	,	_	0	SENT_93	[p7l467t1429r908b1524],
12	intraindividual	JJ	O	intraindividual	amod	13	SENT_93	[p7l948t1428r1579b1508],
13	variations	NNS	O	variation	nsubj	19	SENT_93	[p7l1610t1429r2028b1508],
14	in	IN	O	in	_	0	SENT_93	[p7l2066t1429r2148b1506],
15	response	NN	O	response	prep_in	13	SENT_93	[p7l12t1583r395b1658],
16	to	TO	O	to	_	0	SENT_93	[p7l438t1574r519b1636],
17	warfarin	NN	O	warfarin	prep_to	15	SENT_93	[p7l558t1557r934b1636],
18	may	MD	O	may	aux	19	SENT_93	[p7l976t1583r1156b1658],
19	depend	VB	O	depend	_	0	SENT_93	[p7l1194t1557r1508b1658],
20	largely	RB	O	largely	advmod	19	SENT_93	[p7l1548t1557r1840b1658],
21	on	IN	O	on	_	0	SENT_93	[p7l1879t1583r1985b1636],
22	acquired	VBN	O	acquire	amod	23	SENT_93	[p7l2026t1584r2147b1636, p7l12t1685r290b1786],
23	factors	NNS	O	factor	prep_on	19	SENT_93	[p7l325t1685r684b1764],
24	?	.	O	?	_	0	SENT_93	[p7l325t1685r684b1764],

1	Schwarz	NNP	PERSON	Schwarz	_	0	SENT_94	[p7l144t1813r503b1892],
2	et	FW	O	et	nn	3	SENT_94	[p7l546t1830r624b1892],
3	al.	FW	O	al.	dep	1	SENT_94	[p7l660t1813r757b1892],
4	found	VBN	O	find	partmod	1	SENT_94	[p7l804t1813r1058b1892],
5	that	IN	O	that	complm	15	SENT_94	[p7l1100t1813r1273b1892],
6	the	DT	O	the	det	7	SENT_94	[p7l1310t1813r1444b1892],
7	INR	NN	O	inr	nsubj	15	SENT_94	[p7l1484t1820r1671b1897],
8	at	IN	O	at	_	0	SENT_94	[p7l1701t1830r1781b1892],
9	the	DT	DURATION	the	det	10	SENT_94	[p7l1818t1813r1952b1892],
10	end	NN	DURATION	end	prep_at	7	SENT_94	[p7l1994t1813r2148b1892],
11	of	IN	DURATION	of	_	0	SENT_94	[p7l12t1941r113b2020],
12	the	DT	DURATION	the	det	14	SENT_94	[p7l142t1941r275b2020],
13	first	JJ	DURATION	first	amod	14	SENT_94	[p7l322t1941r507b2020],
14	week	NN	DURATION	week	prep_of	10	SENT_94	[p7l544t1941r769b2021],
15	correlated	VBD	O	correlate	ccomp	4	SENT_94	[p7l812t1941r1245b2020],
16	with	IN	O	with	_	0	SENT_94	[p7l1287t1941r1483b2020],
17	VKORC1	NN	O	vkorc1	nn	18	SENT_94	[p7l1529t1948r1853b2021],
18	geno274Z	NN	O	geno274z	prep_with	15	SENT_94	[p7l1903t1967r2147b2042, p7l149t2117r226b2139],

1	N	NN	O	n	nn	3	SENT_95	[p7l927t2127r941b2142],
2	ENGLJ	NN	O	englj	nn	3	SENT_95	[p7l955t2127r1033b2149],
3	MED	NN	O	med	_	0	SENT_95	[p7l1048t2127r1100b2142],
4	358	CD	NUMBER	358	dep	3	SENT_95	[p7l1110t2121r1185b2149],
5	;	:	O	;	_	0	SENT_95	[p7l1110t2121r1185b2149],
6	25	CD	NUMBER	25	num	8	SENT_95	[p7l1110t2121r1185b2149],
7	WWW.NEJM.ORG	NN	O	www.nejm.org	nn	8	SENT_95	[p7l1218t2127r1419b2149],
8	JUNE19	NN	O	june19	dep	4	SENT_95	[p7l1450t2127r1558b2149],
9	,	,	O	,	_	0	SENT_95	[p7l1450t2127r1558b2149],
10	2008	CD	DATE	2008	appos	8	SENT_95	[p7l1570t2121r1633b2143],

1	The	DT	O	the	det	4	SENT_96	[p7l936t2160r987b2184],
2	New	NNP	O	New	nn	4	SENT_96	[p7l996t2161r1058b2184],
3	England	NNP	O	England	nn	4	SENT_96	[p7l1067t2160r1178b2191],
4	Journal	NNP	O	Journal	_	0	SENT_96	[p7l1187t2160r1284b2184],
5	of	IN	O	of	_	0	SENT_96	[p7l1294t2160r1323b2184],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_96	[p7l1330t2160r1455b2184],

1	Downloaded	VBN	O	download	_	0	SENT_97	[p7l378t2201r548b2224],
2	from	IN	O	from	_	0	SENT_97	[p7l557t2201r622b2224],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_97	[p7l630t2201r749b2231],
4	at	IN	O	at	_	0	SENT_97	[p7l759t2205r782b2224],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_97	[p7l790t2201r973b2224],
6	on	IN	O	on	_	0	SENT_97	[p7l982t2208r1015b2224],
7	January	NNP	DATE	January	prep_on	1	SENT_97	[p7l1023t2201r1126b2231],
8	5	CD	DATE	5	num	7	SENT_97	[p7l1136t2201r1159b2228],
9	,	,	DATE	,	_	0	SENT_97	[p7l1136t2201r1159b2228],
10	2014	CD	DATE	2014	num	7	SENT_97	[p7l1169t2201r1242b2224],
11	.	.	O	.	_	0	SENT_97	[p7l1169t2201r1242b2224],

1	For	IN	O	for	_	0	SENT_98	[p7l1252t2201r1299b2224],
2	personal	JJ	O	personal	amod	3	SENT_98	[p7l1307t2201r1419b2231],
3	use	NN	O	use	pobj	1	SENT_98	[p7l1428t2208r1472b2224],
4	only	RB	O	only	advmod	3	SENT_98	[p7l1481t2201r1546b2231],
5	.	.	O	.	_	0	SENT_98	[p7l1481t2201r1546b2231],

1	No	DT	O	no	det	3	SENT_99	[p7l1557t2201r1596b2224],
2	other	JJ	O	other	amod	3	SENT_99	[p7l1606t2201r1674b2224],
3	uses	NNS	O	use	_	0	SENT_99	[p7l1683t2208r1739b2224],
4	without	IN	O	without	_	0	SENT_99	[p7l1749t2201r1850b2224],
5	permission	NN	O	permission	prep_without	3	SENT_99	[p7l1858t2201r2011b2231],
6	.	.	O	.	_	0	SENT_99	[p7l1858t2201r2011b2231],

1	Copyright	NN	O	copyright	_	0	SENT_100	[p7l729t2242r863b2273],
2	©	CD	NUMBER	©	num	6	SENT_100	[p7l872t2242r896b2266],
3	2008	CD	DATE	2008	num	6	SENT_100	[p7l906t2242r970b2266],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_100	[p7l980t2242r1171b2266],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_100	[p7l1181t2242r1289b2266],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_100	[p7l1300t2242r1405b2273],
7	.	.	O	.	_	0	SENT_100	[p7l1300t2242r1405b2273],

1	All	DT	O	all	det	2	SENT_101	[p7l1416t2242r1457b2266],
2	rights	NNS	O	rights	nsubj	3	SENT_101	[p7l1466t2242r1541b2273],
3	reserved	VBN	O	reserve	_	0	SENT_101	[p7l1551t2242r1669b2266],
4	.	.	O	.	_	0	SENT_101	[p7l1551t2242r1669b2266],

1	OOOOOOOOOOOO	NNP	O	OOOOOOOOOOOO	nn	2	SENT_102	[p7l926t2348r1191b2367],
2	CE	NNP	O	CE	_	0	SENT_102	[p7l1195t2348r1233b2367],

1	types	NNS	O	type	_	0	SENT_103	[p7l12t2579r261b2663],
2	.	.	O	.	_	0	SENT_103	[p7l12t2579r261b2663],

1	Conversely	RB	O	conversely	advmod	5	SENT_104	[p7l308t2562r788b2663],
2	,	,	O	,	_	0	SENT_104	[p7l308t2562r788b2663],
3	one	CD	NUMBER	one	nsubj	5	SENT_104	[p7l835t2588r987b2641],
4	could	MD	O	could	aux	5	SENT_104	[p7l1029t2562r1264b2641],
5	conclude	VB	O	conclude	_	0	SENT_104	[p7l1305t2562r1687b2641],
6	that	IN	O	that	complm	13	SENT_104	[p7l1728t2562r1901b2641],
7	measuring	VBG	O	measure	csubj	13	SENT_104	[p7l1936t2588r2145b2641, p7l13t2692r291b2792],
8	the	DT	O	the	det	9	SENT_104	[p7l337t2691r470b2770],
9	INR	NN	O	inr	dobj	7	SENT_104	[p7l518t2698r705b2775],
10	at	IN	O	at	_	0	SENT_104	[p7l743t2708r822b2770],
11	1	CD	DURATION	1	num	12	SENT_104	[p7l869t2697r913b2769],
12	Week	NN	DURATION	week	prep_at	7	SENT_104	[p7l958t2691r1183b2771],
13	obviates	VBZ	O	obviate	ccomp	5	SENT_104	[p7l1228t2691r1578b2770],
14	the	DT	O	the	det	15	SENT_104	[p7l1630t2691r1762b2770],
15	need	NN	O	need	dobj	13	SENT_104	[p7l1812t2691r2014b2770],
16	to	TO	O	to	aux	17	SENT_104	[p7l2064t2708r2145b2770],
17	analyze	VB	O	analyze	infmod	15	SENT_104	[p7l11t2829r335b2930],
18	VKORC1	NN	O	vkorc1	nn	19	SENT_104	[p7l369t2836r694b2909],
19	polymorphisms	NNS	O	polymorphism	dobj	17	SENT_104	[p7l730t2829r1437b2930],
20	.	.	O	.	_	0	SENT_104	[p7l730t2829r1437b2930],

1	Phenotypic	JJ	MISC	phenotypic	amod	2	SENT_105	[p7l1476t2829r1955b2930],
2	variables	NNS	O	variable	nsubj	19	SENT_105	[p7l1984t2855r2145b2908, p7l11t2968r250b3047],
3	such	JJ	O	such	_	0	SENT_105	[p7l285t2968r477b3047],
4	as	IN	O	as	_	0	SENT_105	[p7l508t2995r593b3047],
5	the	DT	O	the	det	17	SENT_105	[p7l626t2968r758b3047],
6	IN	IN	O	in	amod	17	SENT_105	[p7l788t2976r898b3047],
7	R	NN	O	r	nn	10	SENT_105	[p7l900t2975r973b3052],
8	and	CC	O	and	_	0	SENT_105	[p7l994t2968r1151b3047],
9	plasma	NN	O	plasma	nn	10	SENT_105	[p7l1181t2968r1487b3069],
10	concentrations	NNS	O	concentration	dep	6	SENT_105	[p7l1518t2969r2145b3047],
11	of	IN	O	of	_	0	SENT_105	[p7l12t3108r112b3187],
12	warfarin	NN	O	warfarin	prep_of	10	SENT_105	[p7l126t3108r503b3187],
13	and	CC	O	and	_	0	SENT_105	[p7l539t3108r698b3187],
14	7	CD	NUMBER	7	num	15	SENT_105	[p7l737t3108r1158b3209],
15	—	CD	NUMBER	—	conj_and	12	SENT_105	[p7l737t3108r1158b3209],
16	hydroXy	NN	O	hydroxy	nn	17	SENT_105	[p7l737t3108r1158b3209],
17	warfarin	NN	O	warfarin	prep_such_as	2	SENT_105	[p7l1186t3108r1563b3187],
18	may	MD	O	may	aux	19	SENT_105	[p7l1600t3134r1780b3209],
19	account	VB	O	account	_	0	SENT_105	[p7l1812t3125r2152b3187],
20	for	IN	O	for	mark	38	SENT_105	[p7l11t3248r133b3327],
21	inherited	VBN	O	inherit	csubj	38	SENT_105	[p7l166t3248r551b3327],
22	as	IN	O	as	_	0	SENT_105	[p7l587t3275r672b3327],
23	Well	NNP	O	Well	prep_as	21	SENT_105	[p7l707t3248r882b3328],
24	as	IN	O	as	_	0	SENT_105	[p7l918t3275r1003b3327],
25	acquired	VBN	O	acquire	amod	26	SENT_105	[p7l1042t3248r1407b3349],
26	factors	NNS	O	factor	prep_as	21	SENT_105	[p7l1443t3248r1729b3327],
27	affecting	VBG	O	affect	partmod	26	SENT_105	[p7l1767t3248r2151b3349],
28	the	DT	O	the	det	33	SENT_105	[p7l12t3387r145b3466],
29	warfarin	NN	O	warfarin	nn	33	SENT_105	[p7l195t3387r572b3466],
30	dose	NN	O	dose	nn	33	SENT_105	[p7l627t3387r1266b3488],
31	—	NN	O	—	nn	33	SENT_105	[p7l627t3387r1266b3488],
32	response	NN	O	response	nn	33	SENT_105	[p7l627t3387r1266b3488],
33	relationship	NN	O	relationship	dobj	27	SENT_105	[p7l1322t3387r1839b3488],
34	better	JJR	O	better	amod	33	SENT_105	[p7l1896t3387r2150b3466],
35	than	IN	O	than	_	0	SENT_105	[p7l12t3526r209b3605],
36	pharmacogenomic	JJ	O	pharmacogenomic	amod	37	SENT_105	[p7l247t3526r1063b3627],
37	approaches	NNS	O	approach	prep_than	34	SENT_105	[p7l1102t3526r1587b3627],
38	do	VBP	O	do	advcl	19	SENT_105	[p7l1630t3526r1856b3605],
39	.3	NN	NUMBER	.3	nn	43	SENT_105	[p7l1630t3526r1856b3605],
40	v4	NN	O	v4	nn	43	SENT_105	[p7l1630t3526r1856b3605],
41	Uday	NNP	PERSON	Uday	nn	43	SENT_105	[p7l18t3672r236b3778],
42	P.	NNP	PERSON	P.	nn	43	SENT_105	[p7l274t3680r342b3752],
43	Kulkarni	NNP	PERSON	Kulkarni	dobj	38	SENT_105	[p7l386t3672r763b3767],
44	,	,	O	,	_	0	SENT_105	[p7l386t3672r763b3767],
45	M.B.	NNP	LOCATION	M.B.	nn	47	SENT_105	[p7l808t3680r1028b3767],
46	,	,	O	,	_	0	SENT_105	[p7l808t3680r1028b3767],
47	B.S.	NNP	O	B.S.	appos	43	SENT_105	[p7l1073t3679r1230b3752],

1	Dilip	NNP	PERSON	Dilip	nn	3	SENT_106	[p8l20t28r218b133],
2	R.	NNP	PERSON	R.	nn	3	SENT_106	[p8l259t36r330b108],
3	Karnad	NNP	PERSON	Karnad	_	0	SENT_106	[p8l375t28r701b123],
4	,	,	O	,	_	0	SENT_106	[p8l375t28r701b123],
5	M.D.	NNP	PERSON	M.D.	nn	6	SENT_106	[p8l746t36r953b108],
6	Nithyaj	NNP	PERSON	Nithyaj	appos	3	SENT_106	[p8l20t141r381b247],
7	.	.	O	.	_	0	SENT_106	[p8l20t141r381b247],

1	Gogtay	NNP	O	Gogtay	nn	10	SENT_107	[p8l419t148r750b247],
2	,	,	O	,	_	0	SENT_107	[p8l419t148r750b247],
3	M.D.	NNP	O	M.D.	appos	10	SENT_107	[p8l795t149r1029b236],
4	,	,	O	,	_	0	SENT_107	[p8l795t149r1029b236],
5	D.N.B.	NNP	ORGANIZATION	D.N.B.	appos	10	SENT_107	[p8l1074t149r1359b221],
6	King	NNP	ORGANIZATION	King	nn	10	SENT_107	[p8l16t279r160b354],
7	Edward	NNP	ORGANIZATION	Edward	nn	10	SENT_107	[p8l189t274r429b335],
8	Memorial	NNP	ORGANIZATION	Memorial	nn	10	SENT_107	[p8l463t274r781b334],
9	Hospital	NNP	ORGANIZATION	Hospital	nn	10	SENT_107	[p8l815t274r1095b353],
10	Mumbai	NNP	ORGANIZATION	Mumbai	_	0	SENT_107	[p8l16t370r290b431],
11	400012	CD	NUMBER	400012	num	10	SENT_107	[p8l316t374r582b441],
12	,	,	O	,	_	0	SENT_107	[p8l316t374r582b441],
13	India	NNP	LOCATION	India	nn	15	SENT_107	[p8l616t370r776b430],
14	upk30@rediffmai	NN	O	upk30@rediffmai	nn	15	SENT_107	[p8l14t465r796b545],
15	|	NN	O	|	appos	10	SENT_107	[p8l14t465r796b545],
16	.	.	O	.	_	0	SENT_107	[p8l14t465r796b545],

1	com	NN	O	com	_	0	SENT_108	[p8l14t465r796b545],
2	1	CD	NUMBER	1	dep	1	SENT_108	[p8l13t589r62b641],
3	.	.	O	.	_	0	SENT_108	[p8l13t589r62b641],

1	Anderson	NNP	PERSON	Anderson	nn	2	SENT_109	[p8l137t581r459b641],
2	IL	NN	O	il	_	0	SENT_109	[p8l476t586r564b654],
3	,	,	O	,	_	0	SENT_109	[p8l476t586r564b654],
4	Home	NNP	O	Home	nn	5	SENT_109	[p8l592t586r798b641],
5	BD	NNP	O	BD	appos	2	SENT_109	[p8l821t586r934b653],
6	,	,	O	,	_	0	SENT_109	[p8l821t586r934b653],
7	Stevens	NNP	PERSON	Stevens	nn	8	SENT_109	[p8l965t585r1207b641],
8	SM	NNP	O	SM	appos	2	SENT_109	[p8l1234t585r1352b654],
9	,	,	O	,	_	0	SENT_109	[p8l1234t585r1352b654],
10	et	FW	O	et	nn	11	SENT_109	[p8l1380t594r1440b640],
11	al.	FW	O	al.	appos	2	SENT_109	[p8l1460t581r1535b641],
12	.	.	O	.	_	0	SENT_109	[p8l1460t581r1535b641],

1	Randomized	VBN	O	randomize	_	0	SENT_110	[p8l1562t581r1987b644],
2	trial	NN	O	trial	dobj	1	SENT_110	[p8l2011t581r2148b640],
3	of	IN	O	of	_	0	SENT_110	[p8l11t677r87b737],
4	genotype-guided	JJ	O	genotype-guided	prep_of	2	SENT_110	[p8l99t677r660b754],
5	versus	CC	O	versus	prep	4	SENT_110	[p8l683t697r889b737],
6	standard	JJ	O	standard	amod	8	SENT_110	[p8l917t677r1209b737],
7	warfarin	NN	O	warfarin	nn	8	SENT_110	[p8l1232t677r1520b737],
8	dosing	NN	O	dosing	dep	5	SENT_110	[p8l1547t677r1771b754],
9	in	IN	O	in	_	0	SENT_110	[p8l1794t678r1858b736],
10	patients	NNS	O	patient	prep_in	1	SENT_110	[p8l1883t678r2147b753],
11	initiating	VBG	O	initiate	partmod	10	SENT_110	[p8l9t776r322b852],
12	oral	JJ	O	oral	amod	13	SENT_110	[p8l346t775r474b835],
13	anticoagulation	NN	O	anticoagulation	dobj	11	SENT_110	[p8l499t775r1042b852],
14	.	.	O	.	_	0	SENT_110	[p8l499t775r1042b852],

1	Circulation	NN	O	circulation	_	0	SENT_111	[p8l1072t775r1444b835],
2	2007	CD	DATE	2007	num	1	SENT_111	[p8l1470t779r2061b847],
3	;	:	O	;	_	0	SENT_111	[p8l1470t779r2061b847],
4	116:2563	CD	NUMBER	116:2563	number	5	SENT_111	[p8l1470t779r2061b847],
5	—	CD	NUMBER	—	dep	1	SENT_111	[p8l1470t779r2061b847],
6	70	CD	NUMBER	70	dep	5	SENT_111	[p8l1470t779r2061b847],
7	.	.	O	.	_	0	SENT_111	[p8l1470t779r2061b847],

1	2	LS	NUMBER	2	_	0	SENT_112	[p8l9t879r63b930],
2	.	.	O	.	_	0	SENT_112	[p8l9t879r63b930],

1	Wadelius	NNP	MISC	Wadelius	nn	2	SENT_113	[p8l137t871r438b931],
2	M	NNP	O	M	_	0	SENT_113	[p8l460t877r542b944],
3	,	,	O	,	_	0	SENT_113	[p8l460t877r542b944],
4	Pirmohamed	NNP	PERSON	Pirmohamed	nn	6	SENT_113	[p8l567t871r997b931],
5	M.	NNP	PERSON	M.	nn	6	SENT_113	[p8l1017t877r1099b931],
6	Pharmacogenetics	NNP	PERSON	Pharmacogenetics	appos	2	SENT_113	[p8l1125t871r1733b948],
7	of	IN	O	of	_	0	SENT_113	[p8l1757t871r1833b931],
8	warfarin	NN	O	warfarin	prep_of	6	SENT_113	[p8l1837t871r2145b931],
9	:	:	O	:	_	0	SENT_113	[p8l1837t871r2145b931],
10	current	JJ	DATE	current	amod	11	SENT_113	[p8l11t982r253b1029],
11	status	NN	O	status	dep	2	SENT_113	[p8l273t982r467b1029],
12	and	CC	O	and	_	0	SENT_113	[p8l491t969r611b1029],
13	future	JJ	DATE	future	amod	14	SENT_113	[p8l634t969r836b1029],
14	challenges	NNS	O	challenge	conj_and	11	SENT_113	[p8l860t969r1228b1046],
15	.	.	O	.	_	0	SENT_113	[p8l860t969r1228b1046],

1	PharmacogenomicsJ	NN	O	pharmacogenomicsj	_	0	SENT_114	[p8l1253t969r1953b1046],
2	2007	CD	DATE	2007	num	1	SENT_114	[p8l1974t973r2145b1041],
3	;	:	O	;	_	0	SENT_114	[p8l1974t973r2145b1041],
4	7:99	CD	NUMBER	7:99	number	5	SENT_114	[p8l11t1070r304b1126],
5	-111	CD	NUMBER	-111	dep	1	SENT_114	[p8l11t1070r304b1126],
6	.	.	O	.	_	0	SENT_114	[p8l11t1070r304b1126],

1	3	LS	NUMBER	3	_	0	SENT_115	[p8l10t1170r60b1223],
2	.	.	O	.	_	0	SENT_115	[p8l10t1170r60b1223],

1	Millican	NNP	ORGANIZATION	Millican	nn	2	SENT_116	[p8l138t1163r415b1222],
2	EA	NN	ORGANIZATION	ea	_	0	SENT_116	[p8l448t1168r559b1235],
3	,	,	O	,	_	0	SENT_116	[p8l448t1168r559b1235],
4	Lenzini	NNP	ORGANIZATION	Lenzini	nn	5	SENT_116	[p8l596t1164r846b1222],
5	PA	NN	ORGANIZATION	pa	appos	2	SENT_116	[p8l879t1168r982b1235],
6	,	,	O	,	_	0	SENT_116	[p8l879t1168r982b1235],
7	Milligan	NNP	PERSON	Milligan	nn	8	SENT_116	[p8l1018t1163r1301b1240],
8	PE	NNP	O	PE	appos	2	SENT_116	[p8l1335t1168r1434b1235],
9	,	,	O	,	_	0	SENT_116	[p8l1335t1168r1434b1235],
10	et	FW	O	et	nn	11	SENT_116	[p8l1473t1176r1532b1222],
11	al.	FW	O	al.	appos	2	SENT_116	[p8l1562t1163r1637b1223],
12	.	.	O	.	_	0	SENT_116	[p8l1562t1163r1637b1223],

1	Genetic	JJ	O	genetic	amod	2	SENT_117	[p8l1676t1163r2148b1223],
2	—	NN	O	—	nsubj	3	SENT_117	[p8l1676t1163r2148b1223],
3	based	VBN	O	base	_	0	SENT_117	[p8l1676t1163r2148b1223],
4	dosing	NN	O	dosing	dobj	3	SENT_117	[p8l11t1260r235b1337],
5	in	IN	O	in	_	0	SENT_117	[p8l252t1261r316b1319],
6	orthopedic	JJ	O	orthopedic	amod	7	SENT_117	[p8l338t1260r699b1336],
7	patients	NNS	O	patient	prep_in	3	SENT_117	[p8l719t1261r982b1336],
8	beginning	VBG	O	begin	_	0	SENT_117	[p8l1005t1260r1349b1337],
9	Warfarin	NNP	O	Warfarin	nn	10	SENT_117	[p8l1364t1260r1652b1320],
10	therapy	NN	O	therapy	prep_beginning	7	SENT_117	[p8l1674t1260r1932b1336],
11	.	.	O	.	_	0	SENT_117	[p8l1674t1260r1932b1336],

1	Blood	NN	O	blood	_	0	SENT_118	[p8l1957t1260r2148b1320],
2	2007	CD	DATE	2007	num	1	SENT_118	[p8l10t1360r559b1428],
3	;	:	O	;	_	0	SENT_118	[p8l10t1360r559b1428],
4	110:1511	CD	NUMBER	110:1511	number	5	SENT_118	[p8l10t1360r559b1428],
5	—	CD	NUMBER	—	dep	1	SENT_118	[p8l10t1360r559b1428],
6	5	CD	NUMBER	5	dep	5	SENT_118	[p8l10t1360r559b1428],
7	.	.	O	.	_	0	SENT_118	[p8l10t1360r559b1428],

1	4	LS	NUMBER	4	_	0	SENT_119	[p8l8t1461r62b1512],
2	.	.	O	.	_	0	SENT_119	[p8l8t1461r62b1512],

1	Kulkarni	NNP	PERSON	Kulkarni	_	0	SENT_120	[p8l139t1453r433b1514],
2	UP	RP	O	up	dep	1	SENT_120	[p8l456t1458r563b1525],
3	,	,	O	,	_	0	SENT_120	[p8l456t1458r563b1525],
4	Swar	JJ	O	swar	amod	5	SENT_120	[p8l593t1457r754b1513],
5	BD	NN	O	bd	appos	1	SENT_120	[p8l774t1458r888b1524],
6	,	,	O	,	_	0	SENT_120	[p8l774t1458r888b1524],
7	Karnad	NNP	PERSON	Karnad	nn	8	SENT_120	[p8l917t1453r1159b1514],
8	DR	NN	O	dr	appos	1	SENT_120	[p8l1183t1458r1303b1525],
9	,	,	O	,	_	0	SENT_120	[p8l1183t1458r1303b1525],
10	et	FW	O	et	nn	11	SENT_120	[p8l1332t1466r1391b1512],
11	al.	FW	O	al.	appos	1	SENT_120	[p8l1412t1453r1487b1512],
12	.	.	O	.	_	0	SENT_120	[p8l1412t1453r1487b1512],

1	A	DT	O	a	det	3	SENT_121	[p8l1513t1458r1563b1511],
2	pilot	NN	O	pilot	nn	3	SENT_121	[p8l1583t1453r1738b1528],
3	study	NN	O	study	_	0	SENT_121	[p8l1760t1453r1937b1528],
4	of	IN	O	of	_	0	SENT_121	[p8l1958t1453r2035b1512],
5	the	DT	O	the	det	6	SENT_121	[p8l2045t1453r2148b1512],
6	association	NN	O	association	prep_of	3	SENT_121	[p8l10t1550r384b1608],
7	of	IN	O	of	_	0	SENT_121	[p8l415t1549r491b1608],
8	pharmacokinetic	JJ	O	pharmacokinetic	amod	11	SENT_121	[p8l508t1549r1074b1624],
9	and	CC	O	and	_	0	SENT_121	[p8l1104t1549r1225b1608],
10	pharmacodynamic	JJ	O	pharmacodynamic	amod	11	SENT_121	[p8l1255t1549r1879b1624],
11	parameters	NNS	O	parameter	prep_of	6	SENT_121	[p8l1909t1568r2147b1624, p8l11t1658r166b1704],
12	of	IN	O	of	_	0	SENT_121	[p8l194t1645r271b1705],
13	warfarin	NN	O	warfarin	prep_of	3	SENT_121	[p8l280t1645r568b1705],
14	with	IN	O	with	_	0	SENT_121	[p8l591t1645r741b1705],
15	the	DT	O	the	det	16	SENT_121	[p8l768t1645r870b1704],
16	dose	NN	O	dose	prep_with	3	SENT_121	[p8l897t1645r1046b1705],
17	in	IN	O	in	_	0	SENT_121	[p8l1072t1646r1136b1704],
18	patients	NNS	O	patient	prep_in	16	SENT_121	[p8l1161t1646r1425b1721],
19	on	IN	O	on	_	0	SENT_121	[p8l1453t1665r1534b1705],
20	long-term	JJ	O	long-term	amod	21	SENT_121	[p8l1561t1645r1890b1722],
21	anticoagulation	NN	O	anticoagulation	prep_on	18	SENT_121	[p8l1915t1646r2147b1705, p8l10t1743r343b1820],
22	.	.	O	.	_	0	SENT_121	[p8l1915t1646r2147b1705, p8l10t1743r343b1820],

1	Br	NN	O	br	nn	4	SENT_122	[p8l373t1748r491b1812],
2	]	CD	NUMBER	]	num	4	SENT_122	[p8l373t1748r491b1812],
3	Clin	NNP	O	Clin	nn	4	SENT_122	[p8l516t1743r651b1803],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_122	[p8l677t1743r1032b1803],
5	2008	CD	DATE	2008	dep	4	SENT_122	[p8l1057t1747r1574b1815],
6	;	:	O	;	_	0	SENT_122	[p8l1057t1747r1574b1815],
7	65:787	CD	NUMBER	65:787	number	8	SENT_122	[p8l1057t1747r1574b1815],
8	—	CD	NUMBER	—	dep	4	SENT_122	[p8l1057t1747r1574b1815],
9	90	CD	NUMBER	90	dep	8	SENT_122	[p8l1057t1747r1574b1815],
10	.	.	O	.	_	0	SENT_122	[p8l1057t1747r1574b1815],

1	To	TO	O	to	dep	6	SENT_123	[p8l9t2038r121b2093],
2	THE	DT	O	the	det	3	SENT_123	[p8l168t2039r333b2093],
3	EDITOR	NN	O	editor	pobj	1	SENT_123	[p8l388t2038r726b2094],
4	:	:	O	:	_	0	SENT_123	[p8l388t2038r726b2094],
5	The	DT	O	the	det	6	SENT_123	[p8l778t2015r940b2094],
6	finding	NN	O	finding	_	0	SENT_123	[p8l993t2015r1320b2116],
7	of	IN	O	of	_	0	SENT_123	[p8l1369t2015r1470b2094],
8	Schwarz	NNP	PERSON	Schwarz	prep_of	6	SENT_123	[p8l1506t2015r1866b2095],
9	et	FW	O	et	nn	10	SENT_123	[p8l1919t2032r1997b2094],
10	al.	FW	O	al.	dep	8	SENT_123	[p8l2044t2015r2141b2094],
11	that	IN	O	that	dep	24	SENT_123	[p8l12t2143r185b2222],
12	the	DT	O	the	det	14	SENT_123	[p8l217t2143r350b2222],
13	anticoagulant	JJ	O	anticoagulant	amod	14	SENT_123	[p8l387t2143r991b2244],
14	response	NN	O	response	nsubjpass	24	SENT_123	[p8l1022t2169r1405b2244],
15	during	IN	O	during	_	0	SENT_123	[p8l1443t2143r1734b2244],
16	the	DT	O	the	det	17	SENT_123	[p8l1767t2143r1900b2222],
17	initiation	NN	O	initiation	prep_during	14	SENT_123	[p8l1937t2144r2145b2222, p8l11t2272r229b2350],
18	of	IN	O	of	_	0	SENT_123	[p8l260t2271r360b2350],
19	warfarin	NN	O	warfarin	nn	20	SENT_123	[p8l368t2271r744b2350],
20	therapy	NN	O	therapy	prep_of	17	SENT_123	[p8l774t2271r1098b2372],
21	is	VBZ	O	be	auxpass	24	SENT_123	[p8l1123t2272r1189b2350],
22	more	RBR	O	more	advmod	23	SENT_123	[p8l1221t2297r1442b2350],
23	strongly	RB	O	strongly	advmod	24	SENT_123	[p8l1474t2271r1827b2372],
24	associated	VBN	O	associate	dep	6	SENT_123	[p8l1852t2272r2145b2350, p8l11t2399r190b2478],
25	with	IN	O	with	_	0	SENT_123	[p8l221t2399r418b2478],
26	VKORCI	NN	O	vkorcus	prep_with	24	SENT_123	[p8l453t2406r778b2479],
27	than	IN	O	than	mark	32	SENT_123	[p8l817t2399r1015b2478],
28	with	IN	O	with	_	0	SENT_123	[p8l1047t2399r1243b2478],
29	CYPZC9	NN	O	cypzc9	prep_with	32	SENT_123	[p8l1279t2406r1577b2478],
30	genetic	JJ	O	genetic	amod	31	SENT_123	[p8l1613t2400r1923b2500],
31	Variants	NNS	O	variant	nsubj	32	SENT_123	[p8l1954t2400r2145b2478, p8l11t2544r189b2606],
32	is	VBZ	O	be	advcl	24	SENT_123	[p8l235t2528r302b2606],
33	of	IN	O	of	_	0	SENT_123	[p8l350t2527r450b2606],
34	uncertain	JJ	O	uncertain	amod	36	SENT_123	[p8l477t2528r894b2606],
35	clinical	JJ	O	clinical	amod	36	SENT_123	[p8l940t2527r1255b2606],
36	impact	NN	O	impact	prep_of	32	SENT_123	[p8l1299t2528r1618b2628],
37	.	.	O	.	_	0	SENT_123	[p8l1299t2528r1618b2628],

1	In	IN	O	in	_	0	SENT_124	[p8l1668t2535r1757b2605],
2	patients	NNS	O	patient	prep_in	31	SENT_124	[p8l1801t2528r2144b2628],
3	Who	WP	O	who	nsubj	5	SENT_124	[p8l7t2655r186b2735],
4	are	VBP	O	be	cop	5	SENT_124	[p8l217t2681r343b2734],
5	sensitive	JJ	O	sensitive	rcmod	2	SENT_124	[p8l376t2656r724b2734],
6	to	TO	O	to	_	0	SENT_124	[p8l755t2672r835b2734],
7	warfarin	NN	O	warfarin	prep_to	5	SENT_124	[p8l862t2655r1244b2751],
8	,	,	O	,	_	0	SENT_124	[p8l862t2655r1244b2751],
9	determination	NN	O	determination	nsubj	31	SENT_124	[p8l1282t2655r1875b2734],
10	of	IN	O	of	_	0	SENT_124	[p8l1906t2655r2005b2734],
11	the	DT	O	the	det	12	SENT_124	[p8l2018t2655r2147b2734],
12	response	NN	O	response	prep_of	9	SENT_124	[p8l11t2810r402b2885],
13	to	TO	O	to	_	0	SENT_124	[p8l442t2801r525b2863],
14	therapy	NN	O	therapy	prep_to	12	SENT_124	[p8l566t2784r896b2885],
15	(	CD	NUMBER	(	num	14	SENT_124	[p8l935t2791r1137b2885],
16	e.g.	FW	O	e.g.	tmod	12	SENT_124	[p8l935t2791r1137b2885],
17	,	,	O	,	_	0	SENT_124	[p8l935t2791r1137b2885],
18	a	DT	O	a	det	20	SENT_124	[p8l1181t2811r1225b2863],
19	high	JJ	O	high	amod	20	SENT_124	[p8l1263t2784r1463b2885],
20	INR	NN	O	inr	appos	16	SENT_124	[p8l1500t2791r1690b2868],
21	measured	VBN	O	measure	partmod	20	SENT_124	[p8l1718t2784r2147b2863],
22	2	CD	DURATION	2	number	24	SENT_124	[p8l11t2918r58b2990],
23	to	TO	DURATION	to	dep	24	SENT_124	[p8l116t2929r198b2991],
24	3	CD	DURATION	3	num	25	SENT_124	[p8l255t2918r298b2991],
25	days	NNS	NUMBER	day	tmod	21	SENT_124	[p8l357t2912r543b3013],
26	after	IN	O	after	_	0	SENT_124	[p8l599t2912r803b2991],
27	the	DT	O	the	det	30	SENT_124	[p8l855t2912r988b2991],
28	initial	JJ	O	initial	amod	30	SENT_124	[p8l1043t2912r1300b2991],
29	dose	NN	O	dose	nn	30	SENT_124	[p8l1356t2912r1576b3004],
30	)	NN	O	)	prep_after	21	SENT_124	[p8l1356t2912r1576b3004],
31	enables	VBZ	O	enable	_	0	SENT_124	[p8l1636t2912r1956b2991],
32	the	DT	O	the	det	33	SENT_124	[p8l2013t2912r2147b2991],
33	practitioner	NN	O	practitioner	dobj	31	SENT_124	[p8l10t3041r520b3141],
34	to	TO	O	to	aux	35	SENT_124	[p8l557t3057r639b3119],
35	adjust	VB	O	adjust	infmod	33	SENT_124	[p8l681t3040r939b3141],
36	subsequent	JJ	O	subsequent	amod	37	SENT_124	[p8l976t3040r1465b3141],
37	doses	NNS	O	dose	dobj	35	SENT_124	[p8l1501t3040r1764b3119],
38	.	.	O	.	_	0	SENT_124	[p8l1501t3040r1764b3119],

1	What	WP	O	what	nsubj	4	SENT_125	[p8l1806t3040r2044b3119],
2	is	VBZ	O	be	cop	4	SENT_125	[p8l2079t3041r2144b3119],
3	clinically	RB	O	clinically	advmod	4	SENT_125	[p8l12t3168r405b3269],
4	important	JJ	O	important	csubj	11	SENT_125	[p8l429t3169r873b3269],
5	but	CC	O	but	_	0	SENT_125	[p8l898t3168r1038b3247],
6	still	RB	O	still	advmod	7	SENT_125	[p8l1064t3168r1226b3247],
7	unknown	JJ	O	unknown	csubj	11	SENT_125	[p8l1254t3168r1672b3248],
8	is	VBZ	O	be	cop	11	SENT_125	[p8l1700t3169r1766b3247],
9	Whether	NNP	O	Whether	nn	11	SENT_125	[p8l1793t3168r2150b3248],
10	genetic	JJ	O	genetic	amod	11	SENT_125	[p8l11t3297r321b3397],
11	variants	NNS	O	variant	_	0	SENT_125	[p8l356t3297r701b3375],
12	associated	VBN	O	associate	partmod	11	SENT_125	[p8l742t3296r1190b3375],
13	With	IN	O	with	_	0	SENT_125	[p8l1225t3296r1421b3375],
14	Warfarin	NNP	O	Warfarin	prep_with	18	SENT_125	[p8l1457t3296r1833b3375],
15	hyper	JJ	O	hyper	amod	17	SENT_125	[p8l1872t3296r2145b3397],
16	—	NN	O	—	nn	17	SENT_125	[p8l1872t3296r2145b3397],
17	sensitivity	NN	O	sensitivity	nsubj	18	SENT_125	[p8l13t3425r448b3525],
18	confer	VBP	O	confer	ccomp	12	SENT_125	[p8l484t3424r760b3503],
19	a	DT	O	a	det	21	SENT_125	[p8l796t3451r841b3503],
20	higher	JJR	O	higher	amod	21	SENT_125	[p8l878t3424r1161b3525],
21	risk	NN	O	risk	dobj	18	SENT_125	[p8l1197t3424r1363b3504],
22	of	IN	O	of	_	0	SENT_125	[p8l1399t3424r1499b3503],
23	bleeding	VBG	O	bleed	prepc_of	21	SENT_125	[p8l1521t3424r1894b3525],
24	com	NN	O	com	nn	26	SENT_125	[p8l1931t3450r2145b3503],
25	—	NN	O	—	nn	26	SENT_125	[p8l1931t3450r2145b3503],
26	plications	NNS	O	plication	dobj	23	SENT_125	[p8l10t3552r432b3653],
27	and	CC	O	and	_	0	SENT_125	[p8l466t3552r625b3631],
28	Whether	IN	O	whether	complm	32	SENT_125	[p8l652t3552r1010b3632],
29	this	DT	O	this	det	30	SENT_125	[p8l1039t3552r1200b3631],
30	risk	NN	O	risk	nsubjpass	32	SENT_125	[p8l1234t3552r1399b3632],
31	is	VBZ	O	be	auxpass	32	SENT_125	[p8l1426t3553r1492b3631],
32	diminished	VBN	O	diminish	conj_and	18	SENT_125	[p8l1527t3552r2021b3631],
33	by	IN	O	by	_	0	SENT_125	[p8l2054t3552r2152b3653],
34	pretreatment	NN	O	pretreatment	nn	35	SENT_125	[p8l10t3697r578b3781],
35	genotyping	NN	O	genotyping	agent	32	SENT_125	[p8l609t3681r1121b3781],
36	.	.	O	.	_	0	SENT_125	[p8l609t3681r1121b3781],

1	Although	IN	O	although	mark	8	SENT_126	[p8l1159t3680r1569b3781],
2	genetic	JJ	O	genetic	amod	3	SENT_126	[p8l1604t3681r1914b3781],
3	tests	NNS	O	test	nsubjpass	8	SENT_126	[p8l1950t3697r2145b3759],
4	for	IN	O	for	_	0	SENT_126	[p9l11t20r135b99],
5	Warfarin	NNP	O	Warfarin	nn	6	SENT_126	[p9l169t20r545b99],
6	sensitivity	NN	O	sensitivity	prep_for	3	SENT_126	[p9l588t21r1024b121],
7	are	VBP	O	be	auxpass	8	SENT_126	[p9l1060t46r1189b99],
8	licensed	VBN	O	license	advcl	17	SENT_126	[p9l1230t20r1582b99],
9	by	IN	O	by	_	0	SENT_126	[p9l1623t20r1721b121],
10	the	DT	O	the	det	14	SENT_126	[p9l1758t20r1891b99],
11	Food	NNP	ORGANIZATION	Food	nn	14	SENT_126	[p9l1931t20r2147b99],
12	and	CC	ORGANIZATION	and	_	0	SENT_126	[p9l11t148r169b227],
13	Drug	NNP	ORGANIZATION	Drug	conj_and	11	SENT_126	[p9l196t155r419b249],
14	Administration	NNP	ORGANIZATION	Administration	agent	8	SENT_126	[p9l441t148r1134b244],
15	,	,	O	,	_	0	SENT_126	[p9l441t148r1134b244],
16	we	PRP	O	we	nsubj	17	SENT_126	[p9l1165t175r1283b227],
17	think	VBP	O	think	_	0	SENT_126	[p9l1313t148r1552b228],
18	that	IN	O	that	complm	31	SENT_126	[p9l1577t148r1750b227],
19	their	PRP$	O	they	poss	20	SENT_126	[p9l1774t148r1979b227],
20	use	NN	O	use	nsubj	31	SENT_126	[p9l2005t175r2147b227],
21	is	VBZ	O	be	rcmod	20	SENT_126	[p9l11t277r76b355],
22	still	RB	O	still	dep	21	SENT_126	[p9l129t276r291b355],
23	clinically	RB	O	clinically	advmod	24	SENT_126	[p9l340t276r734b377],
24	unjustified	JJ	O	unjustified	dep	22	SENT_126	[p9l778t276r1272b377],
25	,	,	O	,	_	0	SENT_126	[p9l778t276r1272b377],
26	costly	JJ	O	costly	conj_and	22	SENT_126	[p9l1327t276r1591b377],
27	,	,	O	,	_	0	SENT_126	[p9l1327t276r1591b377],
28	and	CC	O	and	_	0	SENT_126	[p9l1645t276r1804b355],
29	associ	NN	O	assocus	dep	21	SENT_126	[p9l1852t277r2145b355],
30	—	CD	NUMBER	—	num	29	SENT_126	[p9l1852t277r2145b355],
31	ated	VBD	O	ate	ccomp	17	SENT_126	[p9l11t404r190b483],
32	With	IN	O	with	_	0	SENT_126	[p9l229t404r425b483],
33	the	DT	O	the	det	35	SENT_126	[p9l469t404r602b483],
34	emotional	JJ	O	emotional	amod	35	SENT_126	[p9l646t404r1086b483],
35	implications	NNS	O	implication	prep_with	31	SENT_126	[p9l1127t404r1666b505],
36	of	IN	O	of	_	0	SENT_126	[p9l1713t404r1813b483],
37	genetic	JJ	O	genetic	amod	38	SENT_126	[p9l1837t405r2148b505],
38	testing	NN	O	testing	prep_of	35	SENT_126	[p9l12t533r329b633],
39	.	.	O	.	_	0	SENT_126	[p9l12t533r329b633],

1	The	DT	O	the	det	3	SENT_127	[p9l365t532r527b611],
2	National	NNP	O	National	nn	3	SENT_127	[p9l559t532r934b611],
3	Heart	NNP	O	Heart	nsubj	11	SENT_127	[p9l966t540r1235b628],
4	,	,	O	,	_	0	SENT_127	[p9l966t540r1235b628],
5	Lung	NN	O	lung	conj_and	3	SENT_127	[p9l1273t540r1513b633],
6	,	,	O	,	_	0	SENT_127	[p9l1273t540r1513b633],
7	and	CC	O	and	_	0	SENT_127	[p9l1551t532r1710b611],
8	Blood	NNP	ORGANIZATION	Blood	nn	9	SENT_127	[p9l1741t532r1992b611],
9	Institute	NNP	ORGANIZATION	Institute	conj_and	3	SENT_127	[p9l2025t540r2145b610, p9l13t661r282b739],
10	is	VBZ	O	be	aux	11	SENT_127	[p9l313t661r380b739],
11	planning	VBG	O	plan	_	0	SENT_127	[p9l412t660r808b761],
12	a	DT	O	a	det	14	SENT_127	[p9l835t687r880b739],
13	randomized	JJ	O	randomized	amod	14	SENT_127	[p9l909t660r1434b739],
14	trial	NN	O	trial	dobj	11	SENT_127	[p9l1465t660r1739b739],
15	”	CD	NUMBER	”	num	14	SENT_127	[p9l1465t660r1739b739],
16	to	TO	O	to	aux	17	SENT_127	[p9l1771t677r1853b739],
17	establish	VB	O	establish	xcomp	11	SENT_127	[p9l1887t660r2145b739, p9l10t788r166b867],
18	whether	IN	O	whether	complm	26	SENT_127	[p9l221t788r578b867],
19	initial	JJ	O	initial	amod	21	SENT_127	[p9l634t788r893b867],
20	warfarin	NN	O	warfarin	nn	21	SENT_127	[p9l947t788r1324b867],
21	dosing	NN	O	dosing	nsubj	26	SENT_127	[p9l1384t788r1677b889],
22	based	VBN	O	base	_	0	SENT_127	[p9l1734t788r1980b867],
23	on	IN	O	on	prepc_based_on	21	SENT_127	[p9l2040t814r2147b867],
24	genotyping	NN	O	genotyping	pobj	21	SENT_127	[p9l11t917r504b1017],
25	is	VBZ	O	be	cop	26	SENT_127	[p9l547t917r612b995],
26	superior	JJ	O	superior	ccomp	17	SENT_127	[p9l663t917r1020b1017],
27	to	TO	O	to	_	0	SENT_127	[p9l1064t933r1146b995],
28	standard	JJ	O	standard	amod	30	SENT_127	[p9l1195t916r1577b995],
29	prescription	NN	O	prescription	nn	30	SENT_127	[p9l1622t917r2147b1017],
30	strategies	NNS	O	strategy	prep_to	26	SENT_127	[p9l13t1045r450b1145],
31	.	.	O	.	_	0	SENT_127	[p9l13t1045r450b1145],

1	Unfortunately	RB	O	unfortunately	advmod	11	SENT_128	[p9l496t1044r1120b1145],
2	,	,	O	,	_	0	SENT_128	[p9l496t1044r1120b1145],
3	the	DT	O	the	det	5	SENT_128	[p9l1167t1044r1300b1123],
4	primary	JJ	O	primary	amod	5	SENT_128	[p9l1341t1045r1694b1145],
5	outcomes	NNS	O	outcome	nsubj	11	SENT_128	[p9l1731t1061r2145b1123],
6	of	IN	O	of	_	0	SENT_128	[p9l12t1172r112b1251],
7	this	DT	O	this	det	8	SENT_128	[p9l126t1172r286b1251],
8	trial	NN	O	trial	prep_of	5	SENT_128	[p9l321t1172r499b1251],
9	are	VBP	O	be	cop	11	SENT_128	[p9l530t1198r660b1251],
10	not	RB	O	not	neg	11	SENT_128	[p9l691t1189r835b1251],
11	bleeding	VBG	O	bleed	_	0	SENT_128	[p9l862t1172r1236b1273],
12	and	CC	O	and	_	0	SENT_128	[p9l1264t1172r1422b1251],
13	thrombosis	NN	O	thrombosis	conj_and	11	SENT_128	[p9l1454t1172r1974b1268],
14	,	,	O	,	_	0	SENT_128	[p9l1454t1172r1974b1268],
15	but	CC	O	but	_	0	SENT_128	[p9l2012t1172r2153b1251],
16	surrogates	NNS	O	surrogate	conj_but	11	SENT_128	[p9l13t1317r452b1401],
17	such	JJ	O	such	_	0	SENT_128	[p9l487t1300r677b1379],
18	as	IN	O	as	_	0	SENT_128	[p9l707t1327r791b1379],
19	the	DT	O	the	det	20	SENT_128	[p9l825t1300r955b1379],
20	percentage	NN	O	percentage	prep_such_as	16	SENT_128	[p9l985t1317r1444b1401],
21	of	IN	O	of	_	0	SENT_128	[p9l1476t1300r1574b1379],
22	time	NN	O	time	prep_of	20	SENT_128	[p9l1587t1301r1777b1379],
23	that	IN	O	that	dep	27	SENT_128	[p9l1808t1300r1977b1379],
24	the	DT	O	the	det	26	SENT_128	[p9l2003t1300r2133b1379],
25	IN	IN	O	in	amod	26	SENT_128	[p9l9t1436r119b1507],
26	R	NN	O	r	nsubj	27	SENT_128	[p9l123t1435r195b1512],
27	is	VBZ	O	be	dep	16	SENT_128	[p9l219t1429r285b1507],
28	Within	IN	O	within	dep	16	SENT_128	[p9l318t1428r602b1508],
29	the	DT	O	the	det	31	SENT_128	[p9l637t1428r769b1507],
30	therapeutic	JJ	O	therapeutic	amod	31	SENT_128	[p9l805t1428r1290b1529],
31	range	NN	O	range	pobj	28	SENT_128	[p9l1324t1454r1587b1529],
32	.	.	O	.	_	0	SENT_128	[p9l1324t1454r1587b1529],

1	Pier	NNP	O	Pier	nn	3	SENT_129	[p9l20t1569r180b1641],
2	M.	NNP	PERSON	M.	nn	3	SENT_129	[p9l217t1569r319b1641],
3	Mannucci	NNP	PERSON	Mannucci	_	0	SENT_129	[p9l363t1569r814b1655],
4	,	,	O	,	_	0	SENT_129	[p9l363t1569r814b1655],
5	M.D.	NNP	PERSON	M.D.	nn	7	SENT_129	[p9l858t1569r1064b1641],
6	Marta	NNP	PERSON	Marta	nn	7	SENT_129	[p9l20t1696r268b1768],
7	Spreafico	NNP	PERSON	Spreafico	appos	3	SENT_129	[p9l305t1688r733b1792],
8	,	,	O	,	_	0	SENT_129	[p9l305t1688r733b1792],
9	Ph.D.	NNP	O	Ph.D.	appos	7	SENT_129	[p9l778t1688r1007b1768],
10	.	.	O	.	_	0	SENT_129	[p9l778t1688r1007b1768],

1	Flora	NNP	PERSON	Flora	nn	2	SENT_130	[p9l20t1815r229b1895],
2	Peyvandi	NNP	PERSON	Peyvandi	_	0	SENT_130	[p9l270t1815r674b1921],
3	,	,	O	,	_	0	SENT_130	[p9l270t1815r674b1921],
4	M.D.	NNP	O	M.D.	nn	6	SENT_130	[p9l719t1823r951b1910],
5	,	,	O	,	_	0	SENT_130	[p9l719t1823r951b1910],
6	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_130	[p9l995t1815r1224b1895],
7	.	.	O	.	_	0	SENT_130	[p9l995t1815r1224b1895],

1	Maggiore	NNP	ORGANIZATION	Maggiore	nn	5	SENT_131	[p9l16t1980r330b2055],
2	University	NNP	ORGANIZATION	University	nn	5	SENT_131	[p9l358t1980r695b2054],
3	Hospital	NNP	ORGANIZATION	Hospital	nn	5	SENT_131	[p9l722t1975r1000b2054],
4	20122	CD	NUMBER	20122	num	5	SENT_131	[p9l11t2092r206b2149],
5	Milan	NNP	LOCATION	Milan	_	0	SENT_131	[p9l238t2088r438b2159],
6	,	,	O	,	_	0	SENT_131	[p9l238t2088r438b2159],
7	Italy	NNP	LOCATION	Italy	nn	8	SENT_131	[p9l471t2088r606b2167],
8	pmmannucci@libero.it	NN	O	pmmannucci@libero.it	appos	5	SENT_131	[p9l15t2172r795b2251],

1	1	LS	NUMBER	1	_	0	SENT_132	[p9l13t2395r61b2446],
2	.	.	O	.	_	0	SENT_132	[p9l13t2395r61b2446],

1	Department	NNP	ORGANIZATION	Department	_	0	SENT_133	[p9l138t2393r531b2463],
2	of	IN	ORGANIZATION	of	_	0	SENT_133	[p9l553t2387r628b2446],
3	Health	NNP	ORGANIZATION	Health	nn	6	SENT_133	[p9l639t2388r857b2446],
4	and	CC	ORGANIZATION	and	_	0	SENT_133	[p9l881t2388r999b2446],
5	Human	NNP	ORGANIZATION	Human	nn	6	SENT_133	[p9l1023t2393r1267b2447],
6	Services	NNPS	ORGANIZATION	Services	prep_of	1	SENT_133	[p9l1294t2388r1568b2447],
7	.	.	O	.	_	0	SENT_133	[p9l1294t2388r1568b2447],

1	Federal	NNP	O	Federal	_	0	SENT_134	[p9l1596t2388r1832b2446],
2	business	NN	O	business	nn	3	SENT_134	[p9l1857t2388r2133b2447],
3	opportunities	NNS	O	opportunity	dep	1	SENT_134	[p9l11t2484r468b2559],
4	.	.	O	.	_	0	SENT_134	[p9l11t2484r468b2559],

1	(	NN	O	(	_	0	SENT_135	[p9l510t2484r821b2552],
2	Accessed	VBN	O	access	partmod	1	SENT_135	[p9l510t2484r821b2552],
3	May	NNP	DATE	May	tmod	2	SENT_135	[p9l852t2489r988b2559],
4	30	CD	DATE	30	num	3	SENT_135	[p9l1019t2488r1110b2555],
5	,	,	DATE	,	_	0	SENT_135	[p9l1019t2488r1110b2555],
6	2008	CD	DATE	2008	num	3	SENT_135	[p9l1148t2488r1322b2555],
7	,	,	O	,	_	0	SENT_135	[p9l1148t2488r1322b2555],
8	at	IN	O	at	_	0	SENT_135	[p9l1359t2496r1418b2542],
9	https	NNS	O	http	prep_at	2	SENT_135	[p9l1448t2483r2132b2559],
10	:	:	O	:	_	0	SENT_135	[p9l1448t2483r2132b2559],
11	l/wWw	NN	O	l/www	dobj	2	SENT_135	[p9l1448t2483r2132b2559],
12	.	.	O	.	_	0	SENT_135	[p9l1448t2483r2132b2559],

1	fbo	NN	O	fbo	_	0	SENT_136	[p9l1448t2483r2132b2559],
2	.	.	O	.	_	0	SENT_136	[p9l1448t2483r2132b2559],

1	gov	NN	O	gov	nsubj	2	SENT_137	[p9l1448t2483r2132b2559],
2	/	:	O	/	_	0	SENT_137	[p9l1448t2483r2132b2559],
3	?	.	O	?	_	0	SENT_137	[p9l11t2577r2108b2654],

1	s	NNS	O	s	_	0	SENT_138	[p9l11t2577r2108b2654],
2	=	JJ	O	=	amod	3	SENT_138	[p9l11t2577r2108b2654],
3	opportunity	NN	O	opportunity	dep	1	SENT_138	[p9l11t2577r2108b2654],
4	&	CC	O	&	_	0	SENT_138	[p9l11t2577r2108b2654],
5	mode	NN	O	mode	nn	7	SENT_138	[p9l11t2577r2108b2654],
6	=	JJ	O	=	amod	7	SENT_138	[p9l11t2577r2108b2654],
7	form	NN	O	form	conj_and	3	SENT_138	[p9l11t2577r2108b2654],
8	&	CC	O	&	_	0	SENT_138	[p9l11t2577r2108b2654],
9	id	NN	O	id	conj_and	3	SENT_138	[p9l11t2577r2108b2654],
10	=	JJ	O	=	amod	12	SENT_138	[p9l11t2577r2108b2654],
11	Oaaf5fd39b29aOe8f175fa0122d	NN	O	oaaf5fd39b29aoe8f175fa0122d	nn	12	SENT_138	[p9l11t2577r2108b2654],
12	519f3	NN	O	519f3	dep	1	SENT_138	[p9l12t2674r928b2742],
13	&	CC	O	&	_	0	SENT_138	[p9l12t2674r928b2742],
14	tab	NN	O	tab	nn	16	SENT_138	[p9l12t2674r928b2742],
15	=	JJ	O	=	amod	16	SENT_138	[p9l12t2674r928b2742],
16	core	NN	O	core	conj_and	12	SENT_138	[p9l12t2674r928b2742],
17	&	CC	O	&	_	0	SENT_138	[p9l12t2674r928b2742],
18	_	NN	O	_	nn	19	SENT_138	[p9l12t2674r928b2742],
19	cVieW	NN	O	cview	conj_and	12	SENT_138	[p9l12t2674r928b2742],
20	=	JJ	O	=	amod	22	SENT_138	[p9l12t2674r928b2742],
21	1	CD	NUMBER	1	tmod	20	SENT_138	[p9l12t2674r928b2742],
22	)	NN	O	)	dep	19	SENT_138	[p9l12t2674r928b2742],
23	.	.	O	.	_	0	SENT_138	[p9l12t2674r928b2742],

1	2	LS	NUMBER	2	_	0	SENT_139	[p9l9t2777r63b2828],
2	.	.	O	.	_	0	SENT_139	[p9l9t2777r63b2828],

1	Shurin	NNP	PERSON	Shurin	nn	2	SENT_140	[p9l141t2770r358b2829],
2	SB	NN	O	sb	_	0	SENT_140	[p9l382t2774r479b2841],
3	,	,	O	,	_	0	SENT_140	[p9l382t2774r479b2841],
4	Nabel	NNP	PERSON	Nabel	nn	5	SENT_140	[p9l505t2770r696b2829],
5	EG	NNP	O	EG	appos	2	SENT_140	[p9l717t2774r831b2828],
6	.	.	O	.	_	0	SENT_140	[p9l717t2774r831b2828],

1	Pharmacogenomics	NNS	O	pharmacogenomic	nsubj	2	SENT_141	[p9l858t2770r1507b2845],
2	—	VBP	O	—	_	0	SENT_141	[p9l1529t2804r1610b2809],
3	ready	JJ	O	ready	acomp	2	SENT_141	[p9l1630t2770r1807b2845],
4	for	IN	O	for	_	0	SENT_141	[p9l1826t2769r1920b2828],
5	prime	JJ	O	prime	amod	6	SENT_141	[p9l1940t2770r2134b2845],
6	time	NN	O	time	prep_for	2	SENT_141	[p9l11t2863r186b2923],
7	?	.	O	?	_	0	SENT_141	[p9l11t2863r186b2923],

1	N	NN	O	n	nn	3	SENT_142	[p9l211t2871r268b2924],
2	Engl	NNP	O	Engl	nn	3	SENT_142	[p9l291t2865r439b2940],
3	J	NNP	O	J	nsubj	4	SENT_142	[p9l457t2871r486b2933],
4	Med	VBD	O	med	_	0	SENT_142	[p9l507t2865r649b2924],
5	2008	CD	DATE	2008	dobj	4	SENT_142	[p9l675t2869r1225b2936],
6	;	:	O	;	_	0	SENT_142	[p9l675t2869r1225b2936],
7	358:1061	CD	NUMBER	358:1061	number	8	SENT_142	[p9l675t2869r1225b2936],
8	—	CD	NUMBER	—	dep	5	SENT_142	[p9l675t2869r1225b2936],
9	3	CD	NUMBER	3	dep	8	SENT_142	[p9l675t2869r1225b2936],
10	.	.	O	.	_	0	SENT_142	[p9l675t2869r1225b2936],

1	TH	NN	O	th	nn	4	SENT_143	[p9l9t3158r114b3212],
2	E	NN	O	e	nn	4	SENT_143	[p9l130t3158r167b3212],
3	AUTHORS	NNS	O	author	nn	4	SENT_143	[p9l190t3157r579b3213],
4	REPLY	NN	O	reply	_	0	SENT_143	[p9l609t3158r858b3213],
5	:	:	O	:	_	0	SENT_143	[p9l609t3158r858b3213],
6	Schillinger	NNP	PERSON	Schillinger	nsubj	7	SENT_143	[p9l890t3134r1336b3235],
7	suggests	VBZ	O	suggest	dep	4	SENT_143	[p9l1361t3151r1713b3235],
8	that	IN	O	that	complm	13	SENT_143	[p9l1743t3134r1908b3213],
9	careful	JJ	O	careful	amod	10	SENT_143	[p9l1931t3160r2132b3213, p9l11t3262r125b3341],
10	communication	NN	O	communication	nsubj	13	SENT_143	[p9l177t3263r860b3341],
11	with	IN	O	with	_	0	SENT_143	[p9l909t3262r1104b3341],
12	patients	NNS	O	patient	prep_with	10	SENT_143	[p9l1156t3263r1498b3363],
13	improves	VBZ	O	improve	ccomp	7	SENT_143	[p9l1553t3263r1944b3363],
14	the	DT	O	the	det	15	SENT_143	[p9l2001t3262r2133b3341],
15	outcomes	NNS	O	outcome	dobj	13	SENT_143	[p9l12t3407r423b3469],
16	of	IN	O	of	_	0	SENT_143	[p9l463t3390r563b3469],
17	warfarin	NN	O	warfarin	nn	18	SENT_143	[p9l577t3390r951b3470],
18	therapy	NN	O	therapy	prep_of	15	SENT_143	[p9l988t3390r1323b3491],
19	,	,	O	,	_	0	SENT_143	[p9l988t3390r1323b3491],
20	and	CC	O	and	_	0	SENT_143	[p9l1365t3390r1523b3469],
21	Kulkarni	NNP	PERSON	Kulkarni	nsubj	24	SENT_143	[p9l1559t3390r1940b3471],
22	and	CC	O	and	_	0	SENT_143	[p9l1975t3390r2134b3469],
23	colleagues	NNS	O	colleague	conj_and	21	SENT_143	[p9l12t3518r440b3619],
24	suggest	VBP	O	suggest	conj_and	7	SENT_143	[p9l473t3535r787b3619],
25	that	IN	O	that	complm	35	SENT_143	[p9l812t3518r977b3597],
26	a	DT	O	a	det	28	SENT_143	[p9l1001t3545r1046b3597],
27	phenotypic	JJ	O	phenotypic	amod	28	SENT_143	[p9l1072t3518r1531b3619],
28	outcome	NN	O	outcome	nsubj	35	SENT_143	[p9l1560t3535r1916b3597],
29	such	JJ	O	such	_	0	SENT_143	[p9l1947t3518r2134b3597],
30	as	IN	O	as	_	0	SENT_143	[p9l11t3673r96b3725],
31	the	DT	O	the	det	33	SENT_143	[p9l128t3646r261b3725],
32	IN	IN	O	in	amod	33	SENT_143	[p9l291t3654r400b3725],
33	R	NN	O	r	prep_such_as	28	SENT_143	[p9l404t3653r477b3730],
34	will	MD	O	will	aux	35	SENT_143	[p9l492t3646r656b3726],
35	capture	VB	O	capture	ccomp	24	SENT_143	[p9l687t3663r1006b3747],
36	variability	NN	O	variability	dobj	35	SENT_143	[p9l1032t3646r1468b3747],
37	in	IN	O	in	_	0	SENT_143	[p9l1493t3647r1576b3724],
38	the	DT	O	the	det	39	SENT_143	[p9l1607t3646r1739b3725],
39	patient	NN	O	patient	poss	41	SENT_143	[p9l1769t3647r2131b3747],
40	’s	POS	O	’s	_	0	SENT_143	[p9l1769t3647r2131b3747],
41	response	NN	O	response	prep_in	36	SENT_143	[p10l11t46r392b121],
42	to	TO	O	to	_	0	SENT_143	[p10l435t37r517b99],
43	therapy	NN	O	therapy	prep_to	35	SENT_143	[p10l561t20r883b121],
44	due	JJ	O	due	_	0	SENT_143	[p10l921t20r1070b99],
45	to	TO	O	to	_	0	SENT_143	[p10l1113t37r1195b99],
46	acquired	VBN	O	acquire	amod	47	SENT_143	[p10l1238t20r1608b121],
47	factors	NNS	O	factor	prep_due_to	43	SENT_143	[p10l1650t20r1965b99],
48	.	.	O	.	_	0	SENT_143	[p10l1650t20r1965b99],

1	Indeed	RB	O	indeed	advmod	11	SENT_144	[p10l2011t28r2132b98, p10l12t148r229b244],
2	,	,	O	,	_	0	SENT_144	[p10l2011t28r2132b98, p10l12t148r229b244],
3	the	DT	O	the	det	4	SENT_144	[p10l260t148r391b227],
4	concept	NN	O	concept	nsubjpass	11	SENT_144	[p10l417t165r746b249],
5	of	IN	O	of	_	0	SENT_144	[p10l767t148r865b227],
6	personalized	JJ	O	personalized	amod	7	SENT_144	[p10l871t148r1416b249],
7	medicine	NN	O	medicine	prep_of	4	SENT_144	[p10l1441t148r1826b227],
8	should	MD	O	should	aux	11	SENT_144	[p10l1853t148r2134b227],
9	not	RB	O	not	neg	11	SENT_144	[p10l11t293r154b355],
10	be	VB	O	be	auxpass	11	SENT_144	[p10l189t276r285b355],
11	applied	VBN	O	apply	_	0	SENT_144	[p10l324t276r637b377],
12	exclusively	RB	O	exclusively	advmod	11	SENT_144	[p10l676t276r1128b377],
13	to	TO	O	to	_	0	SENT_144	[p10l1164t293r1245b355],
14	the	DT	O	the	det	16	SENT_144	[p10l1286t276r1419b355],
15	genetic	JJ	O	genetic	amod	16	SENT_144	[p10l1458t277r1767b377],
16	components	NNS	O	component	prep_to	11	SENT_144	[p10l1806t302r2132b377, p10l11t421r242b483],
17	of	IN	O	of	_	0	SENT_144	[p10l282t404r382b483],
18	variation	NN	O	variation	prep_of	16	SENT_144	[p10l397t405r780b483],
19	in	IN	O	in	_	0	SENT_144	[p10l817t405r900b482],
20	response	NN	O	response	prep_in	18	SENT_144	[p10l938t430r1319b505],
21	to	TO	O	to	_	0	SENT_144	[p10l1357t421r1439b483],
22	a	DT	O	a	det	23	SENT_144	[p10l1477t431r1521b483],
23	drug	NN	O	drug	prep_to	11	SENT_144	[p10l1558t404r1781b505],
24	.	.	O	.	_	0	SENT_144	[p10l1558t404r1781b505],

1	Factors	NNS	O	factor	nsubj	31	SENT_145	[p10l1823t412r2130b483],
2	such	JJ	O	such	_	0	SENT_145	[p10l13t532r200b611],
3	as	IN	O	as	_	0	SENT_145	[p10l229t559r312b611],
4	adherence	NN	O	adherence	prep_such_as	1	SENT_145	[p10l343t532r762b611],
5	to	TO	O	to	_	0	SENT_145	[p10l792t549r871b611],
6	the	DT	O	the	det	8	SENT_145	[p10l902t532r1031b611],
7	medication	NN	O	medication	nn	8	SENT_145	[p10l1061t532r1524b611],
8	regimen	NN	O	regimen	prep_to	4	SENT_145	[p10l1554t533r1918b633],
9	,	,	O	,	_	0	SENT_145	[p10l1554t533r1918b633],
10	diet	NN	O	diet	prep_to	4	SENT_145	[p10l1954t532r2128b628],
11	,	,	O	,	_	0	SENT_145	[p10l1954t532r2128b628],
12	and	CC	O	and	_	0	SENT_145	[p10l11t660r168b739],
13	monitoring	NN	O	monitoring	conj_and	8	SENT_145	[p10l208t661r720b761],
14	,	,	O	,	_	0	SENT_145	[p10l208t661r720b761],
15	as	RB	O	as	_	0	SENT_145	[p10l764t687r850b739],
16	well	RB	O	well	_	0	SENT_145	[p10l888t660r1065b740],
17	as	IN	O	as	_	0	SENT_145	[p10l1103t687r1189b739],
18	expert	JJ	O	expert	amod	19	SENT_145	[p10l1231t677r1502b761],
19	adjustment	NN	O	adjustment	conj_and	4	SENT_145	[p10l1535t660r2017b761],
20	of	IN	O	of	_	0	SENT_145	[p10l2052t660r2152b739],
21	the	DT	O	the	det	23	SENT_145	[p10l12t788r144b867],
22	warfarin	NN	O	warfarin	nn	23	SENT_145	[p10l178t788r553b868],
23	dose	NN	O	dose	prep_of	19	SENT_145	[p10l592t788r786b867],
24	according	VBG	O	accord	_	0	SENT_145	[p10l823t788r1251b889],
25	to	TO	O	to	prepc_according_to	23	SENT_145	[p10l1286t805r1367b867],
26	the	DT	O	the	det	27	SENT_145	[p10l1408t788r1540b867],
27	INR	NN	O	inr	pobj	23	SENT_145	[p10l1578t795r1777b884],
28	,	,	O	,	_	0	SENT_145	[p10l1578t795r1777b884],
29	are	VBP	O	be	cop	31	SENT_145	[p10l1820t814r1950b867],
30	important	JJ	O	important	amod	31	SENT_145	[p10l1988t789r2132b866, p10l10t933r336b1017],
31	determinants	NNS	O	determinant	_	0	SENT_145	[p10l359t916r935b995],
32	of	IN	O	of	_	0	SENT_145	[p10l966t916r1066b995],
33	variation	NN	O	variation	prep_of	31	SENT_145	[p10l1071t917r1453b995],
34	in	IN	O	in	_	0	SENT_145	[p10l1480t917r1563b994],
35	the	DT	O	the	det	36	SENT_145	[p10l1592t916r1724b995],
36	response	NN	O	response	prep_in	33	SENT_145	[p10l1752t942r2133b1017],
37	to	TO	O	to	_	0	SENT_145	[p10l12t1061r93b1123],
38	therapy	NN	O	therapy	prep_to	36	SENT_145	[p10l137t1044r472b1145],
39	.	.	O	.	_	0	SENT_145	[p10l137t1044r472b1145],

1	In	IN	O	in	_	0	SENT_146	[p10l519t1052r608b1122],
2	addition	NN	O	addition	prep_in	8	SENT_146	[p10l650t1044r1030b1140],
3	,	,	O	,	_	0	SENT_146	[p10l650t1044r1030b1140],
4	the	DT	O	the	det	5	SENT_146	[p10l1079t1044r1211b1123],
5	patient	NN	O	patient	poss	7	SENT_146	[p10l1253t1045r1616b1145],
6	’s	POS	O	’s	_	0	SENT_146	[p10l1253t1045r1616b1145],
7	age	NN	O	age	nsubj	8	SENT_146	[p10l1660t1071r1804b1145],
8	affects	VBZ	O	affect	_	0	SENT_146	[p10l1846t1044r2131b1123],
9	his	PRP$	O	he	amod	12	SENT_146	[p10l11t1172r134b1251],
10	or	CC	O	or	_	0	SENT_146	[p10l164t1198r252b1251],
11	her	PRP$	O	she	amod	12	SENT_146	[p10l276t1172r412b1251],
12	response	NN	O	response	dobj	8	SENT_146	[p10l437t1198r810b1273],
13	to	TO	O	to	_	0	SENT_146	[p10l839t1189r919b1251],
14	warfarin	NN	O	warfarin	prep_to	8	SENT_146	[p10l943t1172r1332b1268],
15	,	,	O	,	_	0	SENT_146	[p10l943t1172r1332b1268],
16	and	CC	O	and	_	0	SENT_146	[p10l1364t1172r1519b1251],
17	as	IN	O	as	mark	21	SENT_146	[p10l1546t1199r1630b1251],
18	Neville	NNP	PERSON	Neville	nsubj	21	SENT_146	[p10l1658t1172r1950b1251],
19	and	CC	O	and	_	0	SENT_146	[p10l1978t1172r2133b1251],
20	colleagues	NNS	O	colleague	conj_and	18	SENT_146	[p10l12t1300r459b1401],
21	point	VBP	O	point	advcl	27	SENT_146	[p10l497t1301r727b1401],
22	out	RP	O	out	prt	21	SENT_146	[p10l760t1317r919b1396],
23	,	,	O	,	_	0	SENT_146	[p10l760t1317r919b1396],
24	pediatric	JJ	O	pediatric	amod	25	SENT_146	[p10l961t1300r1343b1401],
25	studies	NNS	O	study	nsubj	27	SENT_146	[p10l1381t1300r1680b1379],
26	will	MD	O	will	aux	27	SENT_146	[p10l1716t1300r1880b1380],
27	be	VB	O	be	conj_and	8	SENT_146	[p10l1917t1300r2014b1379],
28	of	IN	O	of	_	0	SENT_146	[p10l2052t1300r2152b1379],
29	interest	NN	O	interest	prep_of	27	SENT_146	[p10l11t1429r357b1506],
30	.	.	O	.	_	0	SENT_146	[p10l11t1429r357b1506],

1	We	PRP	O	we	nsubj	2	SENT_147	[p10l136t1563r268b1634],
2	showed	VBD	O	show	_	0	SENT_147	[p10l300t1555r617b1634],
3	that	IN	O	that	complm	7	SENT_147	[p10l647t1555r816b1634],
4	the	DT	O	the	det	6	SENT_147	[p10l841t1555r972b1634],
5	VKORC1	NN	O	vkorc1	nn	6	SENT_147	[p10l1001t1562r1318b1635],
6	haplotype	NN	O	haplotype	nsubj	7	SENT_147	[p10l1351t1555r1766b1656],
7	contributes	VBZ	O	contribute	ccomp	2	SENT_147	[p10l1797t1555r2132b1634, p10l11t1700r179b1762],
8	to	TO	O	to	_	0	SENT_147	[p10l212t1700r293b1762],
9	the	DT	O	the	det	11	SENT_147	[p10l327t1683r460b1762],
10	initial	JJ	O	initial	amod	11	SENT_147	[p10l492t1683r748b1762],
11	variability	NN	O	variability	prep_to	7	SENT_147	[p10l775t1683r1211b1784],
12	in	IN	O	in	_	0	SENT_147	[p10l1237t1684r1320b1761],
13	the	DT	O	the	det	16	SENT_147	[p10l1353t1683r1486b1762],
14	IN	IN	O	in	amod	16	SENT_147	[p10l1517t1691r1627b1762],
15	R	NN	O	r	nn	16	SENT_147	[p10l1631t1690r1703b1767],
16	response	NN	O	response	prep_in	11	SENT_147	[p10l1725t1709r2129b1784],
17	;	:	O	;	_	0	SENT_147	[p10l1725t1709r2129b1784],
18	Kulkarni	NNP	PERSON	Kulkarni	nsubj	21	SENT_147	[p10l11t1811r392b1892],
19	and	CC	O	and	_	0	SENT_147	[p10l443t1811r600b1890],
20	colleagues	NNS	O	colleague	conj_and	18	SENT_147	[p10l653t1811r1100b1912],
21	ask	VBP	O	ask	parataxis	2	SENT_147	[p10l1154t1811r1298b1891],
22	the	DT	O	the	det	24	SENT_147	[p10l1347t1811r1479b1890],
23	obverse	NN	O	obverse	nn	24	SENT_147	[p10l1533t1811r1853b1890],
24	question	NN	O	question	dobj	21	SENT_147	[p10l1906t1837r2132b1912, p10l12t1940r204b2018],
25	:	:	O	:	_	0	SENT_147	[p10l1906t1837r2132b1912, p10l12t1940r204b2018],
26	does	VBZ	O	do	aux	36	SENT_147	[p10l251t1939r443b2018],
27	consideration	NN	O	consideration	nsubj	36	SENT_147	[p10l488t1939r1071b2018],
28	of	IN	O	of	_	0	SENT_147	[p10l1113t1939r1213b2018],
29	the	DT	O	the	det	31	SENT_147	[p10l1236t1939r1369b2018],
30	initial	JJ	O	initial	amod	31	SENT_147	[p10l1409t1939r1666b2018],
31	variability	NN	O	variability	prep_of	27	SENT_147	[p10l1702t1939r2138b2040],
32	in	IN	O	in	_	0	SENT_147	[p10l11t2068r94b2145],
33	the	DT	O	the	det	35	SENT_147	[p10l140t2067r272b2146],
34	INR	NN	O	inr	nn	35	SENT_147	[p10l317t2074r503b2151],
35	response	NN	O	response	prep_in	31	SENT_147	[p10l538t2093r918b2168],
36	eliminate	VB	O	eliminate	dep	24	SENT_147	[p10l965t2067r1371b2146],
37	the	DT	O	the	det	38	SENT_147	[p10l1417t2067r1550b2146],
38	contribution	NN	O	contribution	dobj	36	SENT_147	[p10l1596t2067r2133b2146],
39	of	IN	O	of	_	0	SENT_147	[p10l12t2194r112b2273],
40	the	DT	O	the	det	42	SENT_147	[p10l126t2195r259b2273],
41	VKORC1	NN	O	vkorc1	nn	42	SENT_147	[p10l291t2201r613b2274],
42	haplotype	NN	O	haplotype	prep_of	38	SENT_147	[p10l648t2192r1110b2295],
43	?	.	O	?	_	0	SENT_147	[p10l648t2192r1110b2295],

1	As	IN	O	as	mark	3	SENT_148	[p10l1139t2202r1245b2273],
2	We	PRP	O	we	nsubj	3	SENT_148	[p10l1276t2221r1394b2274],
3	discussed	VBD	O	discuss	advcl	42	SENT_148	[p10l1427t2195r1843b2273],
4	in	IN	O	in	_	0	SENT_148	[p10l1874t2196r1957b2272],
5	our	PRP$	O	we	poss	6	SENT_148	[p10l1991t2220r2136b2274],
6	article	NN	O	article	prep_in	3	SENT_148	[p10l11t2323r301b2419],
7	,	,	O	,	_	0	SENT_148	[p10l11t2323r301b2419],
8	in	IN	O	in	_	0	SENT_148	[p10l368t2324r452b2401],
9	92	CD	NUMBER	92	num	10	SENT_148	[p10l514t2329r611b2402],
10	patients	NNS	O	patient	prep_in	3	SENT_148	[p10l673t2324r1015b2424],
11	with	IN	O	with	_	0	SENT_148	[p10l1075t2323r1270b2403],
12	orthopedic	JJ	O	orthopedic	amod	13	SENT_148	[p10l1333t2323r1802b2424],
13	conditions	NNS	O	condition	prep_with	10	SENT_148	[p10l1864t2323r2132b2402, p10l12t2453r223b2531],
14	who	WP	O	who	nsubj	15	SENT_148	[p10l260t2452r443b2531],
15	received	VBD	O	receive	rcmod	10	SENT_148	[p10l484t2452r830b2531],
16	their	PRP$	O	they	poss	18	SENT_148	[p10l870t2452r1074b2531],
17	initial	JJ	O	initial	amod	18	SENT_148	[p10l1110t2452r1367b2531],
18	dose	NN	O	dose	dobj	15	SENT_148	[p10l1407t2452r1600b2531],
19	of	IN	O	of	_	0	SENT_148	[p10l1642t2452r1742b2531],
20	warfarin	NN	O	warfarin	prep_of	18	SENT_148	[p10l1759t2452r2133b2531],
21	tailored	VBN	O	tailor	partmod	20	SENT_148	[p10l12t2580r344b2659],
22	according	VBG	O	accord	_	0	SENT_148	[p10l402t2580r828b2681],
23	to	TO	O	to	prepc_according_to	21	SENT_148	[p10l884t2597r965b2659],
24	clinical	JJ	O	clinical	amod	27	SENT_148	[p10l1026t2580r1339b2659],
25	and	CC	O	and	_	0	SENT_148	[p10l1396t2580r1554b2659],
26	genetic	JJ	O	genetic	conj_and	24	SENT_148	[p10l1611t2581r1920b2681],
27	factors	NNS	O	factor	pobj	21	SENT_148	[p10l1978t2580r2132b2659, p10l12t2724r198b2802],
28	,	,	O	,	_	0	SENT_148	[p10l1978t2580r2132b2659, p10l12t2724r198b2802],
29	much	RB	O	much	nsubjpass	42	SENT_148	[p10l243t2707r482b2786],
30	of	IN	O	of	_	0	SENT_148	[p10l522t2707r621b2785],
31	the	DT	O	the	det	32	SENT_148	[p10l643t2707r776b2785],
32	contribution	NN	O	contribution	prep_of	29	SENT_148	[p10l816t2707r1353b2786],
33	of	IN	O	of	_	0	SENT_148	[p10l1393t2707r1493b2785],
34	VKORC1	NN	O	vkorc1	prep_of	32	SENT_148	[p10l1512t2714r1835b2787],
35	to	TO	O	to	_	0	SENT_148	[p10l1878t2724r1959b2785],
36	the	DT	O	the	det	37	SENT_148	[p10l2001t2707r2133b2785],
37	prediction	NN	O	prediction	prep_to	34	SENT_148	[p10l10t2835r452b2936],
38	of	IN	O	of	_	0	SENT_148	[p10l505t2835r605b2914],
39	warfarin	NN	O	warfarin	nn	40	SENT_148	[p10l635t2835r1008b2914],
40	sensitivity	NN	O	sensitivity	prep_of	37	SENT_148	[p10l1063t2836r1496b2936],
41	was	VBD	O	be	auxpass	42	SENT_148	[p10l1539t2862r1702b2914],
42	captured	VBN	O	capture	_	0	SENT_148	[p10l1757t2835r2133b2936],
43	by	IN	O	by	_	0	SENT_148	[p10l12t2963r109b3064],
44	the	DT	O	the	det	46	SENT_148	[p10l144t2963r277b3042],
45	IN	IN	O	in	amod	46	SENT_148	[p10l315t2971r425b3042],
46	R	NN	O	r	agent	42	SENT_148	[p10l429t2970r501b3047],
47	after	IN	O	after	mark	78	SENT_148	[p10l529t2963r731b3042],
48	three	CD	NUMBER	three	num	49	SENT_148	[p10l768t2963r988b3042],
49	doses	NNS	O	dose	nsubj	78	SENT_148	[p10l1028t2963r1265b3042],
50	of	IN	O	of	_	0	SENT_148	[p10l1307t2963r1407b3042],
51	warfarin	NN	O	warfarin	prep_of	49	SENT_148	[p10l1423t2963r1862b3042],
52	.1	CD	NUMBER	.1	num	51	SENT_148	[p10l1423t2963r1862b3042],
53	However	RB	O	however	advmod	51	SENT_148	[p10l1900t2971r2132b3042, p10l12t3116r201b3185],
54	,	,	O	,	_	0	SENT_148	[p10l1900t2971r2132b3042, p10l12t3116r201b3185],
55	in	IN	O	in	_	0	SENT_148	[p10l243t3091r327b3167],
56	that	DT	O	that	det	58	SENT_148	[p10l364t3090r537b3168],
57	statistical	JJ	O	statistical	amod	58	SENT_148	[p10l570t3090r986b3168],
58	model	NN	O	model	prep_in	78	SENT_148	[p10l1023t3090r1313b3185],
59	,	,	O	,	_	0	SENT_148	[p10l1023t3090r1313b3185],
60	the	DT	O	the	det	62	SENT_148	[p10l1356t3090r1489b3168],
61	initial	JJ	O	initial	amod	62	SENT_148	[p10l1526t3090r1782b3168],
62	dose	NN	O	dose	nsubj	78	SENT_148	[p10l1819t3090r2014b3168],
63	of	IN	O	of	_	0	SENT_148	[p10l2052t3090r2152b3168],
64	warfarin	NN	O	warfarin	prep_of	62	SENT_148	[p10l7t3218r381b3298],
65	(	CD	NUMBER	(	num	64	SENT_148	[p10l427t3218r946b3309],
66	determined	VBN	O	determine	partmod	64	SENT_148	[p10l427t3218r946b3309],
67	in	IN	O	in	_	0	SENT_148	[p10l987t3219r1070b3296],
68	part	NN	O	part	prep_in	66	SENT_148	[p10l1111t3235r1290b3319],
69	by	IN	O	by	_	0	SENT_148	[p10l1327t3218r1424b3319],
70	the	DT	O	the	det	72	SENT_148	[p10l1462t3218r1594b3297],
71	VKORCI	NNP	O	VKORCI	nn	72	SENT_148	[p10l1635t3225r1957b3298],
72	genotype	NN	O	genotype	agent	66	SENT_148	[p10l2002t3245r2132b3319, p10l11t3363r304b3447],
73	in	IN	O	in	_	0	SENT_148	[p10l346t3347r430b3424],
74	some	DT	O	some	det	76	SENT_148	[p10l475t3372r698b3425],
75	patients	NNS	O	patient	nn	76	SENT_148	[p10l741t3347r1108b3447],
76	)	NN	O	)	prep_in	72	SENT_148	[p10l741t3347r1108b3447],
77	did	VBD	O	do	aux	78	SENT_148	[p10l1157t3346r1292b3425],
78	contribute	VB	O	contribute	advcl	42	SENT_148	[p10l1336t3346r1777b3425],
79	signiﬁcantly	NN	O	signiﬁcantly	dobj	78	SENT_148	[p10l1822t3346r2132b3447, p10l12t3474r284b3575],
80	.	.	O	.	_	0	SENT_148	[p10l1822t3346r2132b3447, p10l12t3474r284b3575],

1	In	IN	O	in	_	0	SENT_149	[p10l332t3482r420b3552],
2	another	DT	O	another	det	3	SENT_149	[p10l463t3474r799b3553],
3	study	NN	O	study	pobj	1	SENT_149	[p10l840t3474r1070b3575],
4	of	IN	O	of	_	0	SENT_149	[p10l1110t3474r1209b3553],
5	132	CD	NUMBER	132	prep_of	3	SENT_149	[p10l1238t3480r1385b3553],
6	hospitalized	VBN	O	hospitalize	partmod	5	SENT_149	[p10l1429t3474r1959b3575],
7	patients	NNS	O	patient	nsubj	15	SENT_149	[p10l2001t3500r2132b3575, p10l12t3603r272b3698],
8	,	,	O	,	_	0	SENT_149	[p10l2001t3500r2132b3575, p10l12t3603r272b3698],
9	the	DT	O	the	det	11	SENT_149	[p10l317t3602r450b3681],
10	IN	IN	O	in	amod	11	SENT_149	[p10l488t3610r597b3681],
11	R	NN	O	r	appos	7	SENT_149	[p10l601t3609r674b3686],
12	on	IN	O	on	_	0	SENT_149	[p10l702t3628r808b3681],
13	day	NN	DURATION	day	prep_on	11	SENT_149	[p10l848t3602r995b3703],
14	4	CD	NUMBER	4	num	13	SENT_149	[p10l1027t3608r1078b3681],
15	accounted	VBD	O	account	ccomp	6	SENT_149	[p10l1116t3602r1552b3681],
16	for	IN	O	for	_	0	SENT_149	[p10l1591t3602r1715b3681],
17	31.0	CD	PERCENT	31.0	num	18	SENT_149	[p10l1751t3608r2013b3681],
18	%	NN	PERCENT	%	prep_for	15	SENT_149	[p10l1751t3608r2013b3681],
19	of	IN	O	of	_	0	SENT_149	[p10l2052t3602r2152b3681],
20	the	DT	O	the	det	21	SENT_149	[p11l12t20r142b99],
21	variability	NN	O	variability	prep_of	18	SENT_149	[p11l170t20r594b121],
22	in	IN	O	in	_	0	SENT_149	[p11l621t21r703b98],
23	the	DT	O	the	det	25	SENT_149	[p11l736t20r866b99],
24	warfarin	NN	O	warfarin	nn	25	SENT_149	[p11l894t20r1261b99],
25	dose	NN	O	dose	prep_in	21	SENT_149	[p11l1293t20r1484b99],
26	on	IN	O	on	_	0	SENT_149	[p11l1517t46r1622b99],
27	day	NN	DURATION	day	prep_on	25	SENT_149	[p11l1654t20r1799b121],
28	14	CD	NUMBER	14	num	27	SENT_149	[p11l1829t26r1941b116],
29	,	,	O	,	_	0	SENT_149	[p11l1829t26r1941b116],
30	and	CC	O	and	advmod	15	SENT_149	[p11l1978t20r2133b99],

1	N	NN	O	n	nn	3	SENT_150	[p11l534t206r548b221],
2	ENGLJ	NN	O	englj	nn	3	SENT_150	[p11l563t206r640b228],
3	MED	NN	O	med	_	0	SENT_150	[p11l655t206r707b221],
4	358	CD	NUMBER	358	dep	3	SENT_150	[p11l717t200r792b228],
5	;	:	O	;	_	0	SENT_150	[p11l717t200r792b228],
6	25	CD	NUMBER	25	num	8	SENT_150	[p11l717t200r792b228],
7	WWW.NEJM.ORG	NN	O	www.nejm.org	nn	8	SENT_150	[p11l825t206r1027b228],
8	UNE19	NN	O	une19	dep	4	SENT_150	[p11l1072t206r1165b227],
9	,	,	O	,	_	0	SENT_150	[p11l1072t206r1165b227],
10	2008	CD	DATE	2008	num	11	SENT_150	[p11l1177t200r1240b222],
11	2743	CD	DATE	2743	appos	8	SENT_150	[p11l1939t196r2015b219],

1	The	DT	O	the	det	6	SENT_151	[p11l702t239r753b263],
2	New	NNP	O	New	nn	6	SENT_151	[p11l762t240r824b263],
3	England	NNP	O	England	nn	6	SENT_151	[p11l833t239r944b270],
4	J	NNP	O	J	nn	6	SENT_151	[p11l952t240r965b263],
5	ouma	NN	O	ouma	nn	6	SENT_151	[p11l966t247r1041b263],
6	o	NN	O	o	_	0	SENT_151	[p11l1059t247r1075b263],
7	Medicine	NN	O	medicine	dep	6	SENT_151	[p11l1095t239r1220b263],

1	Downloaded	VBN	O	download	_	0	SENT_152	[p11l144t280r314b303],
2	from	IN	O	from	_	0	SENT_152	[p11l323t280r387b303],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_152	[p11l396t280r514b310],
4	at	IN	O	at	_	0	SENT_152	[p11l524t284r547b303],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_152	[p11l556t280r738b303],
6	on	IN	O	on	_	0	SENT_152	[p11l748t287r780b303],
7	January	NNP	DATE	January	prep_on	1	SENT_152	[p11l789t280r892b310],
8	5	CD	DATE	5	num	7	SENT_152	[p11l902t280r924b308],
9	,	,	DATE	,	_	0	SENT_152	[p11l902t280r924b308],
10	2014	CD	DATE	2014	num	7	SENT_152	[p11l935t280r1007b303],
11	.	.	O	.	_	0	SENT_152	[p11l935t280r1007b303],

1	For	IN	O	for	_	0	SENT_153	[p11l1018t280r1064b303],
2	personal	JJ	O	personal	amod	3	SENT_153	[p11l1072t280r1185b310],
3	use	NN	O	use	pobj	1	SENT_153	[p11l1194t287r1237b303],
4	only	RB	O	only	advmod	3	SENT_153	[p11l1247t280r1312b310],
5	.	.	O	.	_	0	SENT_153	[p11l1247t280r1312b310],

1	No	DT	O	no	det	3	SENT_154	[p11l1322t280r1362b303],
2	other	JJ	O	other	amod	3	SENT_154	[p11l1372t280r1440b303],
3	uses	NNS	O	use	_	0	SENT_154	[p11l1448t287r1504b303],
4	without	IN	O	without	_	0	SENT_154	[p11l1515t280r1616b303],
5	permission	NN	O	permission	prep_without	3	SENT_154	[p11l1624t280r1776b310],
6	.	.	O	.	_	0	SENT_154	[p11l1624t280r1776b310],

1	Copyright	NN	O	copyright	_	0	SENT_155	[p11l494t321r629b352],
2	©	CD	NUMBER	©	num	6	SENT_155	[p11l638t321r661b345],
3	2008	CD	DATE	2008	num	6	SENT_155	[p11l671t321r736b345],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_155	[p11l746t321r937b345],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_155	[p11l947t321r1055b345],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_155	[p11l1065t321r1170b352],
7	.	.	O	.	_	0	SENT_155	[p11l1065t321r1170b352],

1	All	DT	O	all	det	2	SENT_156	[p11l1181t321r1223b345],
2	rights	NNS	O	rights	nsubj	3	SENT_156	[p11l1232t321r1306b352],
3	reserved	VBN	O	reserve	_	0	SENT_156	[p11l1316t321r1435b345],
4	.	.	O	.	_	0	SENT_156	[p11l1316t321r1435b345],

1	The	DT	O	the	det	4	SENT_157	[p11l673t427r718b448],
2	NEW	NNP	O	NEW	nn	4	SENT_157	[p11l737t429r822b448],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_157	[p11l841t429r1029b448],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_157	[p11l1048t429r1227b455],
5	of	IN	O	of	_	0	SENT_157	[p11l1247t427r1275b454],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_157	[p11l1287t429r1486b448],

1	the	DT	O	the	det	5	SENT_158	[p11l10t649r143b728],
2	CYPZC9	NN	O	cypzc9	nn	5	SENT_158	[p11l179t656r475b728],
3	and	CC	O	and	_	0	SENT_158	[p11l511t649r669b728],
4	VKORC1	NN	O	vkorc1	nn	5	SENT_158	[p11l704t656r1027b729],
5	genotypes	NNS	O	genotype	nsubj	6	SENT_158	[p11l1066t666r1503b750],
6	accounted	VBD	O	account	_	0	SENT_158	[p11l1541t649r1979b728],
7	for	IN	O	for	_	0	SENT_158	[p11l2015t649r2138b728],
8	6.5	CD	PERCENT	6.5	num	9	SENT_158	[p11l10t782r222b856],
9	%	NN	PERCENT	%	prep_for	6	SENT_158	[p11l10t782r222b856],
10	of	IN	O	of	_	0	SENT_158	[p11l282t777r382b856],
11	the	DT	O	the	det	12	SENT_158	[p11l426t777r558b856],
12	Variability	NN	O	variability	prep_of	9	SENT_158	[p11l614t777r1051b878],
13	in	IN	O	in	_	0	SENT_158	[p11l1106t778r1189b855],
14	the	DT	O	the	det	16	SENT_158	[p11l1251t777r1383b856],
15	Warfarin	NNP	O	Warfarin	nn	16	SENT_158	[p11l1440t777r1815b857],
16	dose	NN	O	dose	prep_in	6	SENT_158	[p11l1876t777r2135b856],
17	?	.	O	?	_	0	SENT_158	[p11l1876t777r2135b856],

1	Thus	RB	O	thus	advmod	7	SENT_159	[p11l6t905r237b1001],
2	,	,	O	,	_	0	SENT_159	[p11l6t905r237b1001],
3	additional	JJ	O	additional	amod	4	SENT_159	[p11l273t905r701b984],
4	studies	NNS	O	study	nsubjpass	7	SENT_159	[p11l732t905r1025b984],
5	will	MD	O	will	aux	7	SENT_159	[p11l1054t905r1215b984],
6	be	VB	O	be	auxpass	7	SENT_159	[p11l1246t905r1341b984],
7	required	VBN	O	require	_	0	SENT_159	[p11l1371t905r1727b1006],
8	to	TO	O	to	aux	9	SENT_159	[p11l1757t922r1838b984],
9	deﬁne	VB	O	deﬁne	xcomp	7	SENT_159	[p11l1870t905r2135b984],
10	the	DT	O	the	det	12	SENT_159	[p11l10t1033r139b1112],
11	independent	JJ	O	independent	amod	12	SENT_159	[p11l170t1033r687b1134],
12	contributions	NNS	O	contribution	dobj	9	SENT_159	[p11l714t1033r1267b1112],
13	of	IN	O	of	_	0	SENT_159	[p11l1301t1033r1399b1112],
14	the	DT	O	the	det	15	SENT_159	[p11l1413t1033r1541b1112],
15	genotype	NN	O	genotype	prep_of	12	SENT_159	[p11l1572t1050r1951b1134],
16	and	CC	O	and	_	0	SENT_159	[p11l1982t1033r2135b1112],
17	phenotype	NN	O	phenotype	prep_of	12	SENT_159	[p11l8t1161r461b1262],
18	for	IN	O	for	_	0	SENT_159	[p11l501t1161r625b1240],
19	guiding	VBG	O	guide	amod	21	SENT_159	[p11l661t1161r1000b1262],
20	warfarin	NN	O	warfarin	nn	21	SENT_159	[p11l1032t1161r1406b1240],
21	dosing	NN	O	dosing	prep_for	15	SENT_159	[p11l1446t1161r1757b1262],
22	.	.	O	.	_	0	SENT_159	[p11l1446t1161r1757b1262],

1	Mannucci	NNP	PERSON	Mannucci	nsubj	4	SENT_160	[p11l136t1290r562b1368],
2	and	CC	O	and	_	0	SENT_160	[p11l607t1289r765b1368],
3	colleagues	NNS	O	colleague	nsubj	4	SENT_160	[p11l811t1289r1259b1390],
4	suggest	VBP	O	suggest	_	0	SENT_160	[p11l1309t1306r1637b1390],
5	that	IN	O	that	complm	16	SENT_160	[p11l1679t1289r1851b1368],
6	genotyping	NN	O	genotyping	nn	7	SENT_160	[p11l1892t1315r2134b1390, p11l10t1418r288b1518],
7	patients	NNS	O	patient	nsubj	16	SENT_160	[p11l322t1418r664b1518],
8	who	WP	O	who	nsubjpass	10	SENT_160	[p11l700t1417r883b1496],
9	are	VBP	O	be	auxpass	10	SENT_160	[p11l923t1443r1052b1496],
10	treated	VBN	O	treat	rcmod	7	SENT_160	[p11l1091t1417r1390b1496],
11	with	IN	O	with	_	0	SENT_160	[p11l1424t1417r1620b1496],
12	warfarin	NN	O	warfarin	prep_with	10	SENT_160	[p11l1654t1417r2029b1496],
13	is	VBZ	O	be	cop	16	SENT_160	[p11l2067t1418r2133b1496],
14	not	RB	O	not	neg	16	SENT_160	[p11l10t1562r152b1624],
15	clinically	RB	O	clinically	advmod	16	SENT_160	[p11l208t1545r599b1646],
16	justified	JJ	O	justified	ccomp	4	SENT_160	[p11l641t1545r1009b1646],
17	until	IN	O	until	mark	21	SENT_160	[p11l1069t1545r1272b1624],
18	randomized	VBN	O	randomize	csubj	21	SENT_160	[p11l1331t1545r1853b1624],
19	trials	NNS	O	trial	dobj	18	SENT_160	[p11l1913t1545r2133b1624],
20	have	VBP	O	have	aux	21	SENT_160	[p11l10t1674r193b1753],
21	shown	VBN	O	show	advcl	16	SENT_160	[p11l225t1674r499b1753],
22	that	IN	O	that	complm	24	SENT_160	[p11l530t1674r696b1753],
23	it	PRP	O	it	nsubj	24	SENT_160	[p11l721t1675r778b1753],
24	decreases	VBZ	O	decrease	ccomp	21	SENT_160	[p11l804t1674r1196b1753],
25	the	DT	O	the	det	26	SENT_160	[p11l1229t1674r1357b1753],
26	outcome	NN	O	outcome	dobj	24	SENT_160	[p11l1389t1691r1745b1753],
27	of	IN	O	of	_	0	SENT_160	[p11l1777t1674r1875b1753],
28	bleeding	NN	O	bleeding	prep_of	26	SENT_160	[p11l1888t1674r2134b1753, p11l9t1803r147b1903],
29	or	CC	O	or	_	0	SENT_160	[p11l179t1828r267b1881],
30	thrombosis	NN	O	thrombosis	conj_or	28	SENT_160	[p11l299t1802r805b1881],
31	.	.	O	.	_	0	SENT_160	[p11l299t1802r805b1881],

1	Evidence	NN	O	evidence	nsubj	6	SENT_161	[p11l844t1802r1213b1881],
2	this	DT	O	this	dep	3	SENT_161	[p11l1248t1802r1405b1881],
3	strong	JJ	O	strong	amod	1	SENT_161	[p11l1443t1819r1715b1903],
4	would	MD	O	would	aux	6	SENT_161	[p11l1742t1802r2004b1881],
5	be	VB	O	be	cop	6	SENT_161	[p11l2039t1802r2135b1881],
6	ideal	JJ	O	ideal	_	0	SENT_161	[p11l9t1930r237b2026],
7	;	:	O	;	_	0	SENT_161	[p11l9t1930r237b2026],
8	however	RB	O	however	advmod	26	SENT_161	[p11l288t1930r663b2026],
9	,	,	O	,	_	0	SENT_161	[p11l288t1930r663b2026],
10	many	JJ	O	many	amod	11	SENT_161	[p11l715t1956r954b2031],
11	recommendations	NNS	O	recommendation	nsubjpass	26	SENT_161	[p11l995t1930r1776b2009],
12	regarding	VBG	O	regard	_	0	SENT_161	[p11l1825t1930r2134b2031, p11l9t2059r148b2159],
13	the	DT	O	the	det	14	SENT_161	[p11l179t2058r312b2137],
14	modification	NN	O	modification	prep_regarding	11	SENT_161	[p11l346t2058r908b2137],
15	of	IN	O	of	_	0	SENT_161	[p11l942t2058r1042b2137],
16	the	DT	O	the	det	17	SENT_161	[p11l1058t2058r1191b2137],
17	dose	NN	O	dose	prep_of	14	SENT_161	[p11l1225t2058r1419b2137],
18	of	IN	O	of	_	0	SENT_161	[p11l1454t2058r1554b2137],
19	a	DT	O	a	det	20	SENT_161	[p11l1568t2085r1613b2137],
20	drug	NN	O	drug	prep_of	17	SENT_161	[p11l1645t2058r1850b2159],
21	for	IN	O	for	_	0	SENT_161	[p11l1879t2058r2003b2137],
22	an	DT	O	a	det	24	SENT_161	[p11l2033t2084r2135b2137],
23	individual	JJ	O	individual	amod	24	SENT_161	[p11l9t2186r441b2265],
24	patient	NN	O	patient	prep_for	20	SENT_161	[p11l476t2187r779b2287],
25	are	VBP	O	be	auxpass	26	SENT_161	[p11l809t2213r939b2265],
26	based	VBN	O	base	parataxis	6	SENT_161	[p11l976t2186r1222b2265],
27	on	IN	O	on	_	0	SENT_161	[p11l1259t2212r1365b2265],
28	pharmacokinetic	JJ	O	pharmacokinetic	amod	31	SENT_161	[p11l1401t2186r2136b2287],
29	or	CC	O	or	_	0	SENT_161	[p11l10t2340r99b2393],
30	pharmacodynamic	JJ	O	pharmacodynamic	conj_or	28	SENT_161	[p11l127t2314r940b2415],
31	observations	NNS	O	observation	prep_on	26	SENT_161	[p11l972t2314r1541b2393],
32	.	.	O	.	_	0	SENT_161	[p11l972t2314r1541b2393],

1	For	IN	O	for	_	0	SENT_162	[p11l1578t2322r1720b2393],
2	example	NN	O	example	prep_for	16	SENT_162	[p11l1751t2314r2130b2415],
3	,	,	O	,	_	0	SENT_162	[p11l1751t2314r2130b2415],
4	few	JJ	O	few	amod	5	SENT_162	[p11l10t2442r164b2521],
5	(	CD	NUMBER	(	nsubj	16	SENT_162	[p11l209t2442r314b2534],
6	if	IN	O	if	mark	9	SENT_162	[p11l209t2442r314b2534],
7	any	DT	O	any	det	8	SENT_162	[p11l338t2449r510b2543],
8	)	NN	O	)	nsubj	9	SENT_162	[p11l338t2449r510b2543],
9	randomized	VBN	O	randomize	dep	5	SENT_162	[p11l559t2442r1081b2521],
10	trials	NNS	O	trial	dobj	9	SENT_162	[p11l1125t2442r1343b2521],
11	with	IN	O	with	_	0	SENT_162	[p11l1385t2442r1581b2521],
12	clinical	JJ	O	clinical	amod	14	SENT_162	[p11l1624t2442r1938b2521],
13	end	NN	O	end	nn	14	SENT_162	[p11l1981t2442r2135b2521],
14	points	NNS	O	point	prep_with	9	SENT_162	[p11l8t2571r278b2671],
15	have	VBP	O	have	aux	16	SENT_162	[p11l325t2570r514b2649],
16	provided	VBN	O	provide	_	0	SENT_162	[p11l558t2570r932b2671],
17	data	NNS	O	datum	dobj	16	SENT_162	[p11l977t2570r1161b2649],
18	on	IN	O	on	_	0	SENT_162	[p11l1204t2596r1310b2649],
19	the	DT	O	the	det	20	SENT_162	[p11l1355t2570r1488b2649],
20	adjustment	NN	O	adjustment	prep_on	17	SENT_162	[p11l1532t2570r2014b2671],
21	of	IN	O	of	_	0	SENT_162	[p11l2053t2570r2153b2649],
22	drug	NN	O	drug	nn	23	SENT_162	[p11l10t2698r214b2799],
23	doses	NNS	O	dose	prep_of	20	SENT_162	[p11l258t2698r494b2777],
24	in	IN	O	in	_	0	SENT_162	[p11l541t2699r625b2776],
25	renal	JJ	O	renal	amod	28	SENT_162	[p11l670t2698r887b2777],
26	or	CC	O	or	_	0	SENT_162	[p11l932t2724r1021b2777],
27	hepatic	JJ	O	hepatic	conj_or	25	SENT_162	[p11l1064t2698r1375b2799],
28	dysfunction	NN	O	dysfunction	prep_in	16	SENT_162	[p11l1420t2698r1953b2799],
29	,	,	O	,	_	0	SENT_162	[p11l1420t2698r1953b2799],
30	despite	IN	O	despite	_	0	SENT_162	[p11l2004t2698r2134b2777, p11l11t2827r209b2927],
31	the	DT	O	the	det	35	SENT_162	[p11l247t2826r381b2905],
32	widespread	JJ	O	widespread	amod	35	SENT_162	[p11l414t2826r906b2927],
33	and	CC	O	and	_	0	SENT_162	[p11l944t2826r1102b2905],
34	appropriate	JJ	O	appropriate	conj_and	32	SENT_162	[p11l1139t2827r1634b2927],
35	use	NN	O	use	prep_despite	16	SENT_162	[p11l1673t2853r1813b2905],
36	of	IN	O	of	_	0	SENT_162	[p11l1853t2826r1953b2905],
37	this	DT	O	this	det	38	SENT_162	[p11l1973t2826r2132b2905],
38	information	NN	O	information	prep_of	35	SENT_162	[p11l9t2954r533b3033],
39	in	IN	O	in	_	0	SENT_162	[p11l576t2955r659b3032],
40	patient	NN	O	patient	nn	41	SENT_162	[p11l701t2955r1003b3055],
41	care	NN	O	care	prep_in	38	SENT_162	[p11l1043t2981r1241b3033],
42	.	.	O	.	_	0	SENT_162	[p11l1043t2981r1241b3033],

1	Thus	RB	O	thus	advmod	4	SENT_163	[p11l1286t2954r1523b3050],
2	,	,	O	,	_	0	SENT_163	[p11l1286t2954r1523b3050],
3	there	EX	O	there	expl	4	SENT_163	[p11l1572t2954r1789b3033],
4	are	VBP	O	be	_	0	SENT_163	[p11l1832t2980r1961b3033],
5	advocates	NNS	O	advocate	nsubj	4	SENT_163	[p11l2004t2954r2134b3033, p11l7t3099r320b3161],
6	both	CC	O	both	dep	4	SENT_163	[p11l366t3082r564b3161],
7	for	IN	O	for	_	0	SENT_163	[p11l605t3082r729b3161],
8	the	DT	O	the	det	9	SENT_163	[p11l769t3082r901b3161],
9	introduction	NN	O	introduction	prep_for	4	SENT_163	[p11l943t3082r1483b3161],
10	of	IN	O	of	_	0	SENT_163	[p11l1527t3082r1626b3161],
11	genotyping	VBG	O	genotype	prepc_of	9	SENT_163	[p11l1650t3083r2140b3183],
12	into	IN	O	into	_	0	SENT_163	[p11l11t3211r180b3289],
13	warfarin	NN	O	warfarin	nn	16	SENT_163	[p11l244t3210r949b3311],
14	—	CD	NUMBER	—	num	16	SENT_163	[p11l244t3210r949b3311],
15	dosing	NN	O	dosing	nn	16	SENT_163	[p11l244t3210r949b3311],
16	algorithms	NNS	O	algorithm	prep_into	11	SENT_163	[p11l1011t3210r1483b3311],
17	and	CC	O	and	_	0	SENT_163	[p11l1551t3210r1709b3289],
18	for	IN	O	for	_	0	SENT_163	[p11l1775t3210r1899b3289],
19	randomized	VBN	O	randomize	prepc_for	11	SENT_163	[p11l1962t3236r2135b3289, p11l12t3338r388b3417],
20	clinical	JJ	O	clinical	amod	21	SENT_163	[p11l442t3338r756b3417],
21	trials	NNS	O	trial	nsubj	23	SENT_163	[p11l810t3338r1030b3417],
22	to	TO	O	to	aux	23	SENT_163	[p11l1087t3355r1168b3417],
23	compare	VB	O	compare	xcomp	19	SENT_163	[p11l1225t3364r1594b3439],
24	genotyping	VBG	O	genotype	xcomp	23	SENT_163	[p11l1649t3339r2140b3439],
25	with	IN	O	with	_	0	SENT_163	[p11l7t3466r203b3545],
26	the	DT	O	the	det	27	SENT_163	[p11l245t3466r378b3545],
27	standard	NN	O	standard	prep_with	24	SENT_163	[p11l421t3466r800b3545],
28	of	IN	O	of	_	0	SENT_163	[p11l843t3466r943b3545],
29	care	NN	O	care	prep_of	27	SENT_163	[p11l967t3493r1166b3562],
30	,	,	O	,	_	0	SENT_163	[p11l967t3493r1166b3562],
31	and	CC	O	and	_	0	SENT_163	[p11l1212t3466r1370b3545],
32	both	DT	O	both	det	33	SENT_163	[p11l1412t3466r1610b3545],
33	approaches	NNS	O	approach	nsubjpass	36	SENT_163	[p11l1652t3466r2134b3567],
34	are	VBP	O	be	aux	36	SENT_163	[p11l11t3620r140b3673],
35	being	VBG	O	be	auxpass	36	SENT_163	[p11l181t3594r422b3695],
36	studied	VBN	O	study	conj_and	4	SENT_163	[p11l460t3594r797b3673],
37	.	.	O	.	_	0	SENT_163	[p11l460t3594r797b3673],

1	C.	NNP	PERSON	C.	nn	3	SENT_164	[p12l14t30r93b103],
2	Michael	NNP	PERSON	Michael	nn	3	SENT_164	[p12l137t23r471b103],
3	Stein	NNP	PERSON	Stein	_	0	SENT_164	[p12l511t30r750b117],
4	,	,	O	,	_	0	SENT_164	[p12l511t30r750b117],
5	M.B.	NNP	O	M.B.	nn	7	SENT_164	[p12l795t31r1014b117],
6	,	,	O	,	_	0	SENT_164	[p12l795t31r1014b117],
7	Ch	NNP	O	Ch	appos	3	SENT_164	[p12l1053t23r1280b103],
8	.	.	O	.	_	0	SENT_164	[p12l1053t23r1280b103],

1	B.	NNP	PERSON	B.	nn	4	SENT_165	[p12l1053t23r1280b103],
2	Dan	NNP	PERSON	Dan	nn	4	SENT_165	[p12l20t159r186b231],
3	M.	NNP	PERSON	M.	nn	4	SENT_165	[p12l232t159r334b231],
4	Roden	NNP	PERSON	Roden	_	0	SENT_165	[p12l378t151r672b245],
5	,	,	O	,	_	0	SENT_165	[p12l378t151r672b245],
6	M.D.	NNP	O	M.D.	nn	9	SENT_165	[p12l717t159r923b231],
7	Vanderbilt	NNP	ORGANIZATION	Vanderbilt	nn	9	SENT_165	[p12l9t299r358b360],
8	University	NNP	ORGANIZATION	University	nn	9	SENT_165	[p12l385t305r723b379],
9	School	NNP	ORGANIZATION	School	appos	4	SENT_165	[p12l746t299r969b360],
10	of	IN	ORGANIZATION	of	_	0	SENT_165	[p12l997t299r1070b360],
11	Medicine	NNP	ORGANIZATION	Medicine	nn	12	SENT_165	[p12l1088t299r1393b360],
12	Nashville	NNP	ORGANIZATION	Nashville	prep_of	9	SENT_165	[p12l17t412r340b484],
13	,	,	O	,	_	0	SENT_165	[p12l17t412r340b484],
14	TN	NN	O	tn	appos	4	SENT_165	[p12l366t418r462b472],
15	37232-6602	CD	NUMBER	37232-6602	num	16	SENT_165	[p12l494t416r878b473],
16	michae	NNS	O	micha	dep	17	SENT_165	[p12l15t498r1032b572],
17	|	RB	O	|	amod	14	SENT_165	[p12l15t498r1032b572],
18	.	.	O	.	_	0	SENT_165	[p12l15t498r1032b572],

1	stein@vanderbi	NNS	O	stein@vanderbi	nsubj	2	SENT_166	[p12l15t498r1032b572],
2	|	VBP	O	|	_	0	SENT_166	[p12l15t498r1032b572],
3	t.edu	IN	O	t.edu	prep	2	SENT_166	[p12l15t498r1032b572],

1	Ute	NNP	PERSON	Ute	nn	3	SENT_167	[p12l19t670r164b743],
2	I.	NNP	PERSON	I.	nn	3	SENT_167	[p12l204t670r245b742],
3	Schwarz	NNP	PERSON	Schwarz	_	0	SENT_167	[p12l283t662r667b756],
4	,	,	O	,	_	0	SENT_167	[p12l283t662r667b756],
5	M.D.	NNP	ORGANIZATION	M.D.	nn	9	SENT_167	[p12l712t670r919b742],
6	University	NNP	ORGANIZATION	University	nn	9	SENT_167	[p12l16t816r352b890],
7	ofWestern	NNP	O	ofWestern	nn	9	SENT_167	[p12l375t810r734b871],
8	Ontario	NNP	LOCATION	Ontario	nn	9	SENT_167	[p12l762t815r1022b871],
9	London	NNP	LOCATION	London	dep	3	SENT_167	[p12l17t906r287b977],
10	,	,	O	,	_	0	SENT_167	[p12l17t906r287b977],
11	ON	IN	O	on	_	0	SENT_167	[p12l315t911r427b967],
12	N6A	NN	O	n6a	nn	13	SENT_167	[p12l462t910r605b967],
13	5A5	NN	O	5a5	prep_on	9	SENT_167	[p12l628t910r770b977],
14	,	,	O	,	_	0	SENT_167	[p12l628t910r770b977],
15	Canada	NNP	LOCATION	Canada	dep	3	SENT_167	[p12l798t906r1046b967],

1	1	LS	NUMBER	1	_	0	SENT_168	[p12l13t1097r63b1148],
2	.	.	O	.	_	0	SENT_168	[p12l13t1097r63b1148],

1	Millican	NNP	ORGANIZATION	Millican	nn	2	SENT_169	[p12l138t1090r414b1148],
2	EA	NN	ORGANIZATION	ea	_	0	SENT_169	[p12l447t1095r556b1162],
3	,	,	O	,	_	0	SENT_169	[p12l447t1095r556b1162],
4	Lenzini	NNP	ORGANIZATION	Lenzini	nn	5	SENT_169	[p12l594t1091r842b1148],
5	PA	NN	ORGANIZATION	pa	appos	2	SENT_169	[p12l875t1095r977b1162],
6	,	,	O	,	_	0	SENT_169	[p12l875t1095r977b1162],
7	Milligan	NNP	PERSON	Milligan	nn	8	SENT_169	[p12l1014t1090r1295b1166],
8	PE	NNP	O	PE	appos	2	SENT_169	[p12l1328t1095r1426b1161],
9	,	,	O	,	_	0	SENT_169	[p12l1328t1095r1426b1161],
10	et	FW	O	et	nn	11	SENT_169	[p12l1466t1103r1525b1148],
11	al.	FW	O	al.	appos	2	SENT_169	[p12l1555t1090r1629b1149],
12	.	.	O	.	_	0	SENT_169	[p12l1555t1090r1629b1149],

1	Genetic	JJ	O	genetic	amod	2	SENT_170	[p12l1668t1090r2138b1149],
2	—	NN	O	—	nsubj	3	SENT_170	[p12l1668t1090r2138b1149],
3	based	VBN	O	base	_	0	SENT_170	[p12l1668t1090r2138b1149],
4	dosing	NN	O	dosing	dobj	3	SENT_170	[p12l12t1186r234b1262],
5	in	IN	O	in	_	0	SENT_170	[p12l252t1187r316b1244],
6	orthopedic	JJ	O	orthopedic	amod	7	SENT_170	[p12l337t1186r697b1261],
7	patients	NNS	O	patient	prep_in	3	SENT_170	[p12l716t1187r978b1261],
8	beginning	VBG	O	begin	_	0	SENT_170	[p12l1001t1186r1343b1262],
9	warfarin	NN	O	warfarin	nn	10	SENT_170	[p12l1358t1186r1645b1245],
10	therapy	NN	O	therapy	prep_beginning	7	SENT_170	[p12l1665t1186r1923b1261],
11	.	.	O	.	_	0	SENT_170	[p12l1665t1186r1923b1261],

1	Blood	NN	O	blood	_	0	SENT_171	[p12l1947t1186r2138b1245],
2	2007	CD	DATE	2007	num	1	SENT_171	[p12l11t1286r556b1353],
3	;	:	O	;	_	0	SENT_171	[p12l11t1286r556b1353],
4	110:1511	CD	NUMBER	110:1511	number	5	SENT_171	[p12l11t1286r556b1353],
5	—	CD	NUMBER	—	dep	1	SENT_171	[p12l11t1286r556b1353],
6	5	CD	NUMBER	5	dep	5	SENT_171	[p12l11t1286r556b1353],
7	.	.	O	.	_	0	SENT_171	[p12l11t1286r556b1353],

1	2	LS	NUMBER	2	_	0	SENT_172	[p12l10t1385r64b1436],
2	.	.	O	.	_	0	SENT_172	[p12l10t1385r64b1436],

1	Michaud	NNP	PERSON	Michaud	nn	2	SENT_173	[p12l138t1377r424b1437],
2	V	NNP	PERSON	V	_	0	SENT_173	[p12l453t1382r509b1448],
3	,	,	O	,	_	0	SENT_173	[p12l453t1382r509b1448],
4	Vanier	NNP	O	Vanier	nn	5	SENT_173	[p12l543t1378r755b1436],
5	MC	NNP	O	MC	appos	2	SENT_173	[p12l783t1382r914b1448],
6	,	,	O	,	_	0	SENT_173	[p12l783t1382r914b1448],
7	Brouillette	NNP	PERSON	Brouillette	nn	8	SENT_173	[p12l948t1377r1297b1437],
8	D	NNP	O	D	appos	2	SENT_173	[p12l1328t1382r1380b1435],
9	et	FW	O	et	nn	10	SENT_173	[p12l1412t1390r1472b1436],
10	al.	FW	O	al.	dep	8	SENT_173	[p12l1499t1377r1574b1436],
11	.	.	O	.	_	0	SENT_173	[p12l1499t1377r1574b1436],

1	Combination	NN	O	combination	_	0	SENT_174	[p12l1609t1377r2043b1436],
2	of	IN	O	of	_	0	SENT_174	[p12l2076t1377r2152b1436],
3	phenotype	NN	O	phenotype	nn	4	SENT_174	[p12l10t1473r356b1548],
4	assessments	NNS	O	assessment	prep_of	1	SENT_174	[p12l398t1486r804b1532],
5	and	CC	O	and	_	0	SENT_174	[p12l847t1473r967b1532],
6	CYP2C9	NN	O	cyp2c9	prep_of	1	SENT_174	[p12l1009t1477r1576b1535],
7	.	.	O	.	_	0	SENT_174	[p12l1009t1477r1576b1535],

1	—	NN	O	—	_	0	SENT_175	[p12l1009t1477r1576b1535],
2	.	.	O	.	_	0	SENT_175	[p12l1009t1477r1576b1535],

1	VKORC1	NN	O	vkorc1	nn	2	SENT_176	[p12l1009t1477r1576b1535],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_176	[p12l1616t1473r2136b1548],
3	in	IN	O	in	_	0	SENT_176	[p12l11t1570r74b1627],
4	the	DT	O	the	det	5	SENT_176	[p12l108t1569r209b1628],
5	determination	NN	O	determination	prep_in	2	SENT_176	[p12l243t1569r715b1628],
6	of	IN	O	of	_	0	SENT_176	[p12l748t1569r824b1628],
7	warfarin	NN	O	warfarin	nn	9	SENT_176	[p12l840t1569r1127b1629],
8	dose	NN	O	dose	nn	9	SENT_176	[p12l1160t1569r1309b1628],
9	requirements	NNS	O	requirement	prep_of	5	SENT_176	[p12l1342t1570r1780b1644],
10	in	IN	O	in	_	0	SENT_176	[p12l1815t1570r1878b1627],
11	heavily	RB	O	heavily	advmod	12	SENT_176	[p12l1912t1569r2141b1644],
12	medicated	JJ	O	medicated	amod	13	SENT_176	[p12l11t1665r351b1724],
13	patients	NNS	O	patient	prep_in	2	SENT_176	[p12l375t1666r658b1740],
14	.	.	O	.	_	0	SENT_176	[p12l375t1666r658b1740],

1	Clin	NNP	O	Clin	nn	3	SENT_177	[p12l687t1665r823b1724],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_177	[p12l848t1665r1201b1724],
3	Ther	NNP	O	Ther	_	0	SENT_177	[p12l1224t1665r1378b1724],
4	2008	CD	DATE	2008	num	3	SENT_177	[p12l1402t1669r1881b1736],
5	;	:	O	;	_	0	SENT_177	[p12l1402t1669r1881b1736],
6	83:740	CD	NUMBER	83:740	number	7	SENT_177	[p12l1402t1669r1881b1736],
7	—	CD	NUMBER	—	dep	3	SENT_177	[p12l1402t1669r1881b1736],
8	8	CD	NUMBER	8	dep	7	SENT_177	[p12l1402t1669r1881b1736],
9	.	.	O	.	_	0	SENT_177	[p12l1402t1669r1881b1736],

1	Acute	JJ	O	acute	amod	3	SENT_178	[p12l714t1819r863b1863],
2	Pulmonary	JJ	O	pulmonary	amod	3	SENT_178	[p12l887t1815r1166b1878],
3	Embolism	NN	O	embolism	_	0	SENT_178	[p12l1190t1815r1445b1863],

1	To	TO	O	to	dep	7	SENT_179	[p12l8t2010r121b2065],
2	THE	DT	O	the	det	3	SENT_179	[p12l159t2011r323b2065],
3	EDITOR	NN	O	editor	pobj	1	SENT_179	[p12l370t2010r706b2066],
4	:	:	O	:	_	0	SENT_179	[p12l370t2010r706b2066],
5	We	PRP	O	we	nsubjpass	7	SENT_179	[p12l748t1995r881b2066],
6	were	VBD	O	be	auxpass	7	SENT_179	[p12l920t2013r1122b2066],
7	surprised	VBN	O	surprise	_	0	SENT_179	[p12l1166t1987r1569b2088],
8	that	IN	O	that	complm	13	SENT_179	[p12l1613t1987r1786b2066],
9	the	DT	O	the	det	11	SENT_179	[p12l1824t1987r1956b2066],
10	nephrotic	JJ	O	nephrotic	amod	11	SENT_179	[p12l2000t2013r2132b2066, p12l9t2115r321b2216],
11	syndrome	NN	O	syndrome	nsubjpass	13	SENT_179	[p12l370t2115r793b2216],
12	was	VBD	O	be	auxpass	13	SENT_179	[p12l837t2142r999b2194],
13	omitted	VBN	O	omit	ccomp	7	SENT_179	[p12l1050t2115r1386b2194],
14	from	IN	O	from	_	0	SENT_179	[p12l1434t2115r1644b2194],
15	the	DT	O	the	det	16	SENT_179	[p12l1693t2115r1826b2194],
16	list	NN	O	list	prep_from	13	SENT_179	[p12l1873t2115r2008b2194],
17	of	IN	O	of	_	0	SENT_179	[p12l2052t2115r2152b2194],
18	underlying	VBG	O	underlie	amod	20	SENT_179	[p12l11t2243r476b2344],
19	prothrombotic	JJ	O	prothrombotic	amod	20	SENT_179	[p12l520t2243r1155b2344],
20	conditions	NNS	O	condition	prep_of	16	SENT_179	[p12l1204t2243r1656b2322],
21	in	IN	O	in	_	0	SENT_179	[p12l1706t2244r1789b2321],
22	the	DT	O	the	det	23	SENT_179	[p12l1837t2243r1970b2322],
23	review	NN	O	review	prep_in	20	SENT_179	[p12l2019t2269r2132b2322, p12l7t2372r204b2450],
24	of	IN	O	of	_	0	SENT_179	[p12l256t2371r355b2450],
25	acute	JJ	O	acute	amod	27	SENT_179	[p12l391t2388r612b2450],
26	pulmonary	JJ	O	pulmonary	amod	27	SENT_179	[p12l666t2371r1145b2472],
27	embolism	NN	O	embolism	prep_of	23	SENT_179	[p12l1195t2371r1621b2450],
28	by	IN	O	by	_	0	SENT_179	[p12l1676t2371r1773b2472],
29	Tapson	NNP	PERSON	Tapson	nn	30	SENT_179	[p12l1820t2377r2133b2472],
30	(	NNP	O	(	agent	7	SENT_179	[p12l16t2499r317b2590],
31	March	NNP	DATE	March	tmod	7	SENT_179	[p12l16t2499r317b2590],
32	6	CD	DATE	6	num	31	SENT_179	[p12l349t2505r395b2578],
33	issue	NN	O	issue	dep	7	SENT_179	[p12l426t2500r728b2591],
34	)	CD	NUMBER	)	number	35	SENT_179	[p12l426t2500r728b2591],
35	.1	CD	NUMBER	.1	num	38	SENT_179	[p12l426t2500r728b2591],
36	The	DT	O	the	det	38	SENT_179	[p12l755t2499r915b2578],
37	nephrotic	JJ	O	nephrotic	amod	38	SENT_179	[p12l947t2499r1360b2600],
38	syndrome	NN	O	syndrome	nsubj	41	SENT_179	[p12l1392t2499r1814b2600],
39	is	VBZ	O	be	cop	41	SENT_179	[p12l1845t2500r1911b2578],
40	relatively	RB	O	relatively	advmod	41	SENT_179	[p12l1944t2499r2132b2578, p12l11t2627r234b2728],
41	common	JJ	O	common	rcmod	33	SENT_179	[p12l273t2653r655b2706],
42	in	IN	O	in	_	0	SENT_179	[p12l697t2628r780b2705],
43	comparison	NN	O	comparison	prep_in	41	SENT_179	[p12l822t2628r1332b2728],
44	with	IN	O	with	_	0	SENT_179	[p12l1370t2627r1565b2706],
45	some	DT	O	some	prep_with	41	SENT_179	[p12l1609t2653r1833b2706],
46	of	IN	O	of	_	0	SENT_179	[p12l1876t2627r1976b2706],
47	the	DT	O	the	det	49	SENT_179	[p12l2001t2627r2133b2706],
48	prothrombotic	JJ	O	prothrombotic	amod	49	SENT_179	[p12l9t2755r646b2856],
49	conditions	NNS	O	condition	prep_of	45	SENT_179	[p12l692t2755r1144b2834],
50	listed	VBN	O	list	partmod	49	SENT_179	[p12l1192t2755r1426b2834],
51	by	IN	O	by	_	0	SENT_179	[p12l1473t2755r1570b2856],
52	the	DT	O	the	det	53	SENT_179	[p12l1613t2755r1745b2834],
53	author	NN	O	author	agent	50	SENT_179	[p12l1792t2755r2133b2834],
54	?	.	O	?	_	0	SENT_179	[p12l1792t2755r2133b2834],

1	Thrombotic	JJ	MISC	thrombotic	amod	2	SENT_180	[p12l7t2883r522b2962],
2	events	NNS	O	event	nsubj	12	SENT_180	[p12l563t2900r851b2979],
3	,	,	O	,	_	0	SENT_180	[p12l563t2900r851b2979],
4	including	VBG	O	include	_	0	SENT_180	[p12l897t2883r1307b2984],
5	pulmonary	JJ	O	pulmonary	amod	6	SENT_180	[p12l1343t2883r1822b2984],
6	embolism	NN	O	embolism	prep_including	2	SENT_180	[p12l1859t2883r2132b2962, p12l9t3011r213b3107],
7	,	,	O	,	_	0	SENT_180	[p12l1859t2883r2132b2962, p12l9t3011r213b3107],
8	may	MD	O	may	aux	12	SENT_180	[p12l243t3037r420b3112],
9	be	VB	O	be	cop	12	SENT_180	[p12l441t3011r536b3090],
10	the	DT	O	the	det	12	SENT_180	[p12l561t3011r692b3090],
11	first	JJ	ORDINAL	first	amod	12	SENT_180	[p12l716t3011r896b3090],
12	presentation	NN	O	presentation	_	0	SENT_180	[p12l915t3012r1443b3112],
13	of	IN	O	of	_	0	SENT_180	[p12l1468t3011r1567b3090],
14	the	DT	O	the	det	16	SENT_180	[p12l1574t3011r1704b3090],
15	nephrotic	JJ	O	nephrotic	amod	16	SENT_180	[p12l1729t3011r2134b3112],
16	syndrome	NN	O	syndrome	prep_of	12	SENT_180	[p12l12t3139r449b3240],
17	.	.	O	.	_	0	SENT_180	[p12l12t3139r449b3240],

1	In	IN	O	in	_	0	SENT_181	[p12l486t3147r574b3217],
2	our	PRP$	O	we	poss	3	SENT_181	[p12l607t3165r751b3218],
3	experience	NN	O	experience	prep_in	12	SENT_181	[p12l781t3140r1249b3240],
4	,	,	O	,	_	0	SENT_181	[p12l781t3140r1249b3240],
5	diagnosis	NN	O	diagnosis	nsubjpass	12	SENT_181	[p12l1288t3139r1689b3240],
6	of	IN	O	of	_	0	SENT_181	[p12l1725t3139r1824b3218],
7	the	DT	O	the	det	9	SENT_181	[p12l1838t3139r1969b3218],
8	nephrotic	JJ	O	nephrotic	amod	9	SENT_181	[p12l2002t3165r2132b3218, p12l9t3267r308b3368],
9	syndrome	NN	O	syndrome	prep_of	5	SENT_181	[p12l339t3267r746b3368],
10	is	VBZ	O	be	auxpass	12	SENT_181	[p12l776t3268r839b3346],
11	often	RB	O	often	advmod	12	SENT_181	[p12l872t3267r1086b3346],
12	delayed	VBN	O	delay	_	0	SENT_181	[p12l1117t3267r1422b3368],
13	despite	IN	O	despite	_	0	SENT_181	[p12l1453t3267r1739b3368],
14	the	DT	O	the	det	15	SENT_181	[p12l1770t3267r1898b3346],
15	presence	NN	O	presence	prep_despite	12	SENT_181	[p12l1928t3293r2132b3368, p12l11t3421r194b3474],
16	of	IN	O	of	_	0	SENT_181	[p12l232t3395r332b3474],
17	peripheral	JJ	O	peripheral	amod	18	SENT_181	[p12l351t3395r793b3496],
18	edema	NN	O	edema	prep_of	15	SENT_181	[p12l831t3395r1111b3474],
19	and	CC	O	and	_	0	SENT_181	[p12l1148t3395r1306b3474],
20	abundant	JJ	O	abundant	amod	21	SENT_181	[p12l1344t3395r1756b3474],
21	proteinuria	NN	O	proteinurium	conj_and	18	SENT_181	[p12l1789t3396r2132b3496, p12l11t3524r180b3602],
22	and	CC	O	and	_	0	SENT_181	[p12l204t3523r362b3602],
23	hypoalbuminemia	NN	O	hypoalbuminemia	conj_and	18	SENT_181	[p12l387t3523r1178b3624],
24	at	IN	O	at	_	0	SENT_181	[p12l1201t3540r1280b3602],
25	the	DT	O	the	det	26	SENT_181	[p12l1302t3523r1434b3602],
26	time	NN	O	time	prep_at	12	SENT_181	[p12l1460t3524r1653b3602],
27	of	IN	O	of	_	0	SENT_181	[p12l1680t3523r1779b3602],
28	hospital	NN	O	hospital	nn	29	SENT_181	[p12l1787t3523r2133b3624],
29	admission	NN	O	admission	prep_of	26	SENT_181	[p12l10t3651r466b3730],
30	.	.	O	.	_	0	SENT_181	[p12l10t3651r466b3730],

1	This	DT	O	this	det	2	SENT_182	[p12l495t3651r679b3730],
2	delay	NN	O	delay	nsubj	4	SENT_182	[p12l708t3651r924b3752],
3	may	MD	O	may	aux	4	SENT_182	[p12l946t3677r1123b3752],
4	result	VB	O	result	_	0	SENT_182	[p12l1145t3651r1383b3730],
5	in	IN	O	in	_	0	SENT_182	[p12l1404t3652r1485b3729],
6	further	JJ	O	further	amod	8	SENT_182	[p12l1512t3651r1814b3730],
7	throm	NN	O	throm	nn	8	SENT_182	[p12l1837t3651r2132b3730],
8	—	NN	O	—	prep_in	4	SENT_182	[p12l1837t3651r2132b3730],

1	botic	JJ	O	botic	amod	2	SENT_183	[p13l11t20r220b99],
2	events	NNS	O	event	_	0	SENT_183	[p13l247t37r510b99],
3	or	CC	O	or	_	0	SENT_183	[p13l542t46r630b99],
4	a	DT	O	a	det	5	SENT_183	[p13l656t47r700b99],
5	deterioration	NN	O	deterioration	conj_or	2	SENT_183	[p13l728t20r1285b99],
6	in	IN	O	in	_	0	SENT_183	[p13l1313t21r1396b98],
7	kidney	NN	O	kidney	nn	8	SENT_183	[p13l1424t20r1714b121],
8	function	NN	O	function	prep_in	2	SENT_183	[p13l1738t20r2128b116],
9	,	,	O	,	_	0	SENT_183	[p13l1738t20r2128b116],
10	both	DT	O	both	dep	11	SENT_183	[p13l11t148r209b227],
11	of	IN	O	of	nsubjpass	16	SENT_183	[p13l249t148r350b227],
12	which	WDT	O	which	pobj	11	SENT_183	[p13l367t148r629b227],
13	could	MD	O	could	aux	16	SENT_183	[p13l670t148r905b227],
14	have	VB	O	have	aux	16	SENT_183	[p13l945t148r1134b228],
15	been	VBN	O	be	auxpass	16	SENT_183	[p13l1175t148r1377b227],
16	avoided	VBN	O	avoid	rcmod	8	SENT_183	[p13l1416t148r1803b227],
17	.	.	O	.	_	0	SENT_183	[p13l1416t148r1803b227],

1	-	:	O	-	_	0	SENT_184	[p13l1416t148r1803b227],
2	”	CD	NUMBER	”	num	4	SENT_184	[p13l1416t148r1803b227],
3	Timely	JJ	O	timely	amod	4	SENT_184	[p13l1841t148r2138b249],
4	diagnosis	NN	O	diagnosis	nsubj	10	SENT_184	[p13l11t276r421b377],
5	of	IN	O	of	_	0	SENT_184	[p13l460t276r559b355],
6	the	DT	O	the	det	8	SENT_184	[p13l576t276r709b355],
7	nephrotic	JJ	O	nephrotic	amod	8	SENT_184	[p13l743t276r1157b377],
8	syndrome	NN	O	syndrome	prep_of	4	SENT_184	[p13l1192t276r1615b377],
9	can	MD	O	can	aux	10	SENT_184	[p13l1650t302r1800b355],
10	help	VB	O	help	_	0	SENT_184	[p13l1834t276r2014b377],
11	in	IN	O	in	_	0	SENT_184	[p13l2050t277r2133b354],
12	the	DT	O	the	det	13	SENT_184	[p13l11t404r144b483],
13	identification	NN	O	identification	prep_in	10	SENT_184	[p13l188t404r772b483],
14	of	IN	O	of	_	0	SENT_184	[p13l817t404r917b483],
15	underlying	VBG	O	underlie	prepc_of	13	SENT_184	[p13l943t404r1409b505],
16	glomerular	JJ	O	glomerular	amod	17	SENT_184	[p13l1450t404r1933b505],
17	disease	NN	O	disease	dobj	15	SENT_184	[p13l1976t404r2131b483, p13l11t559r192b611],
18	and	CC	O	and	_	0	SENT_184	[p13l222t532r403b628],
19	,	,	O	,	_	0	SENT_184	[p13l222t532r403b628],
20	where	WRB	O	where	dep	21	SENT_184	[p13l435t532r695b611],
21	appropriate	JJ	O	appropriate	dep	17	SENT_184	[p13l725t533r1243b633],
22	,	,	O	,	_	0	SENT_184	[p13l725t533r1243b633],
23	the	DT	O	the	det	24	SENT_184	[p13l1280t532r1413b611],
24	initiation	NN	O	initiation	dobj	15	SENT_184	[p13l1444t533r1843b611],
25	of	IN	O	of	_	0	SENT_184	[p13l1875t532r1974b611],
26	immunotherapy	NN	O	immunotherapy	prep_of	24	SENT_184	[p13l1987t533r2131b610, p13l11t660r576b761],
27	to	TO	O	to	aux	28	SENT_184	[p13l600t677r681b739],
28	induce	VB	O	induce	infmod	24	SENT_184	[p13l710t660r987b739],
29	remission	NN	O	remission	dobj	28	SENT_184	[p13l1017t661r1431b739],
30	of	IN	O	of	_	0	SENT_184	[p13l1460t660r1559b739],
31	the	DT	O	the	det	33	SENT_184	[p13l1569t660r1699b739],
32	nephrotic	JJ	O	nephrotic	amod	33	SENT_184	[p13l1729t660r2134b761],
33	syndrome	NN	O	syndrome	prep_of	29	SENT_184	[p13l12t788r434b889],
34	and	CC	O	and	_	0	SENT_184	[p13l472t788r630b867],
35	the	DT	O	the	det	38	SENT_184	[p13l667t788r800b867],
36	accompanying	VBG	O	accompany	amod	38	SENT_184	[p13l838t789r1465b889],
37	prothrombotic	JJ	O	prothrombotic	amod	38	SENT_184	[p13l1498t788r2134b889],
38	state	NN	O	state	prep_of	29	SENT_184	[p13l12t933r234b995],
39	.	.	O	.	_	0	SENT_184	[p13l12t933r234b995],

1	Emily	NNP	PERSON	Emily	nn	3	SENT_185	[p13l19t1054r251b1158],
2	P.	NNP	PERSON	P.	nn	3	SENT_185	[p13l288t1061r356b1132],
3	Fraser	NNP	PERSON	Fraser	_	0	SENT_185	[p13l400t1061r686b1147],
4	,	,	O	,	_	0	SENT_185	[p13l400t1061r686b1147],
5	M.B.	NNP	O	M.B.	nn	7	SENT_185	[p13l731t1061r950b1147],
6	,	,	O	,	_	0	SENT_185	[p13l731t1061r950b1147],
7	Ch	NNP	O	Ch	appos	3	SENT_185	[p13l988t1054r1216b1133],
8	.	.	O	.	_	0	SENT_185	[p13l988t1054r1216b1133],

1	B.	NNP	PERSON	B.	nn	4	SENT_186	[p13l988t1054r1216b1133],
2	Colin	NNP	PERSON	Colin	nn	4	SENT_186	[p13l12t1182r232b1261],
3	C.	NNP	PERSON	C.	nn	4	SENT_186	[p13l271t1187r350b1261],
4	Geddes	NNP	PERSON	Geddes	_	0	SENT_186	[p13l388t1182r742b1276],
5	,	,	O	,	_	0	SENT_186	[p13l388t1182r742b1276],
6	M.B.	NNP	LOCATION	M.B.	nn	8	SENT_186	[p13l787t1189r1006b1276],
7	,	,	O	,	_	0	SENT_186	[p13l787t1189r1006b1276],
8	Ch	NNP	O	Ch	appos	4	SENT_186	[p13l1044t1182r1272b1261],
9	.	.	O	.	_	0	SENT_186	[p13l1044t1182r1272b1261],

1	B.	NNP	MISC	B.	nn	4	SENT_187	[p13l1044t1182r1272b1261],
2	Western	NNP	MISC	Western	nn	4	SENT_187	[p13l8t1330r284b1385],
3	Infirmary	NNP	MISC	Infirmary	nn	4	SENT_187	[p13l317t1324r625b1404],
4	Glasgow	NNP	MISC	Glasgow	_	0	SENT_187	[p13l11t1406r299b1486],
5	G11	NN	O	g11	nn	6	SENT_187	[p13l322t1411r446b1467],
6	6NT	NN	O	6nt	dep	4	SENT_187	[p13l475t1411r628b1477],
7	,	,	O	,	_	0	SENT_187	[p13l475t1411r628b1477],
8	United	NNP	LOCATION	United	nn	9	SENT_187	[p13l659t1406r877b1468],
9	Kingdom	NNP	LOCATION	Kingdom	appos	6	SENT_187	[p13l910t1406r1205b1486],
10	emi	FW	O	emi	dep	4	SENT_187	[p13l11t1491r762b1571],
11	|	FW	O	|	nn	13	SENT_187	[p13l11t1491r762b1571],
12	ypf@hotmai	FW	O	ypf@hotmai	nn	13	SENT_187	[p13l11t1491r762b1571],
13	|	NN	O	|	dep	10	SENT_187	[p13l11t1491r762b1571],
14	.	.	O	.	_	0	SENT_187	[p13l11t1491r762b1571],

1	com	NN	O	com	_	0	SENT_188	[p13l11t1491r762b1571],
2	1	CD	NUMBER	1	dep	1	SENT_188	[p13l13t1596r63b1647],
3	.	.	O	.	_	0	SENT_188	[p13l13t1596r63b1647],

1	Tapson	NNP	O	Tapson	nn	2	SENT_189	[p13l138t1593r380b1664],
2	VF	NNP	O	VF	_	0	SENT_189	[p13l402t1594r503b1647],
3	.	.	O	.	_	0	SENT_189	[p13l402t1594r503b1647],

1	Acute	JJ	O	acute	amod	3	SENT_190	[p13l530t1594r717b1648],
2	pulmonary	JJ	O	pulmonary	amod	3	SENT_190	[p13l741t1589r1109b1664],
3	embolism	NN	O	embolism	_	0	SENT_190	[p13l1131t1589r1478b1647],
4	.	.	O	.	_	0	SENT_190	[p13l1131t1589r1478b1647],

1	N	NN	O	n	nn	3	SENT_191	[p13l1506t1594r1563b1648],
2	Engl	NNP	O	Engl	nn	3	SENT_191	[p13l1585t1589r1780b1664],
3	]	NNP	O	]	nsubj	4	SENT_191	[p13l1585t1589r1780b1664],
4	Med	VBD	O	med	_	0	SENT_191	[p13l1802t1589r1945b1647],
5	2008	CD	DATE	2008	dobj	4	SENT_191	[p13l1970t1593r2148b1660],
6	;	:	O	;	_	0	SENT_191	[p13l1970t1593r2148b1660],
7	358:1037	CD	NUMBER	358:1037	number	8	SENT_191	[p13l12t1690r416b1745],
8	—	CD	NUMBER	—	dep	5	SENT_191	[p13l12t1690r416b1745],
9	52	CD	NUMBER	52	dep	8	SENT_191	[p13l12t1690r416b1745],
10	.	.	O	.	_	0	SENT_191	[p13l12t1690r416b1745],

1	2	LS	NUMBER	2	_	0	SENT_192	[p13l10t1789r64b1840],
2	.	.	O	.	_	0	SENT_192	[p13l10t1789r64b1840],

1	Ritz	NNP	PERSON	Ritz	nn	3	SENT_193	[p13l140t1782r275b1844],
2	E.	NNP	O	E.	nn	3	SENT_193	[p13l312t1787r371b1840],
3	The	NNP	O	The	_	0	SENT_193	[p13l411t1782r535b1840],
4	nephrotic	JJ	O	nephrotic	amod	5	SENT_193	[p13l573t1782r893b1857],
5	syndrome	NN	O	syndrome	dep	3	SENT_193	[p13l931t1782r1276b1857],
6	.	.	O	.	_	0	SENT_193	[p13l931t1782r1276b1857],

1	N	NN	O	n	nn	3	SENT_194	[p13l1316t1787r1373b1841],
2	Engl	NNP	O	Engl	nn	3	SENT_194	[p13l1409t1782r1558b1857],
3	J	NNP	O	J	nsubj	4	SENT_194	[p13l1588t1787r1617b1850],
4	Med	VBD	O	med	_	0	SENT_194	[p13l1651t1782r1794b1840],
5	1998	CD	DATE	1998	dobj	4	SENT_194	[p13l1835t1786r2149b1853],
6	;	:	O	;	_	0	SENT_194	[p13l1835t1786r2149b1853],
7	338	CD	NUMBER	338	num	9	SENT_194	[p13l1835t1786r2149b1853],
8	:	:	O	:	_	0	SENT_194	[p13l1835t1786r2149b1853],
9	1202-11	CD	DATE	1202-11	dep	5	SENT_194	[p13l13t1883r284b1938],
10	.	.	O	.	_	0	SENT_194	[p13l13t1883r284b1938],

1	3	LS	NUMBER	3	_	0	SENT_195	[p13l11t1981r62b2033],
2	.	.	O	.	_	0	SENT_195	[p13l11t1981r62b2033],

1	Nandish	JJ	O	nandish	amod	2	SENT_196	[p13l139t1975r420b2033],
2	SS	NN	O	ss	_	0	SENT_196	[p13l449t1979r540b2046],
3	,	,	O	,	_	0	SENT_196	[p13l449t1979r540b2046],
4	Khardori	NNP	PERSON	Khardori	nn	5	SENT_196	[p13l571t1975r872b2035],
5	R	NNP	PERSON	R	appos	2	SENT_196	[p13l896t1980r963b2046],
6	,	,	O	,	_	0	SENT_196	[p13l896t1980r963b2046],
7	Elamin	NNP	PERSON	Elamin	nn	8	SENT_196	[p13l993t1975r1232b2033],
8	EM	NNP	O	EM	appos	5	SENT_196	[p13l1257t1980r1384b2033],
9	.	.	O	.	_	0	SENT_196	[p13l1257t1980r1384b2033],

1	Transient	JJ	MISC	transient	amod	3	SENT_197	[p13l1412t1975r1730b2033],
2	ischemic	JJ	O	ischemic	amod	3	SENT_197	[p13l1752t1975r2045b2033],
3	attack	NN	O	attack	_	0	SENT_197	[p13l2071t1987r2150b2033, p13l11t2072r150b2132],
4	and	CC	O	and	_	0	SENT_197	[p13l178t2072r299b2131],
5	nephrotic	JJ	O	nephrotic	amod	6	SENT_197	[p13l330t2072r650b2148],
6	syndrome	NN	O	syndrome	conj_and	3	SENT_197	[p13l683t2072r1027b2148],
7	:	:	O	:	_	0	SENT_197	[p13l683t2072r1027b2148],
8	case	NN	O	case	nn	9	SENT_197	[p13l1062t2092r1200b2131],
9	report	NN	O	report	dep	3	SENT_197	[p13l1232t2084r1438b2148],
10	and	CC	O	and	_	0	SENT_197	[p13l1465t2072r1586b2131],
11	review	NN	O	review	dep	3	SENT_197	[p13l1618t2072r1834b2132],
12	of	IN	O	of	_	0	SENT_197	[p13l1863t2071r1940b2131],
13	literature	NN	O	literature	prep_of	9	SENT_197	[p13l1956t2072r2150b2131, p13l11t2180r161b2227],
14	.	.	O	.	_	0	SENT_197	[p13l1956t2072r2150b2131, p13l11t2180r161b2227],

1	Am	VBP	O	be	cop	2	SENT_198	[p13l189t2173r352b2236],
2	]	CD	NUMBER	]	_	0	SENT_198	[p13l189t2173r352b2236],
3	Med	JJ	O	med	amod	2	SENT_198	[p13l375t2168r517b2226],
4	Sci	NNP	O	Sci	dep	3	SENT_198	[p13l545t2168r636b2226],
5	2006	CD	DATE	2006	num	4	SENT_198	[p13l662t2172r1140b2239],
6	;	:	O	;	_	0	SENT_198	[p13l662t2172r1140b2239],
7	332:32	CD	NUMBER	332:32	number	8	SENT_198	[p13l662t2172r1140b2239],
8	—	CD	NUMBER	—	dep	2	SENT_198	[p13l662t2172r1140b2239],
9	5	CD	NUMBER	5	dep	8	SENT_198	[p13l662t2172r1140b2239],
10	.	.	O	.	_	0	SENT_198	[p13l662t2172r1140b2239],

1	TO	TO	O	to	aux	3	SENT_199	[p13l10t2457r120b2512],
2	THE	DT	O	the	det	3	SENT_199	[p13l146t2458r307b2512],
3	EDITOR	NN	O	editor	_	0	SENT_199	[p13l341t2457r666b2513],
4	:	:	O	:	_	0	SENT_199	[p13l341t2457r666b2513],
5	Tapson	NNP	PERSON	Tapson	nsubj	19	SENT_199	[p13l696t2440r1005b2535],
6	does	VBZ	O	do	aux	8	SENT_199	[p13l1036t2434r1228b2513],
7	not	RB	O	not	neg	8	SENT_199	[p13l1261t2451r1402b2513],
8	mention	VB	O	mention	dep	3	SENT_199	[p13l1427t2435r1783b2513],
9	concern	NN	O	concern	dobj	8	SENT_199	[p13l1814t2460r2151b2513],
10	about	IN	O	about	_	0	SENT_199	[p13l11t2562r249b2641],
11	deep	JJ	O	deep	amod	13	SENT_199	[p13l273t2562r466b2663],
12	venous	JJ	O	venous	amod	13	SENT_199	[p13l493t2588r779b2641],
13	thromboembolism	NN	O	thromboembolism	prep_about	9	SENT_199	[p13l811t2562r1598b2641],
14	during	IN	O	during	_	0	SENT_199	[p13l1629t2562r1909b2663],
15	pregnancy	NN	O	pregnancy	prep_during	8	SENT_199	[p13l1933t2588r2149b2663, p13l12t2716r261b2791],
16	and	CC	O	and	_	0	SENT_199	[p13l283t2690r442b2769],
17	does	VBZ	O	do	aux	19	SENT_199	[p13l474t2690r669b2769],
18	not	RB	O	not	neg	19	SENT_199	[p13l702t2707r846b2769],
19	discuss	VB	O	discuss	dep	3	SENT_199	[p13l873t2690r1186b2769],
20	certain	JJ	O	certain	amod	21	SENT_199	[p13l1221t2691r1523b2769],
21	speciﬁcs	NNS	O	speciﬁcs	dobj	19	SENT_199	[p13l1556t2690r1930b2791],
22	concerning	VBG	O	concern	_	0	SENT_199	[p13l1964t2716r2149b2769, p13l12t2819r332b2919],
23	this	DT	O	this	det	24	SENT_199	[p13l360t2818r514b2897],
24	disorder	NN	O	disorder	prep_concerning	21	SENT_199	[p13l549t2818r894b2897],
25	in	IN	O	in	_	0	SENT_199	[p13l922t2819r1004b2896],
26	women	NNS	O	woman	prep_in	24	SENT_199	[p13l1031t2844r1341b2898],
27	who	WP	O	who	nsubj	29	SENT_199	[p13l1368t2818r1548b2897],
28	become	VBP	O	become	cop	29	SENT_199	[p13l1581t2818r1903b2897],
29	pregnant	JJ	O	pregnant	rcmod	26	SENT_199	[p13l1933t2844r2149b2919, p13l12t2963r210b3025],
30	with	IN	O	with	_	0	SENT_199	[p13l286t2946r483b3025],
31	the	DT	O	the	det	32	SENT_199	[p13l570t2946r703b3025],
32	use	NN	O	use	prep_with	3	SENT_199	[p13l789t2973r931b3025],
33	of	IN	O	of	_	0	SENT_199	[p13l1018t2946r1119b3025],
34	assisted	JJ	O	assisted	amod	36	SENT_199	[p13l1186t2946r1526b3025],
35	reproductive	JJ	O	reproductive	amod	36	SENT_199	[p13l1611t2946r2150b3047],
36	techniques	NNS	O	technique	prep_of	32	SENT_199	[p13l12t3074r505b3175],
37	.	.	O	.	_	0	SENT_199	[p13l12t3074r505b3175],

1	Although	IN	O	although	mark	3	SENT_200	[p13l534t3074r944b3175],
2	Tapson	NNP	PERSON	Tapson	nsubj	3	SENT_200	[p13l969t3080r1284b3175],
3	cites	VBZ	O	cite	advcl	21	SENT_200	[p13l1312t3075r1502b3153],
4	causes	NNS	O	cause	dobj	3	SENT_200	[p13l1533t3101r1810b3153],
5	of	IN	O	of	_	0	SENT_200	[p13l1841t3074r1941b3153],
6	false	JJ	O	false	amod	11	SENT_200	[p13l1950t3074r2150b3153],
7	positive	JJ	O	positive	amod	11	SENT_200	[p13l11t3203r344b3303],
8	D	NN	O	d	nn	11	SENT_200	[p13l390t3202r754b3281],
9	—	NN	O	—	nn	11	SENT_200	[p13l390t3202r754b3281],
10	dimer	NN	O	dimer	nn	11	SENT_200	[p13l390t3202r754b3281],
11	tests	NNS	O	test	prep_of	4	SENT_200	[p13l795t3219r1015b3298],
12	,	,	O	,	_	0	SENT_200	[p13l795t3219r1015b3298],
13	the	DT	O	the	det	14	SENT_200	[p13l1064t3202r1198b3281],
14	presence	NN	O	presence	nsubjpass	53	SENT_200	[p13l1239t3228r1618b3303],
15	of	IN	O	of	_	0	SENT_200	[p13l1662t3202r1762b3281],
16	D	NN	O	d	nn	18	SENT_200	[p13l1790t3202r2153b3281],
17	—	CD	NUMBER	—	num	18	SENT_200	[p13l1790t3202r2153b3281],
18	dimer	NN	O	dimer	prep_of	14	SENT_200	[p13l1790t3202r2153b3281],
19	during	IN	O	during	_	0	SENT_200	[p13l12t3330r304b3431],
20	pregnancy	NN	O	pregnancy	prep_during	18	SENT_200	[p13l354t3356r811b3431],
21	indicates	VBZ	O	indicate	_	0	SENT_200	[p13l861t3330r1247b3409],
22	coagulation	NN	O	coagulation	nn	23	SENT_200	[p13l1306t3330r1818b3431],
23	activation	NN	O	activation	nsubj	48	SENT_200	[p13l1873t3331r2149b3409, p13l12t3459r183b3537],
24	that	WDT	O	that	nsubj	27	SENT_200	[p13l229t3458r403b3537],
25	is	VBZ	O	be	cop	27	SENT_200	[p13l442t3459r509b3537],
26	actually	RB	O	actually	advmod	27	SENT_200	[p13l557t3458r896b3559],
27	present	JJ	DATE	present	rcmod	23	SENT_200	[p13l936t3475r1258b3559],
28	throughout	IN	O	throughout	_	0	SENT_200	[p13l1299t3458r1795b3559],
29	normal	JJ	O	normal	amod	31	SENT_200	[p13l1836t3458r2152b3537],
30	pregnancy	NN	O	pregnancy	nn	31	SENT_200	[p13l11t3591r522b3687],
31	.1	NN	NUMBER	.1	prep_throughout	27	SENT_200	[p13l11t3591r522b3687],
32	Therefore	RB	O	therefore	advmod	27	SENT_200	[p13l558t3586r1002b3682],
33	,	,	O	,	_	0	SENT_200	[p13l558t3586r1002b3682],
34	during	IN	O	during	_	0	SENT_200	[p13l1048t3586r1340b3687],
35	pregnancy	NN	O	pregnancy	prep_during	27	SENT_200	[p13l1375t3612r1832b3687],
36	and	CC	O	and	_	0	SENT_200	[p13l1868t3586r2027b3665],
37	in	IN	O	in	_	0	SENT_200	[p13l2067t3587r2151b3664],
38	the	DT	O	the	det	40	SENT_200	[p14l12t20r146b99],
39	postpartum	JJ	O	postpartum	amod	40	SENT_200	[p14l186t37r703b121],
40	period	NN	O	period	prep_in	27	SENT_200	[p14l743t20r1045b121],
41	,	,	O	,	_	0	SENT_200	[p14l743t20r1045b121],
42	D	NN	O	d	nn	45	SENT_200	[p14l1095t20r1459b99],
43	—	CD	NUMBER	—	num	45	SENT_200	[p14l1095t20r1459b99],
44	dimer	NN	O	dimer	nn	45	SENT_200	[p14l1095t20r1459b99],
45	testing	NN	O	testing	appos	40	SENT_200	[p14l1498t21r1797b121],
46	may	MD	O	may	aux	48	SENT_200	[p14l1836t46r2016b121],
47	be	VB	O	be	cop	48	SENT_200	[p14l2053t20r2150b99],
48	unhelpful	JJ	O	unhelpful	ccomp	21	SENT_200	[p14l12t148r435b249],
49	and	CC	O	and	_	0	SENT_200	[p14l479t148r638b227],
50	should	MD	O	should	aux	53	SENT_200	[p14l683t148r972b227],
51	not	RB	O	not	neg	53	SENT_200	[p14l1017t165r1160b227],
52	be	VB	O	be	auxpass	53	SENT_200	[p14l1200t148r1297b227],
53	used	VBN	O	use	conj_and	21	SENT_200	[p14l1342t148r1540b227],
54	as	IN	O	as	_	0	SENT_200	[p14l1584t175r1670b227],
55	a	DT	O	a	det	58	SENT_200	[p14l1716t175r1761b227],
56	preliminary	JJ	O	preliminary	amod	58	SENT_200	[p14l1802t148r2149b249, p14l12t302r207b377],
57	laboratory	NN	O	laboratory	nn	58	SENT_200	[p14l233t276r683b377],
58	measure	NN	O	measure	prep_as	53	SENT_200	[p14l711t302r1075b355],
59	for	IN	O	for	_	0	SENT_200	[p14l1108t276r1232b355],
60	the	DT	O	the	det	61	SENT_200	[p14l1261t276r1394b355],
61	presence	NN	O	presence	prep_for	58	SENT_200	[p14l1425t302r1803b377],
62	of	IN	O	of	_	0	SENT_200	[p14l1836t276r1936b355],
63	deep	JJ	O	deep	amod	65	SENT_200	[p14l1950t276r2149b377],
64	venous	JJ	O	venous	amod	65	SENT_200	[p14l7t431r305b484],
65	thromboembolism	NN	O	thromboembolism	prep_of	61	SENT_200	[p14l343t405r1184b484],
66	.	.	O	.	_	0	SENT_200	[p14l343t405r1184b484],

1	Women	NNS	O	woman	nsubj	12	SENT_201	[p14l138t541r472b612],
2	who	WP	O	who	nsubj	4	SENT_201	[p14l519t533r703b612],
3	become	VBP	O	become	cop	4	SENT_201	[p14l756t533r1088b612],
4	pregnant	JJ	O	pregnant	rcmod	1	SENT_201	[p14l1138t550r1535b634],
5	with	IN	O	with	_	0	SENT_201	[p14l1576t533r1773b612],
6	the	DT	O	the	det	7	SENT_201	[p14l1824t533r1958b612],
7	use	NN	O	use	prep_with	4	SENT_201	[p14l2009t560r2150b612],
8	of	IN	O	of	_	0	SENT_201	[p14l12t661r114b740],
9	assisted	JJ	O	assisted	amod	11	SENT_201	[p14l143t661r484b740],
10	reproductive	JJ	O	reproductive	amod	11	SENT_201	[p14l533t661r1072b762],
11	techniques	NNS	O	technique	prep_of	7	SENT_201	[p14l1122t661r1589b762],
12	have	VBP	O	have	_	0	SENT_201	[p14l1641t661r1832b740],
13	an	DT	O	a	det	16	SENT_201	[p14l1881t687r1984b740],
14	increased	VBN	O	increase	amod	16	SENT_201	[p14l2033t662r2149b739, p14l12t789r335b868],
15	thrombophilic	JJ	O	thrombophilic	amod	16	SENT_201	[p14l412t789r1043b890],
16	risk	NN	O	risk	dobj	12	SENT_201	[p14l1119t789r1303b885],
17	,	,	O	,	_	0	SENT_201	[p14l1119t789r1303b885],
18	especially	RB	O	especially	advmod	24	SENT_201	[p14l1386t789r1808b890],
19	if	IN	O	if	dep	24	SENT_201	[p14l1880t789r1958b867],
20	the	DT	O	the	det	23	SENT_201	[p14l2016t789r2150b868],
21	ovarian	JJ	O	ovarian	amod	23	SENT_201	[p14l12t918r327b996],
22	hyperstimulation	NN	O	hyperstimulation	nn	23	SENT_201	[p14l364t917r1098b1018],
23	syndrome	NN	O	syndrome	nsubj	24	SENT_201	[p14l1136t917r1554b1018],
24	occurs	VBZ	O	occur	dep	16	SENT_201	[p14l1592t943r1892b996],
25	.	.	O	.	_	0	SENT_201	[p14l1592t943r1892b996],

1	Deep	JJ	O	deep	amod	3	SENT_202	[p14l1933t924r2149b1018],
2	venous	JJ	O	venous	amod	3	SENT_202	[p14l7t1071r305b1124],
3	thromboembolism	NN	O	thromboembolism	nsubj	12	SENT_202	[p14l366t1045r1183b1124],
4	involving	VBG	O	involve	_	0	SENT_202	[p14l1240t1045r1640b1146],
5	upper	JJ	O	upper	amod	8	SENT_202	[p14l1694t1071r2151b1146],
6	—	NN	O	—	nn	8	SENT_202	[p14l1694t1071r2151b1146],
7	arm	NN	O	arm	nn	8	SENT_202	[p14l1694t1071r2151b1146],
8	veins	NNS	O	vein	prep_involving	3	SENT_202	[p14l7t1174r227b1252],
9	is	VBZ	O	be	cop	12	SENT_202	[p14l262t1174r328b1252],
10	a	DT	O	a	det	12	SENT_202	[p14l364t1200r409b1252],
11	well	RB	O	well	advmod	12	SENT_202	[p14l436t1173r1132b1274],
12	—	JJ	O	—	_	0	SENT_202	[p14l436t1173r1132b1274],
13	recognized	VBN	O	recognize	partmod	12	SENT_202	[p14l436t1173r1132b1274],
14	complication	NN	O	complication	dobj	13	SENT_202	[p14l1166t1173r1797b1274],
15	?	.	O	?	_	0	SENT_202	[p14l1166t1173r1797b1274],

1	In	IN	O	in	_	0	SENT_203	[p14l1830t1181r1920b1251],
2	such	JJ	O	such	pobj	1	SENT_203	[p14l1955t1173r2151b1252],

1	2744	CD	DATE	2744	num	4	SENT_204	[p14l149t1349r226b1371],
2	N	NN	O	n	nn	4	SENT_204	[p14l927t1359r941b1374],
3	ENGLJ	NN	O	englj	nn	4	SENT_204	[p14l955t1359r1033b1381],
4	MED	NN	O	med	_	0	SENT_204	[p14l1048t1359r1100b1374],
5	358	CD	NUMBER	358	dep	4	SENT_204	[p14l1110t1353r1185b1381],
6	;	:	O	;	_	0	SENT_204	[p14l1110t1353r1185b1381],
7	25	CD	NUMBER	25	dep	4	SENT_204	[p14l1110t1353r1185b1381],
8	WWW	NNP	O	WWW	dep	7	SENT_204	[p14l1218t1359r1325b1375],
9	.	.	O	.	_	0	SENT_204	[p14l1218t1359r1325b1375],

1	NE	NNS	O	ne	nsubj	2	SENT_205	[p14l1218t1359r1325b1375],
2	M.ORG	VBP	O	m.org	_	0	SENT_205	[p14l1340t1359r1419b1375],
3	JUNE19	NN	O	june19	dobj	2	SENT_205	[p14l1450t1359r1558b1381],
4	,	,	O	,	_	0	SENT_205	[p14l1450t1359r1558b1381],
5	2008	CD	DATE	2008	appos	3	SENT_205	[p14l1570t1353r1633b1375],

1	The	DT	O	the	det	5	SENT_206	[p14l936t1392r987b1416],
2	New	NNP	O	New	nn	5	SENT_206	[p14l996t1393r1058b1416],
3	England	NNP	O	England	nn	5	SENT_206	[p14l1067t1392r1178b1423],
4	Journal	NNP	O	Journal	nn	5	SENT_206	[p14l1187t1392r1284b1416],
5	o	NN	O	o	_	0	SENT_206	[p14l1294t1400r1309b1416],
6	edicine	NN	O	edicine	dep	5	SENT_206	[p14l1360t1392r1455b1416],

1	Downloaded	VBN	O	download	_	0	SENT_207	[p14l378t1433r548b1456],
2	from	IN	O	from	_	0	SENT_207	[p14l557t1433r622b1456],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_207	[p14l630t1433r749b1463],
4	at	IN	O	at	_	0	SENT_207	[p14l759t1437r782b1456],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_207	[p14l790t1433r973b1456],
6	on	IN	O	on	_	0	SENT_207	[p14l982t1440r1015b1456],
7	January	NNP	DATE	January	prep_on	1	SENT_207	[p14l1023t1433r1126b1463],
8	5	CD	DATE	5	num	7	SENT_207	[p14l1136t1433r1159b1460],
9	,	,	DATE	,	_	0	SENT_207	[p14l1136t1433r1159b1460],
10	2014	CD	DATE	2014	num	7	SENT_207	[p14l1169t1433r1242b1456],
11	.	.	O	.	_	0	SENT_207	[p14l1169t1433r1242b1456],

1	For	IN	O	for	_	0	SENT_208	[p14l1252t1433r1299b1456],
2	personal	JJ	O	personal	amod	3	SENT_208	[p14l1307t1433r1419b1463],
3	use	NN	O	use	pobj	1	SENT_208	[p14l1428t1440r1472b1456],
4	only	RB	O	only	advmod	3	SENT_208	[p14l1481t1433r1546b1463],
5	.	.	O	.	_	0	SENT_208	[p14l1481t1433r1546b1463],

1	No	DT	O	no	det	3	SENT_209	[p14l1557t1433r1596b1456],
2	other	JJ	O	other	amod	3	SENT_209	[p14l1606t1433r1674b1456],
3	uses	NNS	O	use	_	0	SENT_209	[p14l1683t1440r1739b1456],
4	without	IN	O	without	_	0	SENT_209	[p14l1749t1433r1850b1456],
5	permission	NN	O	permission	prep_without	3	SENT_209	[p14l1858t1433r2011b1463],
6	.	.	O	.	_	0	SENT_209	[p14l1858t1433r2011b1463],

1	Copyright	NN	O	copyright	_	0	SENT_210	[p14l729t1474r863b1505],
2	©	CD	NUMBER	©	num	6	SENT_210	[p14l872t1474r896b1498],
3	2008	CD	DATE	2008	num	6	SENT_210	[p14l906t1474r970b1498],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_210	[p14l980t1474r1171b1498],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_210	[p14l1181t1474r1289b1498],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_210	[p14l1300t1474r1405b1505],
7	.	.	O	.	_	0	SENT_210	[p14l1300t1474r1405b1505],

1	All	DT	O	all	det	2	SENT_211	[p14l1416t1474r1457b1498],
2	rights	NNS	O	rights	nsubj	3	SENT_211	[p14l1466t1474r1541b1505],
3	reserved	VBN	O	reserve	_	0	SENT_211	[p14l1551t1474r1669b1498],
4	.	.	O	.	_	0	SENT_211	[p14l1551t1474r1669b1498],

